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3D IMAGING FOR PLANNING OF MINIMALLY INVASIVE
SURGICAL PROCEDURES

UMA NUMBURI
ABSTRACT

Novel minimally invasive surgeries are used for treating cardiovascular diseases
and are performed under 2D fluoroscopic guidance with a C-arm system. 3D multidetector row computed tomography (MDCT) images are routinely used for preprocedural
planning and postprocedural follow-up.
For preprocedural planning, the ability to integrate the MDCT with fluoroscopic
images for intraprocedural guidance is of clinical interest. Registration may be facilitated
by rotating the C-arm to acquire 3D C-arm CT images. This dissertation describes the
development of optimal scan and contrast parameters for C-arm CT in 6 swine. A 5-s
ungated C-arm CT acquisition during rapid ventricular pacing with aortic root injection
using minimal contrast (36 mL), producing high attenuation (1226), few artifacts (2.0),
and measurements similar to those from MDCT (p>0.05) was determined optimal. 3D
MDCT and C-arm CT images were registered to overlay the aortic structures from
MDCT onto fluoroscopic images for guidance in placing the prosthesis. This work also
describes the development of a methodology to develop power equation (R2>0.998) for
estimating dose with C-arm CT based on applied tube voltage. Application in 10 patients
yielded 5.48±2.02 mGy indicating minimal radiation burden.
v

For postprocedural follow-up, combinations of non-contrast, arterial, venous
single energy CT (SECT) scans are used to monitor patients at multiple time intervals
resulting in high cumulative radiation dose. Employing a single dual-energy CT (DECT)
scan to replace two SECT scans can reduce dose. This work focuses on evaluating the
feasibility of DECT imaging in the arterial phase. The replacement of non-contrast and
arterial SECT acquisitions with one arterial DECT acquisition in 30 patients allowed
generation of virtual non-contrast (VNC) images with 31% dose savings. Aortic luminal
attenuation in VNC (32±2 HU) was similar to true non-contrast images (35±4 HU)
indicating presence of unattenuated blood. To improve discrimination between calcium
and iodine, a combined basis spectral and material analysis was developed. The algorithm
differentiated calcium and iodinated pixels in phantom experiments and measured the
mass fraction within 3%. Application in a patient resulted in VNC images with luminal
attenuation of 57 HU indicating removal of contrast. However, high attenuating pixels
with low density values appeared with decreased intensity in VNC images.
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1.

CHAPTER I
INTRODUCTION

Diseases of the aorta such as aneurysm, dissections, ruptures, atherosclerotic
ulcers, and degenerative valvular stenosis are a major problem in industrialized nations
[1-3]. Visualization of the cardiac anatomy is critical for diagnosis, treatment planning
and follow-up in these cases. Traditionally, chest radiography, echocardiography and Xray angiography (using C-arm system) have been used as primary imaging modalities in
the evaluation of these patients. However, these imaging techniques allow only twodimensional (2D) viewing, thus limiting visualization of the lumen and changes in the
vessel wall. Three-dimensional (3D) imaging provides not only precise visualization of
the complex anatomy in physiological conditions, but also allows the measurement of
critical structural and functional parameters. Typically, 3D images are acquired using
multi-detector-row computed tomography (MDCT), magnetic resonance imaging (MRI)
and ultrasound (US). Short examination times, ease of scanning and minimum
dependence on the technologist, along with rapid developments in technology allow
MDCT imaging from pre-operative planning to intra-operative guidance to post-operative
evaluation. Intravenous injection of iodinated contrast medium is required with MDCT to
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opacify the blood pool and visualize the chambers of the heart, great vessels, and
coronary arteries as well as distinguish different parts of cardiac anatomy.
Preprocedural imaging with contrast-enhanced single-energy MDCT plays a vital
role in planning for novel transcatheter and minimally invasive procedures like
percutaneous coronary interventions (PCI), aortic endovascular aneurysm repair (EVAR),
and transcatheter aortic valve implantation (TAVI) by identifying optimal anigographic
views required for the procedure and optimal device size required for the patient [1-10].
Integration of this 3D data into the procedure and overlaying these 3D MDCT images
with the two-dimensional (2D) fluoroscopy images obtained from a C-arm system allows
real-time guidance for more accurate and safer interventions. The use of MDCT data
further enables new approaches for development of devices [11]. However, the direct use
of MDCT images in this way has been limited because of registration challenges between
3D MDCT and 2D fluoroscopic images. By rotating a C-arm system around the patient,
3D images (aka, C-arm CT images) can be acquired in the catheterization laboratory. The
3D images from C-arm CT and preprocedural MDCT can then be registered to facilitate
overlay of the MDCT images onto the live 2D fluoroscopic images for guidance.
In this thesis, optimal contrast and scan protocols for obtaining C-arm CT images
in the context of TAVI were systematically determined in a swine model and image
measurements were compared with those obtained from MDCT. Then, the utility of
overlaying 3D preprocedural MDCT images onto real-time 2D fluoroscopy images for
intraprocedural guidance during TAVI was evaluated, and the feasibility of making postTAVI measurements from C-arm CT images assessed. Finally, a procedure was
developed to obtain a C-arm CT dose metric to estimate the radiation burden with 3D C2

arm acquisition.
MDCT is also routinely used for follow-up of patients after the interventional
procedure to insure accurate placement of the prosthetic valves/stents and their long-term
results [2, 3, 12-14]. In the context of EVAR, triple phase single-energy CT (SECT) is
often used to evaluate patients 1 month, 6 months, and yearly after such repairs [13]. The
combination of non-contrast, arterial phase, and venous phase SECT images is used to
evaluate aneurysm size, stent-graft position and patency, perigraft flow (endoleaks), graft
fractures and kinks, and the patency of native vessels near the graft [2, 3, 12-14]. Of
concern is the high cumulative radiation dose to the patient resulting from three-phase
imaging in multiple follow-up examinations [15-17].
In an attempt to decrease radiation dose, two SECT acquisitions can be replaced
with one dual-energy CT (DECT) acquisition [18, 19]. At DECT, data acquisition at two
x-ray energies is followed by the reconstruction of corresponding image sets with
different attenuation properties [20-23]. DECT data obtained during or after contrast
injection can be used to generate not only arterial and venous phase images but also
virtual non-contrast (VNC) images [18, 19, 22, 24]. Hence, another objective of this
study was to evaluate the feasibility of using arterial DECT imaging to generate VNC
images. However, the presence of high-density iodinated contrast medium adjacent to
other high-density materials, such as a stent and calcium, and, in many cases, the lack of
uniformity of contrast attenuation along the length of the aorta increase the challenge of
generating VNC CT images from arterial DECT data.
During arterial phase contrast medium protocol, which is defined by the volume,
flow rate, iodine concentration, and injection timing (relative to the start of the scan) of
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contrast, can be controlled to influence contrast enhancement. The same contrast
injection protocol is used for all patients undergoing CT for a particular clinical
indication. However, the patient response to the contrast injection and the resulting
enhancement of the vessel of interest is affected by a multitude of patient specific
parameters, such as weight, height, gender and cardiac condition [4]. Consequently,
cardiac enhancement can vary widely within patients with a standardized protocol and
can result in non-uniform enhancement, which causes problems in the generation of VNC
CT images with DECT imaging. Therefore, an advanced injection protocol may be
required to consistently achieve prolonged, uniform vascular enhancement. Although
various modeling techniques have been used to develop contrast injection protocols for
SECT cardiovascular imaging [25-27], these advanced profiles focused on imaging with
single or 16- detector row CT imaging. With rapid improvements in scanner technology,
the scan acquisition time for the latest generation MDCT scanners has decreased
drastically [28]. Moreover, no studies to date have investigated the impact of contrast
optimization during arterial phase DECT imaging. A part of the evaluation of the
feasibility of using arterial DECT to generate VNC images included development of an
algorithm to determine contrast protocols for achieving uniform enhancement during
DECT imaging to improve VNC generation.
This dissertation is organized as background (chapters II-V), hypothesis and
specific aims of the thesis (chapter VI), pilot studies performed for the specific aims
(chapter VII) and implementation of each specific aim (chapters VIII-XI). Chapter II
describes the structure of the heart and its functions. Chapter III explains the
cardiovascular diseases and the paradigm shift in treating patients with safe and efficient
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minimally invasive surgeries. Chapter IV focuses on the basic principles of x-ray based
imaging modalities that are routinely used for planning, guidance and follow-up of the
minimally invasive surgeries. Chapter V shows a thorough literature review of the
extensive work done so far in the use of the imaging modalities for different minimally
invasive surgeries along with the limitations of the studies. Chapter VI describes the
hypothesis and specific aims of this thesis and chapter VII describes the preliminary
studies done in order to develop the imaging and contrast protocols for the specific aims.
Chapter VIII describes specific aim 1 showing the feasibility of arterial phase
DECT imaging to generate VNC images using three-material decomposition algorithm
for follow-up of 30 patients post-EVAR. The study also shows the limitations in VNC
generation due to non-uniform arterial enhancement, false identification of high-density
substances like iodine and stent as contrast agent with the three-material decomposition.
This chapter has been published as “Feasibility of dual-energy CT in the arterial phase:
Imaging after endovascular aortic repair” in American Journal of Roentgenology in 2010.
Chapter IX describes specific aim 2, suggesting improvements in VNC image generation
with use of optimized contrast protocols developed using linear-time invariant modeling
in time domain, three-material decomposition algorithm using basis spectral and basis
material analysis, and employing spectrally well separated x-ray tube voltages for DECT
imaging.
Chapter X, in fulfillment of specific aim 3, focuses on the determination of
optimal contrast and imaging protocols for obtaining C-arm CT images before TAVI in a
swine model and the comparison of the resulting image measurements with those
obtained from MDCT. The study shows that an ungated C-arm CT acquisition during
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rapid pacing with aortic root injection is optimal for evaluation and measurement preTAVI in swine and allows overlaying MDCT on fluoroscopic images for intraprocedural
guidance and finally the assessment of valve position post-TAVI in the interventional
suite. The contents of this chapter has been submitted as a manuscript titled
“Optimization of Acquisition and Contrast-Injection Protocol for C-arm CT Imaging in
Transcatheter Aortic Valve Implantation: Initial Experience in a Swine Model” to Journal
of the American College of Cardiology: Cardiovascular Imaging and is currently under
review. Chapter XI describes development of a procedure to obtain a C-arm CT dose
metric to estimate the radiation burden with 3D C-arm acquisition along with
implementation in patients for dose measurement.
This dissertation concludes with a brief summary of the findings of the research
and its relevance followed by possible future studies. The appendices include the Matlab
programs for patient-specific contrast agent optimization, combined basis spectral and
basis material algorithm for VNC generation, implementation of Savitzky-Golay filter for
simulating dose measurements with C-arm CT experiments, and a potential manuscript
describing development of linear-time invariant modeling for contrast agent optimization
in time domain and predictions of contrast protocols for fast MDCT scans.
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2.

CHAPTER II

THE HEART AND GREAT VESSELS

2.1 Anatomy
The heart is a hollow, conically shaped muscular organ located between the lungs
and enclosed in the cavity of pericardium. The pericardium is a conical membranous sac
in which the heart and the origin of the great vessels are contained [29]. The heart is
subdivided by a muscular septum into right and left lateral halves. A transverse
constriction subdivides each half of the organ into two cavities; the upper cavity on each
side being the atrium and the lower, the ventricle [29].
Three heart is composed of three layers namely, the epicardium or external layer,
the myocardium or middle layer and the endocardium or inner layer. The myocardium
comprises of cardiac muscle tissues and causes the contraction of the heart [29].
Aorta is the largest artery that channels the oxygenated blood to other arterial
branches for supplying nutrients to the tissues of the body. It originates at the upper part
of the left ventricle with a diameter of approximately 3 cm, continues in cranial direction
for a short distance, arches backward to the left side, descends within the thorax to pass
into the abdominal cavity and finally ends near the fourth lumbar vertebra with
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approximately 1.75 cm diameter by dividing into the right and left common iliac arteries
[29].
The aorta can be described based on the location. The portion of the aorta from
the left ventricle extending in the cranial direction is termed as the ascending aorta (AA)
and is approximately 5 cm in length [29]. The three aortic sinuses are present as small
dilatations at the origin of AA opposite to the segments of the aortic valve (Figure 2-1).
Additionally, the two coronary arteries that provide blood supply to the heart also arise
near the commencement of the AA above the margins of the valves. The arch of aorta,
also known as the traverse aorta is the portion that begins after the ascending aorta and
runs cranially and then moves caudally eventually becoming the descending aorta [29].
The descending aorta is further divided into the thoracic and abdominal aorta depending
on its location in the trunk cavity.
The aorta is composed of three layers of tissue: intima, media and adventitia. The
intima is the innermost thin layer lined with endothelial cells. The media is the middle
and thickest layer and consists of layers of elastic tissue. This composition provides the
tensile strength to the aorta. The adventitia is the outermost layer and is composed of
collagen material. This layer contains a network of small blood vessels that supply blood
to the aortic wall.
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Figure 2-1: Schematic of the aorta.

The aortic valve consists of three thin, crescent-shaped cusps, and lies between
the left ventricle and aorta. The three cusps move outwards toward aorta in their open
position and come together to shut the aortic orifice in their closed position. The cusps
are controlled by the pouches of the aortic root called the sinus of valsalva that are
located behind the cusps.

2.2 Function
The heart is a positive displacement pump responsible for blood circulation to the
various organs in the body. The left side of the heart pumps oxygenated blood to the
body, while the right side of the heart pumps deoxygenated blood to the lungs. The
supply of blood to the heart and the body constitutes the systemic circulatory system; the
9

blood flow to the lungs comprises the pulmonary circulatory system. The cardiac cycle
consists of two major functional periods: diastole (ventricular relaxation and filling) and
systole (ventricular contraction and ejection) [29]. In diastole, blood from the right and
left atria enters the right and left ventricles, respectively. In systole, the ventricles
contract and blood is ejected from the right ventricle into the main pulmonary artery and
from the left ventricle into the aorta.
Deoxygenated blood from the body enters the right atrium (RA) through the
superior vena cava (SVC) and inferior vena cava (IVC) (Figure 2-2). The RA contracts to
fill the right ventricle, which then ejects the blood into the lungs. The oxygenated blood
from the lungs enters the left atrium (LA). The LA contracts to fill the left ventricle,
which then pumps blood to the rest of the body through the aorta. Four one-way valves
regulate flow through the heart. Two of these valves, the mitral valve on the left side and
the tricuspid valve on the right side, are located between the atria and the ventricles. The
aortic valve is located between the left ventricle and the aorta, while the pulmonary valve
is located between the right ventricle and the pulmonary artery. With the exception of the
mitral valve, which is a bileaflet valve, the other heart valves are trileaflet valves.
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Figure 2-2: Schematic of the heart.
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3.

CHAPTER III

MINIMALLY INVASIVE CARDIOVASCULAR SURGERIES

Minimally invasive cardiovascular surgeries represent a paradigm shift in treating
patients with cardiovascular diseases. With the rapid development of technology and
improvements in techniques, minimally invasive surgeries have evolved into an
alternative treatment option to traditional open surgery in suitable patients. Minimally
invasive procedures like percutaneous coronary interventions (PCI), endovascular
aneurysm repair (EVAR), transcatheter aortic valve implantation (TAVI) are few
techniques currently used for treating specific cardiovascular diseases like coronary
artery aneurysms, aortic aneurysms and valve repairs by providing greater patient
comfort and recovery with fewer complications. Some of the cardiovascular diseases and
the minimally invasive surgical procedures used for treatment of these diseases are
discussed in this chapter.
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3.1 EVAR
3.1.1

Thoracoabdominal Aneurysm
Thoracoabdominal aortic aneurysms are frequently caused by atherosclerosis [30,

31]. The aneurysms are typically categorized as true or false depending on their
pathologic features [30]. In true aneurysms, all three layers of the aortic wall (intima,
media and adventitia) form the aneurysm, while in false aneurysm, the intima and/or
media may be disrupted leaving the blood in the adventitia layer [32]. Thoracoabdominal
aneurysms have been classified into four types on the basis of their anatomic location
[33]. Type I aneurysm includes the descending thoracic aorta and the upper abdominal
aorta; type II involves both the descending thoracic and abdominal aorta. Type III
aneurysm occurs only in the lower portion of the thoracic aorta and type IV aneurysm
starts at the diaphragm and continues in the caudal direction. MDCT is the most
commonly used modality for diagnosis and treatment planning of aortic aneurysms
followed by transesophageal echocardiography (TEE), MRI and aortography [34].

3.1.2

Management of Thoracoabdominal Aneurysm
Traditionally, surgical intervention was required for treatment of aortic aneurysms

[34]. The choice of surgical techniques depends on the extent of disease, patient age,
long-term anticoagulation therapy, state of the native aortic tissues, status of the aortic
valve, prior aortic surgeries [1, 3]. However, a paradigm shift has occurred with the
emergence of aortic endovascular stent procedures. EVAR has become a reliable
alternative to open surgery for thoracic, thoracoabdominal and abdominal aortic
13

aneurysm treatment [35-37]. During EVAR, an endograft, or stent is placed in the
aneurysm of the aorta. Preprocedural arterial 3D imaging is required to ensure fitting of
the stent in the aneurysm, without blocking flow in the branching vessels. This requires
accurate details of the size, length, wall characteristics of the aneurysm along with
location and rotation angle of the visceral arteries relative to the aorta and other branches.
In addition to device placement, the 3D images are also used for optimizing device
selection specific to a patient using computational modeling. EVAR is associated with
lower morbidity and mortality rates than open surgical repair, along with reduced stay in
the hospital after the procedure [38]. After stent placement, triple-phase SECT is often
used to monitor patients 1 month, 6 months, and yearly [13]. Combinations of the three
phases, namely the pre-contrast (non-contrast), contrast-enhanced (arterial) and postcontrast (venous) SECT images is used to evaluate aneurysm size, stent-graft position
and patency, perigraft flow (endoleaks), graft fractures/kinks, and the patency of native
vessels near the graft [2, 3, 12-14].

3.2 TAVI
3.2.1

Aortic Stenosis
Aortic stenosis is the most frequent native valvular heart disease [39-42] with a

significant impact on cardiovascular mortality and morbidity [40, 41, 43]. Degenerative
aortic valve calcification is an active process similar to atherosclerosis [44-46].
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3.2.2

Management of Aortic Stenosis
Due to the lack of any pharmacological therapy for treating the stenosis [47-50],

traditional open-heart surgical aortic valve replacement (SAVR) is considered as an
effective treatment for advanced disease state in suitable patients [51]. However, for
high-risk patients with unstable hemodynamics or multiple co-morbidities [52-55], lessinvasive interventional procedures like balloon aortic valvuloplasty (BAV) may be
performed. Even though BAV provides temporary relief to patients, restenosis develops
within 6-12 months after the procedure [56, 57]. TAVI is considered a viable option in
these patients, where valve prosthesis is implanted on the existing native valve using
transfemoral, transapical or transseptal methods [58-64]. Current results from clinical
trials show a high success rate and clinical improvement in patients after the procedure
[65-67].
To eliminate complications like vascular injury during device positioning,
coronary artery occlusion, arrhythmias, prosthetic embolization, and imprecise
positioning of the prosthesis (currently available vales cannot be repositioned), it is
critical to perform preprocedural imaging for accurate knowledge of the anatomy and
functionality of the cardiovascular structures and valves. Currently, TEE and cardiac
catheterization are used for image guidance during TAVI. However, these are limited to
2D views of the anatomy. Recently, MDCT has been used routinely to image patients
before TAVI to provide three-dimensional (3D) information on valve morphology,
function, and the extent and location of aortic valve calcifications, in addition to the
vascular access, including calcifications and tortuosity of the aorta and ilio-femoral
arteries, used for the delivery of the prosthesis in these patients. Preprocedural MDCT
15

images also help to accurately determine the relationship between the aortic annulus and
the ostium to avoid complications of TAVI and plan for the procedures [10, 68].
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4.

CHAPTER IV

X-RAY BASED IMAGING

Visualization of the cardiovascular anatomy is critical for planning and follow-up
of minimally invasive surgeries. Traditionally, chest radiography, echocardiography and
X-ray angiography (using C-arm system) have been used as primary imaging modalities
in these procedures. However, these techniques allow only two-dimensional (2D)
viewing, thus limiting visualization of the lumen and changes in the vessel wall. In these
cases, three-dimensional (3D) imaging provides not only precise visualization of the
complex anatomy in physiological conditions, but also allows the measurements of
critical structural and functional parameters. Typically, 3D images are acquired using
multi-detector-row computed tomography (MDCT), magnetic resonance imaging (MRI)
and ultrasound (US). Minimally invasive surgeries rely on using X-ray based imaging for
planning, guidance and follow-up. The technique and basic principles of X-ray based 2D
and 3D imaging modalities are discussed in this chapter.
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4.1 X-ray Physics
4.1.1

X-ray Tube
X-rays are a form of electromagnetic radiation, produced when a fast moving

stream of highly energetic electrons collide with a target metal to convert their kinetic
energy into electromagnetic radiation. The basic elements of an x-ray tube are shown in
Figure 4-1. The x-ray tube consists of a glass tube with two electrodes (the cathode and
the anode) enclosed in vacuum.

Figure 4-1: Components of an x-ray tube required for x-ray production.

The cathode is the negative terminal of the x-ray tube consisting of a helical
filament, which is the source of electrons surrounded by a focusing cup. It also contains
two wires that heat the filament. The heated filament releases electrons by thermionic
emission (emission of electrons due to absorption of thermal energy). The anode is the
positive metal target electrode of the tube. Tungsten is typically used as the anode
material because of the high atomic number and high melting point that allow efficient
production of x-rays and high absorption of heat, respectively. With the application of a
high potential difference (or voltage) between the two electrodes, electrons produced at
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the cathode accelerate towards the anode. Once the electrons strike the target anode, 99%
of the kinetic energy of the electrons gets converted into heat and the remaining 1% gets
transformed into x-rays. The presence of vacuum in the x-ray tube allows independent
control of the number and speed of the accelerated electrons. Critical modifiable
parameters associated with x-ray production include tube voltage and tube current.

4.1.1.1 Tube Voltage
Tube voltage is defined as the potential difference applied between the cathode
and the anode in the x-ray tube to allow the flow of electrons from the former to the latter
[69]. It is typically expressed as the peak voltage applied across the x-ray tube. For
example, 100 kVp indicates that a maximum voltage of 100,000 V is applied across the
tube to accelerate the electrons and the applied voltage fluctuates between some lower
value and the maximum value. An increase in the tube voltage improves the quality of the
x-rays and enables them to penetrate tissue more easily and reach the detector, thus
increasing the signal to noise ratio (SNR) [69]. However, this also increases the radiation
dose proportional to square of the increase in tube voltage [69].

4.1.1.2 Tube Current
Tube current refers to the number of electrons flowing from the cathode to the
target anode per second and is measured in milliamperes (mA) [69]. An increase in the
tube current proportionally increases the number of electrons (quantity) in the x-ray tube
and enables more x-rays to penetrate tissue and reach the detector. This results in an
improvement in SNR and a directly proportional increase in radiation dose [69].
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4.1.2

X-ray Generation
X-rays are generated through two electronic processes: bremsstrahlung and

characteristic x-ray spectrum.
4.1.2.1 Bremsstrahlung Radiation
The Bemsstrahlung radiation is produced when the electrons from the cathode
interact with the nucleus of the target anode. The coulombic forces attract the electron
towards the positively charged nucleus of the target. The electron gets decelerated and
changes in its trajectory. This results in the loss of a part or all of the electron’s kinetic
energy along with the production of an x-ray photon with equivalent energy. The distance
between the electron and nucleus determines the energy of the x-ray. When the distance
is the largest, the coulombic forces of attraction are the weakest resulting in the
production of the lowest energy x-rays. As the distance decreases, the x-ray energy
increases (Figure 4-2) and the highest energy x-rays are produced when the electron
directly impacts the nucleus.
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Figure 4-2: Production of bremmstrahlung spectrum and impact of subatomic distance
between the nucleus and electrons on the production of the energy of x-rays. Adapted
from Bushberg et al [69].

Due to the relatively empty space and the small subatomic distances in the atom,
the probability of a direct interaction between the electron and nucleus is extremely low.
Hence, a greater number of low-energy x-rays are produced as compared to high-energy
x-rays in a bremmstrahlung spectrum (distribution of x-ray photons with respect to
energy) [69]. The unfiltered spectrum shows a linear decrease in the production of x-rays
with energy up to the highest energy determined by the peak tube voltage applied
between the electrodes in the x-ray tube (Figure 4-3) [69]. With the filtered
bremmstrahlung spectrum, the lower-energy x-rays are removed and the average x-ray
energy varies between one third to one half of the maximum x-ray energy (Figure 4-3).

Figure 4-3: The bremmstrahlung spectrum for a 90 kVp peak voltage. The unfiltered
spectrum shows the linear decrease of x-rays with energy up to the maximum energy of

21

90 keV. The filtered spectrum shows the preferential absorption of x-rays below 10 keV.
Adapted from Bushberg et al [69].

4.1.2.2 Characteristic Radiation
Characteristic radiation occurs when an electron strikes the target and releases
electrons from the inner orbitals of the target atoms. The ejection of the electron creates a
positively ionized target atom, which subsequently releases the excess energy to return to
its original state either by removing an additional electron called Auger electron, or by
emitting an x-ray with the excess energy. The characteristic radiation contains only xrays at discrete energies uniquely associated with the binding energy of the ionized atom
of the target material.
Each atom has different shells (K, L, M etc) with distinct binding energies. When
an electron strikes the target anode with energy greater than the binding energy of a shell
in the target atom, the electron from the shell gets ejected resulting in an unstable ionized
atom. An electron from a higher level with lower binding energy fills the vacant orbital
releasing a characteristic x-ray with energy equivalent to the difference between the
binding energies of the two shells (Figure 4-4).
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Figure 4-4: Generation of characteristic x-rays. (1) The incident electron with energy
greater than the binding energy of the electron in the K-shell ejects the electron from the
shell. (2) This creates an unstable positive ion. (3) The electron from the adjacent L-shell
fills in the vacancy in the K-shell. (4) The electron transition causes the emission of
characteristic x-ray with energy equivalent to the difference between the binding energies
of K and L shells. Adapted from Bushberg et al [69].

This can also lead to a cascade of electron transitions producing x-rays at discrete
energies (depending on the difference of the binding energies of the shells) that are
characteristic of the target material. The characteristic x-rays produced in the diagnostic
imaging range are primarily due to vacancies in the K-shell. For example, in the filtered
spectrum from a tungsten target, a Kα characteristic x-ray at 59.3 keV is seen that
corresponds to the difference between the binding energies of the K and L shells (Figure
4-5).

23

Figure 4-5: The filtered bremsstrahlung and characteristic x-ray spectrum of tungsten
material obtained at 90 kVp tube voltage. The curve shows the filtering of low-energy
photons below 10 keV in the bremmstrahlung spectrum superimposed with the
characteristic x-rays from Kα1, Kα2, and Kβ1 transitions at 59.3, 57.9 and 67.2 keV.
Adapted from Bushberg et al [69].

4.1.3

X-ray Interaction with Matter
X-rays interact with matter in different ways: Rayleigh scattering, Compton

scattering, photoelectric absorption, pair production, or photodisintegration. In the range
of diagnostic energy (< 150 keV), x-rays primarily interact with the orbital electrons of
the atoms and can cause disruption of the atomic structure of the tissue. Rayleigh
scattering and compton scattering and photoelectric interactions dominate in the
diagnostic x-ray range.
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4.1.3.1 Rayleight Scattering
Rayleigh scattering occurs when a low energy diagnostic x-ray excites the
electrons of an atom and causes them to vibrate in phase. The atom returns to its stable
state by emitting radiation of the same energy in a different direction (Figure 4-6). This
interaction however does not cause ionization, as the atom does not eject electrons during
this process. However, scatter radiation can contribute to image noise and degrade image
quality. Scatter radiation has a low incidence (less than 5%) as compared to other
interactions in diagnostic energy range.

Figure 4-6: Rayleigh scattering where the incident photon at low energy strikes the atom
causing the electrons of the atom to oscillate and finally ejecting a photon at the same
incident energy, but in a different direction. Adapted from Bushberg et al [69].

4.1.3.2 Compton Scattering
Compton scattering occurs when a high energy incident photon (E0) interacts with
a valence electron to eject the outer orbital electron from the atom with some kinetic
energy (Ee-). Additionally, a scattered photon with reduced energy (ESC) as compared to
25

incident energy is produced (Figure 4-7). According to conservation of energy, the
energy of the incident photon is distributed as the sum of the kinetic energy of the
recoiled electron and the energy of the scattered photon.
E0=Ee- + ESC

(4-1)

Due to the production of scattered photon, Compton scatter results in ionization
and may cause subsequent interactions with matter. The incident energy of the photon
and the angle of the scattered photon determine the energy of the scattered photon. As E0
increases, amount of energy transfer to the scattered photon increases and hence, the
probability of Compton scattering interaction is dominant at higher energies.

Figure 4-7: Compton scattering showing the incident photon ejecting a valence electron
and a Compton scattered photon at an angle θ relative to the incident photon. The energy
E0 is split into ESC and Ee-. Adapted from Bushberg et al [69].
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4.1.3.3 Photoelectric Effect
Photoelectric effect occurs when an incident photon (energy E0) interacts with an
electron with binding energy (Eb) close to but slightly lower than E0. The entire energy of
the photon is used to overcome the binding energy of the electron and eject it from the
orbit to produce a photoelectron (negative ion) with kinetic energy (Ee). The atom left
with a void in the shell allows transition of electron from an adjacent shell yielding the
emission of a characteristic x-ray photon with energy equal to the difference between the
biding energy of the two shells. This leads to a cascade of electron transitions between
the different shells and production of characteristic x-rays of lower energies leaving a
positive ion (atom lacking an electron) at the end. Hence, photoelectric effect produces a
photoelectron, positive ion and characteristic x-rays (Figure 4-8).

Figure 4-8: Photoelectric absorption showing interaction of a 100 keV photon with an
iodine atom. The incident photon interacts with the K shell having binding energy (34
keV) closest to the incident photon and yields a 66 keV photoelectron. The removal of
the electron from K shell triggers a cascade of electron transitions from Lto K, M to L,
and N to L resulting in characteristic x-rays with 29, 4.4 and 0.6 keV respectively as well
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as positive iodine ion without an electron in the N shell. Adapted from Bushberg et al
[69].

As E0 increases, the occurrence of photoelectric effect decreases and hence
photoelectric effect is the dominant interaction with low energy radiation. Moreover,
photoelectric effect produces high contrast in the images. The important interactions of xrays with soft tissue in the diagnostic x-ray energy range are shown in Figure 4-9.

Figure 4-9: Graph showing the occurrence of Rayleigh scatter, Compton scatter,
photoelectric effect, pair production as function of incident x-ray energies when they
interact with soft tissue. Adapted from Bushberg et al [69].

4.1.4

Attenuation
Attenuation is the process of reducing the intensity from a beam of x-rays either

due to absorption or scattering of photons when the beam travels through matter.
Attenuation measures the change in the intensity of the photon and depends both on the
quality and quantity of the x-ray beam. Attenuation also depends on the type of
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interaction of x-ray photons with matter. The attenuation coefficient is used to measure
the amount of x-ray beam attenuation by a substance.

4.1.4.1 Linear Attenuation Coefficient
Linear attenuation coefficient is defined as the fraction of photons removed from
a monoenergetic beam of x-rays per unit thickness of material. It indicates the amount of
attenuation or decrease in intensity of x-ray beam that can occur with a certain amount of
material. It is represented by µ and the units are cm-1. The µ of a substance can be
calculated using the exponential relationship shown below between the number of
incident photons (N0), number of transmitted photons (N) through the substance of
thickness x (in cm).

N = N 0 e (- µx )

(4-2)

The linear attenuation coefficient can also be described as the sum of individual linear
attenuation coefficients from the different interactions between x-rays and matter.

µ = µ Rayleigh + µ Compton + µ Photoelectric + µ Pair Production + µ Photodisintegration

(4-3)

The linear attenuation coefficient depends on the number of atoms of the
substance the x-rays need to pass through per unit distance. Hence, µ is proportional to
the density of the material and is greater for highly dense substances.

4.1.4.2 Mass Attenuation Coefficient
Mass attenuation coefficient is defined as the linear attenuation coefficient per
unit density. It is expressed as µ/ρ and the units are cm2/g.
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The mass attenuation

coefficient is independent of the density of the substance. Hence, for a given photon
energy, a substance has the same mass attenuation coefficient in different states. For
example, water, ice and watervapor have the same mass attenuation coefficient (0.214
cm2/g) even though the linear attenuation coefficients and densities are different in each
state.

4.1.4.3 Factors Affecting Attenuation
Energy (E) of the incident x-rays along with density (ρ), atomic number (Z) and
electrons per gram of the material influence the degree of attenuation of the x-ray beam
as it passes through matter. Increasing the radiation energy decreases attenuation, while
increasing density, atomic number or electrons per gram of the material increases
attenuation. Apart from the individual influence, energy and atomic number together
influence the type of interaction of x-ray with matter. For example, as energy or atomic
number increases, the photoelectric effect dominates. Moreover, with the knowledge of
the percentage of each type of interaction, the total attenuation coefficient can be
calculated as the weighted sum of the individual attenuation coefficients from each
interaction.

4.2 X-ray Based Imaging
4.2.1

Fluoroscopy
Fluoroscopy is a 2D imaging procedure that allows visualization of the anatomy

of the patient in real-time with high temporal resolution. The standard components of
fluoroscopic imaging system contain x-ray tube, filters, collimator to control the x-ray
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beam, anti-scatter grid to eliminate scatter, image intensifier and a video camera. The
image intensifier distinguishes the fluoroscopy equipment from the other x-ray equipment
(Figure 4-10). The image intensifier tube shows the image to the observer by converting
the x-ray photons in light photons, then converting light photons into electrons and finally
into light photons as described below.

Figure 4-10: Schematic illustrating the key components of a fluoroscopic system.

When the x-ray beam travels from the x-ray tube through the patient, it enters the
image intensifier tube which is a vaccum glass tube consisting of input phosphor,
photocathode, electrostatic focusing lens, accelerating anode and output phosphor. The
x-rays are absorbed by the input fluorescent screens and convert the x-ray photons into
light photons. As these light photons interact with the cathode, they emit photoelectrons
which travel towards the accelerating anode from the photocathode due to the potential
difference between the two electrodes. The electrons are focused by the electrostatic lens
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strike the fluorescent screen and emit light photons carrying the fluoroscopic image to the
human eye. Fluoroscopic systems are heavily used during minimally invasive surgical
procedures for guidance during the procedure. However, the inability to obtain 3D
information in the images is a limitation with this technology.

4.2.2

Computed Tomography (CT)
CT is a tomographic imaging technique, which generates cross-sectional images

of the patient by rotating an x-ray source and detector array around the patient. Both the
x-ray source and the detector array are housed inside a gantry. Multiple x-ray projections
at different angulations are obtained with every rotation of the gantry. These projections
are preprocessed to calculate the average linear attenuation coefficients within a crosssection of the body and reconstruct the CT image.
Multi-detector row CT (MDCT) scanners consist of multiple detectors in the
longitudinal (z-axis) direction, which enable acquisition of multiple images with a single
gantry rotation (Figure 4-11). Scanners typically used for cardiovascular imaging acquire
64, 128, 256 or 320 images per gantry rotation depending on specific scanner.

Figure 4-11: Illustration showing multiple detectors in the longitudinal direction in the
MDCT scanners.
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4.2.2.1 Data Acquisition
During data acquisition, a series of x-ray beams with intensity (I0) are projected
from an x-ray source through a patient. The x-rays are differentially absorbed by the
tissue along the path of the x-ray and the beam gets attenuated. The transmitted radiation
is then measured by a detector array lying opposite to the x-ray tube in the gantry. The
intensity of an x-ray which passes through the patient is measured by the detectors as It.
A reference detector measures the intensity of the unattenuated x-ray beam as Io. Io and I
are related by the following equation.

I = I o e (- µx )

(4-4)

where, x is the thickness of the tissue along the ray (in centimeters), and µ is the average
linear attenuation coefficient along the ray (in cm-1) [69]. The intensity values measured
from each ray at the detectors are collected at many orientations as the gantry is rotated
around the patient. This data is then used to calculate the projection data, P(x), which is
independent of the intensity of the x-ray beam.
I 
P(x) = ln  o 
 I 

(4-5)

Combining equations 4-4 and 4-5 results in
P(x) = µx

(4-6)

MDCT imaging is performed using either the sequential (also known as axial or
step and shoot) or spiral (also known as helical) scanning mode. In the sequential mode,
the gantry rotates around the patient in a circular path to obtain a set of cross-sectional
images, and then the patient table is incremented to the next position. This procedure of
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rotating the gantry 360o around the patient and then incrementing the patient table is
repeated until the entire anatomy of interest is covered.
In the spiral mode, both the gantry and the patient table move continuously and
trace a helical path of data acquisition around the patient. This is possible due to the
development of slip ring technology that allows the tube and detectors to move
continuously. With spiral MDCT, acquired projection data are interpolated to reconstruct
images of each axial position.
The ratio of the table translation per gantry rotation (d) to the nominal beam width
(NT) is defined as pitch. This is also known as beam pitch (p) and given as:

p=

d
NT

(4-7)

where, N is the number of rows and T is the thickness of each row. For single-row
detector CT scanners, NT=1 and pitch can be inferred as the table movement per row.
Hence, pitch is a dimensionless quantity and indicates the overlap in data acquisition. A
pitch value of ≥ 1 indicates no overlap in data, and a value < 1 indicates no overlap. In
general, increasing the pitch results in decrease in scan time, linear reduction in radiation
dose and an increase in noise.
MDCT scanners have anatomically adapted tube current modulation, in which the
x-ray tube current is continuously modulated online on the basis of the tissue attenuation
measurements of the patient [70]. The tube current is lowered as the x-rays pass through
thinner sections of the body and increased as they pass through thicker parts. Although
anatomy based modulation decreased radiation dose significantly, same noise levels were
observed with and without modulation [70, 71]
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4.2.2.2 Image Reconstruction
In the image reconstruction process, the acquired projection data (from equation
4-6) are used to produce a reconstructed image of the scanned volume of the patient.
Every picture element (pixel) in the digital image corresponds to a volume element
(voxel) in a cross-section of the patient. The average linear attenuation coefficient for
each voxel is calculated from the projection data, and reflects the degree to which the xray intensity is reduced by a tissue within the voxel. The total attenuation coefficient
along the ray can be simplified as:

µx = µ 1 ∆x + µ 2 ∆x + µ 3 ∆x + .... + µ n ∆x

(4-8)

where, ∆x is the small path length, which factors out from the above equation resulting in
µ = µ1 + µ 2 + µ3 + .... + µ n

(4-9)

Specific attenuation values are then assigned to each individual voxel.

After this

preprocessing step, a reconstruction algorithm is used to produce the CT image.
Filtered back-projection is the most commonly used reconstruction algorithm.
Back-projection is a mathematical process of reversing the image acquisition or the
measurement of projection data to reconstruct an image. The image is reconstructed from
the given projection data by performing 2-D inverse Fourier transforms. According to
this method, the projection data are transferred into the frequency domain using the
Fourier transform, then multiplied with a mathematical filter K(f), and finally
transformed back to the space domain using the Inverse Fourier transform [69]. This can
be mathematically described as

p' (x) = FT -1 {FT [p(x) * K(f)]}
where, p’(x) is the filtered data in the space domain.
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(4-10)

A filter in the frequency domain is equivalent to a kernel in the spatial domain.
Hence, the multiplication operation of the projection data with the filter in the frequency
domain is the same as the convolution operation between the projection data and kernel
in the spatial domain. However, due to the simplicity associated with multiplication,
frequency domain is used for filtering the image before backprojection. A filter is applied
to the projection data to minimize blurring and artifacts, and to typically obtain a more
precise image of the scanned object. Different filters can be applied to the projection data
to highlight certain features depending on the desired image appearance in the CT image.
For example, the Ram-Lak filter allows high frequency data to pass yielding highresolution images at the expense of increased noise [69]. Filters such as the Shepp-Logan
and Hamming window allow passage of data at low frequencies and yield images with
lower noise but decreased image resolution.
Once the raw data are mathematically filtered, they are back-projected into the
spatial domain to obtain the image matrix of the scanned volume. After image
reconstruction, a numerical gray value between 0 and 1 is assigned to each pixel in the
image. This value indicates the average of all the attenuation values contained within the
corresponding voxel.
An alternative to filtered back projection is iterative reconstruction using a
maximum likelihood algorithm [72]. Iterative reconstruction algorithms were used with
early CT scanners but soon replaced as the standard for CT image reconstruction in favor
of faster, less computationally intensive filtered backprojection techniques. Iterative
reconstruction algorithms assume initial attenuation coefficients for all voxels and use
these coefficients to predict projection data. Predicted projection data are compared with
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actual, measured projection data and voxel attenuations are modified until the error
between estimated and measured projection data is acceptable. Compared to standard
analytical reconstruction methods based on filtered back projections, statistical iterative
reconstruction produces equivalent SNRs at lower radiation doses without a loss in
spatial resolution [73, 74]. Recent advances in computer processing hardware and the
increased efficiency of new iterative reconstruction algorithms have sparked the
commercial introduction of these algorithms as an option for CT image reconstruction.

4.2.2.3 Image Display
In order to store these numbers in a computer for image display, pixel values are
scaled up to an integer value and compared to the attenuation coefficient of water. The
resulting number is called the CT number. When the scaling factor equals 1000, the CT
number is described as a Hounsfield Unit (HU) [75]

CT number =

(µ voxel - µ water ) × scaling factor
µ water

(4-11)

CT numbers indicate the brightness of the pixels in the final image [69]. On the
Hounsfield Unit scale, water has an attenuation value of zero. Air and tissues that are less
dense than water, such as fat, have lower attenuation values (Table 4.1) than water and
appear dark on the final image [76]. Tissues denser than water, such as bone and dense
soft tissues have higher attenuation values (Table 4.1) than water and appear bright on the
final CT image [76].
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TISSUE

CT NUMBER (HU)

Bone

50 to 1000

Soft Tissue

40 to 80

Blood

50 to 60

Water

0

Fat

-80 to –100

Lung

-550 to -950

Air

-1000

Table 4.1: CT number of various clinical tissues.

To visualize, distinguish and interpret the different pixels in a CT image with the
human eye, the image is displayed using a gray scale range. The gray scale range is
assigned only to the set of CT values that need to be displayed in the image and is known
as windowing. All the pixels above and below the window level are displayed as white
and black respectively in the CT images [75].

4.2.3

Dual Energy Computed Tomography (DECT)
SECT allows measurement of the linear attenuation coefficient of a tissue at a

given energy and may not able to uniquely identify a tissue. DECT utilizes the energy
dependence of attenuation properties of tissues. DECT imaging can be used to acquire
two sets of data with two x-ray energy spectra to provide two independent measurements
of linear attenuation coefficient of the tissues for characterizing properties of a given
material. The linear attenuation coefficients can be defined as a product of the density (ρ)
and the mass attenuation coefficient (µ/ρ) of each material.
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µ
µ =  (E , Z ) • ρ
ρ

(4-12)

And the mass attenuation coefficient in turn depends on the energy (E) of the x-rays and
the atomic number (Z) of the material. Therefore, tissues with different Z, ρ and E can be
differentiated using DECT quantitative analysis. Basis spectral method and basis material
decomposition are two approaches for quantitative based tissue characterization.
With the basis spectral method, DECT can provide material-specific information
based on the assumption that the attenuation coefficient of any material in the diagnostic
x-ray energy range can be described as a linear combination of Compton and
photoelectric interactions. The linear equations can be solved to obtain the effective
atomic number and density of the mixture [77]. The photoelectric effect is inversely
proportional to E3, and Compton scattering is modeled by the Klein-Nishina formula
(fKN). Hence, Compton scattering dominates at higher energies due to density differences
while photoelectric absorption dominates at lower energies due to differences in effective
atomic numbers [78].

µ ( x, y, E ) = µ P + µ C = A1

1
E3

+ A2 f KN ( E )

(4-13)

The above equation can be solved for A1 and A2 using DECT measurements and further
used to estimate the coefficients a1(x,y) and a2(x,y) representing the atomic number and
physical density of the material where
A1 = ∫ a1 ( x, y )ds and A2 = ∫ a 2 ( x, y )ds

(4-14)

With basis material decomposition, the principle is that mass attenuation
coefficient of a material can be expressed as a linear combination of the mass fractions of
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the basis materials [79]. The composition of a mixture can be solved using this approach
to obtain the mass fraction of the individual constituent elements present in the mixture.
DECT quantification with both basis spectral and basis material methods can be
performed either in the pre- or post-reconstruction space. In the raw data or prereconstruction domain, energy dependent analysis can be applied to the measured
projection data at the two energies prior to reconstruction. In the image or postreconstruction domain analysis, images from the two x-ray energy spectrum are first
reconstructed and then processed to characterize tissue. Although the latter approach is
simpler and easier to implement, the former approach may allow benefits like beam
hardening correction.
DECT imaging requires CT scanners capable of acquiring projection data at two
different energies. There are four methods that are commonly used for DECT imaging.
With the first and the simplest approach, CT data is first acquired using one x-ray energy
spectrum and then data is acquired from the same region using a different energy
spectrum [80]. Although this method allows adjustment of the tube-current for both
energy spectrums independently and noise matching between the two image sets, it
results in misregistration in the DECT image sets. The second technique for DECT
imaging can be performed using dual-source method, where low and high-energy
projections are acquired using two x-ray tube/detector pairs operating simultaneously
during one acquisition [22, 28]. The advantage of this method is simultaneous acquisition
of low and high energy data sets and improved spatial and temporal registration.
However with the existing scanner design, only truncated data is acquired at one energy
due to the limited field of view with the second x-ray tube/detector pair [81].
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A third method employs a single x-ray tube that rapidly switches tube voltage
from low to high values at different projection angles to acquire DECT data with good
spatial and temporal registration. However, as the same x-ray tube is used for low and
high energy, the tube current cannot be modulated separately and may result in more
noise in low energy images [82-84].
With the fourth method, imaging is performed with a single-energy spectra and
the energy separation is performed at the detector level using either dual-layer detectors
[85, 86] or photon counting detectors [87]. The dual layer detector contains of a thin first
layer of scintillator resting on a photodiode placed over a thicker layer of scintillator
resting on a photodiode. While the low energy x-rays are detected in the first layer, the
high energy x-rays are detected in the second layer. Although this approach offers
simultaneous acquisition of low and high energy data sets optimizing spatial and
temporal registration, the energy resolving capabilities of the detectors are limited due to
the overlap in the energy spectrums. With photon counting detectors, the detector
response can be split into energy bins and the attenuated x-rays within each energy bin
used to generate energy-specific images. This technique provides good temporal and
spatial registration between the DECT data sets but prevents adjustment in tube current
with changes in tube voltage.

4.2.4

Cardiac CT
With the advent of MDCT in 1999 [88-90], faster gantry rotations and

multisegment reconstruction algorithms, CT has been used in combination with
intravenous contrast agent injection in routine clinical cardiac imaging [91-98] for
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reliable visualization and analysis of the heart and the great vessels, as well as coronary
circulation. Various clinical applications include evaluating the pericardium, the
myocardium, the coronary arteries, the pulmonary veins, the thoracic and abdominal
aorta, right ventricular dysplasia, stent visualization, graft patency, and to detect anomaly,
malignancy, pericardial lesions and cardiac masses.

4.2.4.1 ECG synchronization
Cardiac CT imaging requires synchronization of data acquisition to the cardiac
cycle for minimizing motion artifacts due to cardiac activity [99]. In cardiac CT, it is
important to synchronize data acquisition with the electrical activity of the heart in order
to obtain images within a specified time-window during the cardiac cycle. It is usually
preferable to obtain data during diastole when the least cardiac motion occurs in order to
avoid motion artifacts. This can be accomplished by using the electrocardiographic
(ECG) signal to either prospectively acquire or retrospectively reconstruct data during the
desired cardiac cycle. Prospective ECG triggering is typically used with sequential data
acquisition while retrospective ECG-gating is typically used with spiral acquisition.
With prospective ECG trigger sequential imaging the patient is scanned at a
predetermined time period of the cardiac cycle [99]. If necessary, the patient table is
incremented and the process is repeated until desired anatomy is covered. All of the data
obtained during the acquisition are used for the image reconstruction. With retrospective
ECG gated, spiral imaging data are acquired continuously along with the recording of the
ECG signal. Data necessary for image reconstruction during one or more cardiac phases
are extracted retrospectively with reference to the ECG signal [100].
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Advantages of the retrospective ECG gated spiral over prospective ECG trigger
sequential include higher spatial and temporal resolutions, because of the retrospective
reconstruction of thinner slices from the acquired data. In addition, retrospective ECG
gated spiral is less sensitive to arrhythmia. The disadvantage of this technique is that it
requires higher radiation than prospective ECG triggered sequential imaging, thereby
increasing the radiation dose to the patient. To minimize this disadvantage, ECG-based
tube current modulation can be employed with spiral imaging, in which maximum tube
current is used to acquire data during the diastolic phase in order to eliminate motion
artifacts, and reduced tube current is used outside diastole. Although retrospective ECGgating with spiral MDCT reduces cardiac motion artifacts, it does not completely
eliminate them. For patients with high heart rate, controlling of this high heart rate with
beta-blocking agents may be necessary to prolong diastole in order to reduce cardiac
motion during scanning.

4.2.5

C-arm Computed Tomography (C-arm CT)
A new approach to acquire 3D CT like images uses a C-arm system. A C-arm

system consists of an x-ray source and a flat-panel detector system mounted parallel to
each other via a C-arm. 3D C-arm CT is a new and innovative imaging technique that
acquires 2D projection data sets at various angular positions by a single rotation of C-arm
system over 180O + 2*fan-angle at a constant angular frequency. Several projection data
are acquired depending on the acquisition protocol and reconstructed using a 3D conebeam reconstruction algorithm to generate 3D data sets [101-104].
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The x-ray tube, generator and control system regulate the tube voltage, tube
current and time of irradiation in a C-arm system. Typically, C-arm systems are operated
at lower tube voltages (compared to CT systems) to allow better image contrast in the
presence of iodinated contrast dye. However, this may also result in higher noise in
images. Hence, C-arm systems use automatic exposure control (AEC) to regulated x-ray
output and maintain constant dose at the detector to optimize image quality. AEC
regulates x-ray output first, by increasing the tube current-time product and then by
increasing the tube voltage.
The flat detectors used in C-arm systems allow conversion of x-rays into
electrical charge into steps [105]. In the first step, x-rays are absorbed by a scintillating
screen, where they are converted into visible light. In the second step, the visible light is
absorbed by a photodiode array and converted into electrical charge (Figure 4-12).

Figure 4-12: Schematic showing conversion of x-rays in the flat detectors using CsI
scintillator and photodiodes.

The scintillating screen improves both energy absorption and x-ray sensitivity, but
decreases the spatial resolution.

Hence, an optimum balance between absorption

properties (x-ray sensitivity) and spatial resolution is critical to choose the thickness and
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type of scintillator material. Cesium iodide (CsI) enables high spatial resolution even at
larger thickness and is typically used as scintillator material [105]. Flat panel detectors
have advantages like homogeneous image quality with good soft-tissue resolution.
Technological developments like use of miniature electronics may allow improvement of
low-contrast resolution of C-arm CT and bring it closer to MDCT.
C-arm CT has initially been used for interventional neuro-radiological
applications. More recently, C-arm CT has been proposed for use during minimally
invasive cardiovascular procedures like PCI and EVAR.

4.2.6

Contrast Administration with X-ray Based Imaging
Contrast agents are water-soluble iodine-based compounds, which are either ionic

or non-ionic compounds. The iodine component in the contrast agent attenuates x-rays
and the absorption is proportional to the concentration of iodine present in the contrast
agent [106]. Owing to similar densities and average atomic numbers, blood vessels
cannot be identified from surrounding heart tissue on x-ray based images without
administration of contrast agent to increase the attenuation coefficient of blood. Contrast
agent opacifies the blood pool and enables visualization and distinction of cardiac
anatomy.

4.2.6.1 Considerations for Fluoroscopy
Contrast agent is routinely used during fluoroscopic imaging to facilitate guidance
and placement of equipment during an interventional procedure. Contrast can be injected
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arterially either with an automated power injector or using hand injectors directly. Hand
injection is fast and can be used to guide advancement of catheters in small vessels.
However, power injection may be required to opacify large vessels like the aorta. High
flow rates ranging from 10 to 20 mL/s are employed during direct injection into the
vessel of interest while acquiring fluoroscopic images. As the contrast is injected directly
into the vessel, fluoroscopic images can be acquired without any delay after contrast
injection. Large volumes of contrast are typically used for guidance and ensuring
accurate placement of prosthesis with fluoroscopy.

4.2.6.2 Considerations for CT
The delivery of contrast agent remains one of the most challenging aspects of
cardiac imaging with MDCT. Peripherally injected contrast agent reaches the heart
through the inferior or superior vena cava. The blood mixes with contrast here, passes
through the pulmonary circulation and reaches the left heart to flow to the rest of the
body through systemic circulation. The contrast agent mixed with blood diffuses through
capillaries primarily into the extracellular space with minor intracellular distribution due
to the lower binding to plasma proteins. Contrast agent is then reabsorbed or excreted by
the tubular cells to a very small extent and mostly removed from the blood stream by
excretion through kidneys [106]. For this reason, contrast agent cannot be administered
to patients with renal disorders. Understanding of pharmacokinetics and physiology of
contrast enhancement, especially during early arterial enhancement is critical to adapt
contrast protocols for state-of-the-art cardiac MDCT scanners. Arterial enhancement is a
function of the administered iodine dose and injection duration. With peripheral injection
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of contrast, it is crucial to determine the transit time of the contrast agent from the site of
injection to the organ of interest being imaged. This transit time varies for patients
depending on individual physiologic parameters, such as the cardiac output, weight, body
mass index (BMI) and used to determine the scan delay or time between the start of
injection and the start of the CT scan. Currently, two techniques are used clinically to
determine the scan delay:
1) Timing Bolus Method
2) Bolus Monitoring Method
With the timing bolus method, a small amount of contrast medium or a “timing
bolus” is injected intravenously at a particular flow rate. Typically, high flow rates are
used with cardiac imaging to achieve high attenuation of cardiac structures in MDCT
images. The organ of interest is imaged repeatedly at a certain level with a low dose
protocol following contrast injection. A region of interest (ROI) is drawn and the
attenuation is measured over time to determine the time to peak enhancement, which
defines the scan delay for the patient. For example, an ROI is placed in a cross-section of
the ascending aorta to obtain the time to peak enhancement for performing imaging of the
coronary arteries. A larger diagnostic or main bolus of contrast material is then injected
intravenously at the same flow rate as the timing bolus. The diagnostic or main scan of
the entire organ of interest (example: heart) is performed after the scan delay determined
from the timing bolus. For cardiac scans, patients are instructed to hold their breath for
the duration of the scan to reduce the movement of the chest and, thus, avoid respiratory
motion artifacts. Timing bolus data can also be used for modeling individual patient’s
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cardiovascular and contrast pharmacokinetic response to optimize main bolus injections
[27, 107-109].
With the bolus monitoring method, a large diagnostic bolus of contrast material is
injected intravenously at a given flow rate. Contrast flow through the organ of interest is
monitored by drawing an ROI and scanning repeatedly with low dose scan after a time
lag following contrast injection. A threshold value of attenuation is predefined. As soon
as this threshold is reached, breathing instructions are given to the patient and the organ
of interest is scanned.
Injection of the entire contrast bolus at a single flow rate, or a uniphasic injection,
results in a steadily increasing enhancement profile with a single peak of enhancement
shortly after completion of injection followed by a rapid decline in enhancement.
However, uniform enhancement during the scan in desired. The shape of the contrast
injection profile can be modified to achieve a more uniform enhancement profile. One
approach is biphasic injection where a portion of the contrast agent volume is injected at
an initial high flow rate for a short duration and the remaining volume is injected at a
lower rate for a long duration without increasing the overall contrast volume [110-112].
The biphasic profile typically results in a relatively flat enhancement profile with two
peaks indicating the end of the two injection phases. Another approach is the use of a
multiphasic, exponentially decaying injection profile, where the contrast agent volume is
injected at an initially high flow rate followed by exponentially decreasing flow rates [25,
113]. The contrast injection profile can also be customized for each patient based on data
obtained from a timing (test) bolus [27, 107, 114].
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Timing and main bolus injections may be followed by injection of saline, referred
to as saline flush or saline chaser. The use of saline flush has several potential
advantages. It creates a tight bolus by reducing intravascular contrast dispersion and
optimizes the delivery of the contrast agent to the vessel of interest by eliminating any
wasted contrast material from the connector tubing and peripheral veins. In fact, it is
estimated that 10 to 12 mL of contrast given to a patient could be replaced by saline flush
with no effect on image quality [115]. Thus, reducing the amount of contrast given to the
patient may reduce some adverse reactions, such as renal toxicity, particularly in patients
with renal insufficiency.
In addition, when saline flush is used without any change in contrast volume, it
results in an increase in peak arterial enhancement with prolonged time to peak
enhancement [116-118]. Saline chase also reduces the streak artifacts arising from
accumulation of contrast in brachiocephalic vein and superior vena cava in thoracic CT
images [119, 120].

4.2.6.3 Considerations for C-arm CT
C-arm CT is a relatively new imaging technique and contrast protocols are still
emerging. Typically, C-arm CT images can be acquired either with peripheral or direct
arterial injections. However, contrast administration needs to be customized depending
on the scan duration of C-arm CT and the clinical application. For example in the context
of using C-arm CT for ablation procedures, 20 mL of contrast agent is injected at a high
flow rate of 20 mL/s into the pulmonary artery and the transit time for the test bolus to
appear in the left atrium is obtained using fluoroscopy. This is followed by a large
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injection of 84 mL of contrast again into the pulmonary artery and images of the left
atrium and pulmonary veins are acquired [121]. In another application, 60 mL of diluted
contrast agent (30 mL contrast mixed with 30 mL of saline) was injected at 6 mL/s at
level of renal ostia for detection and correction of endoleaks [122]

4.2.7

Dose
X-ray photons in the diagnostic energy range interact with a medium by Compton

and photoelectric interactions resulting in a free electron. This high velocity electron
ionizes molecules as it looses its kinetic energy and can cause a cascade of ionization
reactions that are not desirable. With the increasing use of x-ray based modalities, it is
critical to understand the concepts of radiation dose measurement and estimation.
Radiation exposure describes the quantity of x-ray ionization events produced in
air. It is usually expressed in units of roentgen (R) or C/kg. It describes the amount of
ionization present in a given volume of air, but does not indicate the amount absorbed in
the tissue that has been irradiated. Absorbed radiation dose describes the quantity of
radiation deposited per unit mass in a body due to exposure and is calculated using the
exposure and energy absorption estimates. It is expressed in units of rad or gray (Gy). It
describes the amount of energy absorbed in a small volume due to ionizing radiation.

4.2.7.1 Considerations for Fluoroscopy
Fluoroscopic guidance during interventional procedures may result in high patient
radiation doses. The radiation dose depends on the type of imaging (dynamic vs. static)
and imaging modes (normal, high-dose, conventional, digital cine). The receptor entrance
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exposure and skin entrance exposure determine are important factors that affect radiation
dose with fluoroscopic imaging. A patient dose monitoring system during the
fluoroscopic procedures is highly desirable. Currently, patient skin dose can be measured
either using small dosimeters like thermoluminescent dosimeters (TLDs) or photographic
films directly on the patient’s skin [123]. Clinical C-arm systems are equipped with a
dose-area product (DAP) meter, which uses a transmission type air-ionization chamber
placed on the collimator of the x-ray tube. This DAP meter integrates exposure over the
entire field of view and expressed in units of mGy-cm2. Skin entrance dose can be
estimated from the DAP meter reading [123].

4.2.7.2 Considerations for CT
With CT type imaging, the distribution of dose in the scan plane (x-y direction),
perpendicular to scan plane (z-direction) [referred to as the dose profile], and in 3D space
(xyz) [referred as scatter radiation] are important for physical measurement of dose. The
dose profiles in the z-direction indicate the distribution of absorbed dose along the z-axis
of the patient, and can be measured using TLDs. The dose profile includes the impact of
the primary beam, scatter of photons from the object being irradiated and also the
collimation source irregularities.
CT dose index (CTDI) is the fundamental unit for measuring radiation dose with
CT [124]. CTDI represents the integral dose profile measured in the z-axis derived from
measuring dose from a single slice. The maximum value of the dose profile is termed as
peak dose value.
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Typically CTDI measurements are made with ionization chambers or TLDs.
CTDI100 measurements are made with 10 cm ionization chambers to measure the
radiation exposure integrated for a length of 100 mm

CTDI 100, x

1
=
NT

+50 mm

∫ D( z ) ⋅ dz

(4-15)

−50 mm

where, x=air for air measurement; c for center, p for periphery, and w for
weighted in phantom measurements and NT reflects the nominal width of the x-ray beam
during acquisition. CTDI100 can be calculated by performing a single 360° rotation CT
scan with a beam collimation of NT and measuring the exposure E with a pencil
ionization chamber of length L:
CTDI 100, x =

f ⋅C ⋅ E ⋅ L
NT

(4-16)

where, f is the conversion factor from exposure to a dose in air (0.87 rad/R) and C
is the calibration factor for the electrometer used for measuring the exposure. CTDI100 is
measured in Gy or rad using 100 mm of TLDs or ionization chamber in a plexiglass
(polymethyl methaacrylate or PMMA) phantom with 16 or 32 cm diameter to simulate
head and body measurements at the center and four different peripheral positions to
calculate CTDI100,w in units of mGy
1
2
CTDI 100, w = CTDI 100,c + CTDI 100, p − average
3
3

(4-17)

where, p-average is the average measurement obtained from the four peripheral
locations. CTDI100,vol, also expressed in units of mGy, is typically used as the dose
indicator and calculated from CTDI100,w as
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CTDI 100 ,vol =

CTDI 100 , w
pitch

(4-18)

To describe the overall energy deposited by a scan protocol, the absorbed dose is
integrated over the length of region imaged (scan length) to calculate dose-length product
(DLP) in units of mGy-cm.
DLP = CTDI100, vol ⋅ scan length

(4-19)

These CTDI descriptors are considered as parameters to estimate dose, but cannot
determine the exact dose for a specific patient. Effective dose values can be used to
express the biological effect of radiation on the tissue imaged. Effective dose describes
partial body irradiation in terms of equivalent dose to the whole body using weighting
factors based on tissue radiosensitivity. DLP values can be used to estimate effective dose
(E) in milliSeverts (mSv) using appropriate conversion factors depending on the region
imaged.
E = DLP ⋅ k

(4-20)

where, k is a conversion factor in mSv/(mGy-cm) obtained from experimental results.

4.2.7.3 Considerations for C-arm CT
The use of C-arm CT results in radiation dose to the patient due to the use of xray photons. As traditional C-arm systems are associated with 2D imaging, they use dose
area product (DAP) meter to calculate the integral of radiation exposure across the
imaging field. However, these DAP meters do not provide an estimate of the dose
delivered to the patient due to the 3D acquisition. The resulting dose from a 3D C-arm
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CT acquisition is not well established and there is no consensus on estimating the patient
dose.

4.2.8

Image Quality for X-ray based modalities
Spatial and contrast resolution are the major factors that determine the quality of

the x-ray images. Spatial resolution is the ability to distinctly represent two different
objects very close to each other (in proximity) in an image [75]. Contrast resolution is
the ability to display two similar density materials distinctly in the images [75]. Contrast
and spatial resolutions are interrelated and also associated with the radiation dose
absorbed by the detectors (noise). Improving spatial resolution results in an increase in
noise, which reduces the contrast resolution. On the other hand, improving contrast
resolution requires an increase in scan time, which in turn decreases spatial resolution.
Hence, it is desirable to have an adequately high spatial and contrast resolution with a
trade-off between them [75].
Noise and blurring are artifacts that affect the image quality. Blurring refers to an
indistinct appearance of any discrete object in a CT image. This occurs mainly due to the
size of the X-ray source and detectors. Blurring is introduced during the data acquisition
and image reconstruction phases [75]. During data acquisition, an x-ray with a certain
width is projected through a slice of tissue. All the anatomical details within this width of
the x-ray are processed together. Any object that is smaller than the x-ray source or
detector width, or lies in the distance between adjacent x-rays or detectors appears
blurred in the final image. Thus, a smaller voxel size is desirable to reduce blurring. This
can be achieved by using detectors with narrow widths, yielding to images with higher
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spatial resolution. Using sharp filters allows retaining details of the image even at high
frequency, resulting in reduced blurring but increased noise.
Noise also impacts the image quality. It results from either electronic noise from
the electronic components like the detectors or due to quantum random variations in the
number of x-rays absorbed within an individual voxel. While the former cannot be
controlled, the later can be minimized using various approaches during image acquisition
or reconstruction. Radiation absorbed in each voxel affects the noise in the final image.
Increasing voxel size can reduce noise but causes image blurring. Certain filters like the
Hamming window can be applied to reduce noise, but with an increase in blurring
because of the roll-off at high frequencies. Increasing the radiation dose to the patient
would also reduce noise, but is undesirable. Hence, there is always a trade-off between
radiation dose, noise and spatial resolution in x-ray based images.
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5.

CHAPTER V

LITERATURE REVIEW

3D contrast-enhanced x-ray based acquisitions have been increasingly used for
imaging patients pre- and post-minimally invasive cardiovascular interventional
procedures. The goal of this chapter is to provide an extensive overview of the clinical
applications of DECT and C-arm CT technologies in the context of cardiovascular
imaging.

5.1 DECT
The basic principle of DECT is the acquisition of datasets covering the same
anatomical range by employing two different tube voltages. Although DECT has been
extensively studied using two separate scans since the late 1970s [77, 78, 80, 125-129],
technical challenges like unstable CT density values, limited spatial resolution and
temporal resolution, and limitations on power output of the x-ray tubes did not allow
extensive use for clinical applications. With continuous improvements in scanner
technology, DECT measurements can commercially be obtained using simultaneous
image acquisition at two different energies with two sources [21] (Definition and Flash;
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Siemens Medical Systems, Erlangen, Germany), using rapid tube voltage switching
between two energies with a single source [23, 84] (Discovery 750 HD; GE Healthcare,
Milwaukee, Wisconsin, USA), or using energy selective dual-layer detector technology
to filter lower energy radiation in the top layer, leaving higher energy photons in the
bottom layer [20, 85, 86] (Brilliance 64 MultiEnergy; Philips Medical Systems,
Cleveland, Ohio, USA).
DECT data acquired using good separation between low and high-energy spectra
has the ability to discriminate between two materials with differences in effective atomic
numbers or density values. Quantification of material composition can be performed
using either basis spectral analysis or basis material decomposition either in the prereconstruction or post-reconstruction space in CT. While basis spectral analysis results in
the identification of effective atomic number and density from CT images using the
photoelectric effect and Compton scattering, basis material decomposition results in
quantifying mass or volume fraction of the components present in a mixture. Both the
methods have been implemented in both pre-reconstruction [77, 79, 130] and postreconstruction (or image) domain [131, 132]. However, no studies to date have
investigated combined use of these two approaches for quantification of substances with
calcium, iodine and blood as basis materials in the image domain. One approach to
perform basis material decomposition for a three-component mixture is by employing
triple energy CT measurements to get three unique equations correlating mass attenuation
coefficients with amount of components present in the mixture. However, as attenuation
coefficient is a function of only two x-ray interaction mechanisms (photoelectric effect
and Compton scatter) in the x-ray energies used for CT, three equations may not have
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unique data to solve for the three materials. Alternatively, applying law of conservation
of mass (the sum of the total mass fractions of a mixture can be assumed to be equal to
one), a third equation can be generated to solve for the composition of the threecomponent mixture.
DECT has been used in many clinical applications such as bone removal [22],
measurement of bone mineral density [133], identification of nodules in lungs and liver
[134], characterization of urinary stones [135-137], computing tophus volume in
peripheral joints of patients with tophaceous gout [138, 139], quantification of calcified
plaque [86]. For cardiovascular applications, DECT has the potential to differentiate
contrast agent from high density objects like stent or calcium due to the differences in
density and atomic number. This may allow identification of iodine pixels in contrastenhanced cardiac images, which can be eliminated to create VNC images. This
application may particularly decrease radiation dose burden in patients imaged postEVAR, where the high cumulative radiation dose from triple phase (non-contrast, arterial
and venous phase) multiple follow-up examinations is of concern [15-17]. The radiation
exposure can be reduced by replacing two SECT acquisitions with a single DECT
acquisition [18, 19]. DECT data obtained during or after contrast agent injection can be
used to create not only arterial or venous phase images, respectively, but also VNC
(VNC) images [18, 19, 22, 24]. Previous studies [18, 19] have acquired DECT data
during the venous phase, but no studies to date have evaluated the feasibility of arterial
phase DECT acquisition. The presence of high density iodinated contrast adjacent to
other high density materials like stent or calcium and, in many cases, the non-uniformity
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of contrast attenuation along the length of the aorta make generation of VNC images
from arterial DECT data more challenging.
Good spectral separation between the high and low- energy x-rays allows
improved discrimination of materials with less difference in atomic numbers like calcium
vs. iodine, and ensure better identification of iodine pixels for generating reliable VNC
images. Spectral separation can be improved by adding filters to both the lower and
higher energies to improve DECT imaging for material discrimination. Kelcz et al [80]
performed the first study using additional filtration for two different tube voltages to
improve DECT imaging. Rutt et al [140] used a split filter for DECT imaging on a single
source scanner. Marshall et al [141] employed a pre-reconstruction technique to change
beam filtration manually for DECT scans. All these studies emphasized the importance of
additional filtration for DECT to enhance differentiation and quantification of substances.
Recent study by Primak et al [142] on a commercially available dual-source CT scanner
(Flash, Siemens) showed that 100/140 kVp acquisition with additional filtration
decreased noise and increased contrast in images as compared to those obtained from the
previous generation scanner with 80/140 kVp with no additional filtration for large
patients.
Contrast-enhanced CT imaging is critical to visualize and evaluate the cardiac
anatomy, and luminal details. Various cardiovascular indications like evaluation of aortic
dissections, aneurysms, intramural hematoma, atherosclerotic disease, coronary arteries
or bypass grafts, cardiac valves, pericardium, congenital anomalies, mass, or postoperative changes require arterial phase images. With the commercial availability of
dual-energy capable CT scanners, DECT arterial phase imaging is expected to be used for
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many clinical applications. In the context of EVAR, arterial images are important for the
evaluation of luminal details, in particular of smaller branch vessels. With other
indications for aortic imaging (aneurysm, dissection, aortitis, pre- and post- operative
imaging), arterial phase acquisition is the clinical standard. Reliable reconstruction of
VNC images from arterial DECT images could provide information about tissue
characteristics (e.g. intramural hematoma, surgical material, low-density calcium versus
contrast) in these situations. As VNC image generation largely relies on the accurate
identification of contrast pixels using data from the two different energies, uniform
enhancement in the arterial phase DECT images will result in a constant ratio of contrast
attenuation at the two energies in all images. Uniform enhancement also ensures that the
mass fraction of contrast agent mixed with blood will be constant so that contrast pixels
can be easily identified. Thus, differentiation of iodine pixels from blood can be more
robust and contrast agent can be removed more accurately from arterial DECT images to
generate VNC images.
Various modeling techniques have been used to develop contrast injection
protocols for SECT cardiovascular imaging [25-27].

Prolonged uniform aortic

enhancement has been achieved with both biphasic [107] and multiphasic [113] injection
protocols. Bae et al used pharmacokinetic modeling to develop exponentially decreasing
multiphasic injections yielding prolonged, uniform enhancement for single detector-row
cardiac CT [25]. Fleischmann et al developed a “black-box” mathematical approach to
determine individual biphasic protocols for each patient necessary to achieve desired
cardiac enhancement in the aorta with single detector-row CT [26]. However, these
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advanced profiles focused on imaging with single detector row CT with prospective
ECG-triggered sequential techniques and have not been evaluated in cardiac CT imaging.
Numburi et al utilized a “grey-box” modeling approach to obtain multiphasic
patient-specific injections with ≤6 phases developed in the Fourier domain yielding
uniform enhancement of the left heart on ECG-gated spiral MDCT acquired at singleenergy MDCT [27]. With the mathematical modeling approaches [26, 27], a transfer
function was developed using the input (injection) and output (enhancement) of the
patient in the Fourier domain. The patient transfer function was further used to compute
an “ideal” injection necessary to achieve “ideal” uniform enhancement during the scan.
The ideal injection was then modified into a realistic injection protocol by eliminating
negative flow rates. However, the algorithm could not predict injection in one patient due
to problems in computation of transform of the patient in the Fourier domain. The
calculation of the transfer function in the Fourier domain (division of output by input)
required use of 2n numbers in an array (with zero padding where data was not available),
sometimes resulting in division errors and thus unable to achieve a realistic patientspecific injection protocol [27]. Also, this study was developed for a 16 detector-row CT
scanners with average scan time of 20 s.
However, with the latest technological advances, state-of-the-art MDCT scanners
employing dual-source x-ray tube technology [28, 143] and/or an increased number of
detector-rows [144-147] allow DECT aortic and cardiac imaging with short scan times.
No studies to date have evaluated systematic optimization of contrast administration for
these short duration scans, in particular for DECT imaging to insure uniform contrast
enhancement during data acquisition resulting in a constant mass fraction of iodinated
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contrast agent mixed with blood. This requires an adequate understanding of the
pharmacokinetics of contrast medium injection in the human circulatory system to
achieve homogeneous enhancement synchronized with image acquisition. The contrast
enhancement depends on various patient physiological factors (eg, cardiac output, blood
volume, height, weight, body mass index [BMI], and body surface area), contrast agent
characteristics (concentration, density, viscosity) and contrast injection properties (flow
rate, volume, duration). One approach for developing contrast protocols with DECT
imaging is to use linear time invariant (LTI) modeling in the time domain using nonlinear optimization. This method considers the patient as an LTI system with contrast
injection as input and enhancement as output [26]. The output can be modeled as the
convolution integral of the input and impulse response of the patient. The advantage of
this approach is that the impulse response considers the contrast injection and patient
characteristics as part of the system and predicts patient-specific injection protocols
without the limitations of the Fourier domain.

5.2 C-arm CT
Minimally invasive surgical procedures primarily rely on 2D x-ray C-arm
angiography and transesophageal echocardiography (TEE) in the catheterization lab.
Typically, 3D MDCT images are acquired prior to the procedure to provide visualization
of cardiovascular anatomy and detailed information for accurate planning during the
intervention. However, the direct use of the MDCT images in the cardiac catheterization
lab is limited due to challenges involved in the direct integrating of the 3D information
onto the 2D fluoroscopy images. With recent technical advances in flat-panel detector
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technology and improvements in gantry rotations, traditional C-arm systems are capable
of providing 3D C-arm CT images with CT-like soft-tissue image quality. These C-arm
CT images can be used for planning, guidance and evaluate the procedural outcome in
the interventional suite. C-arm CT is commercially available as Axiom Artis with syngo
DynaCT (Siemens AG, Healthcare Sector, Forchheim, Germany), XperCT (Philips
Healthcare, Andover, MA, USA) and Innova CT (GE Healthcare, Chalfont St. Giles,
UK).
C-arm CT has been initially used for neuro-interventional procedures for
assessing cerebral vasculature and hemodynamics [148-156]. Its use has been extended
into other interventional radiology applications like abdominal [122, 157-160], spine
[161] and hepatic [162-166] imaging. Cardiac C-arm CT requires rapid image acquisition
during a single heartbeat to minimize motion artifacts, which is not feasible with the
current C-arm system. However, with improvements in image reconstruction and image
correction algorithms, cardiac C-arm CT may be possible [167, 168]. For cardiac
applications like ablation for atrial fibrillation, C-arm CT images [121] were helpful
despite motion blur. Left atrium and pulmonary veins from C-arm CT were marked and
registered with the electroanatomic mapping system for guidance. In some cases,
adenosine was used to reduce cardiac motion during imaging [169]. A report by
Kempfert et al [170] suggested use of rapid pacing to freeze cardiac motion during C-arm
CT acquisition. ECG-gated cardiac C-arm CT images can also be acquired with ECG
synchronization and images can be reconstructed at a preferred cardiac phase to minimize
motion of the heart [167, 168]. Acquiring images with optimal image quality, minimum
artifacts, contrast and radiation dose in the context of TAVI will help for anatomical
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assessment, quantitative evaluation, procedural guidance or postprocedural follow-up in
patients. A systematic study exploring various C-arm CT imaging protocols in the
context of TAVI has not yet been performed. Proper application of C-arm CT images for
TAVI will facilitate accurate catheter guidance and device positioning to minimize
complications and enable safer procedural outcomes in patients.
Typically during the TAVI procedure, 2D fluoroscopy with C-arm system is
routinely used to visualize the 2D plane of the aortic annulus, sinuses and aortic valve
cusps. In these situations, the overlay of detailed 3D C-arm CT or preprocedural 3D
MDCT images onto the 2D fluoroscopy images from the C-arm system may help to
determine if the three aortic sinuses and valve cusps are in the same plane so that proper
valve position is achieved. In situations where preprocedural 3D MDCT needs to be
overlaid on 2D fluoroscopy images, an intermediate step by rotating the C-arm during the
procedure to acquire 3D images that will help. First, 3D C-arm CT images can be fused
with the 3D MDCT images by registering the center of volumes from the two image sets,
thus allowing the preprocedural MDCT images to be integrated with the 2D fluoroscopic
images for guidance with C-arm system during the interventional procedure. The
availability of the latest 3D anatomical information from the patient along with the ability
to use this information for real-time guidance during intervention is of clinical interest.
The use of C-arm CT results in radiation dose to the patient due to the use of xray photons. As traditional C-arm systems are associated with 2D imaging, they use dose
area product (DAP) meter to calculate the integral of radiation exposure across the x-ray
beam. These DAP meters provide measure of dose which is an indicator of risk to skin,
but not overall dose delivered to the patient due to the 3D acquisition. The resulting dose
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from C-arm CT imaging is not well established and there is no consensus on estimating
the patient dose. One approach to estimate the dose resulting from the 3D C-arm CT
acquisition is to utilize an MDCT dose metric like CTDI100 using a 150 mm phantom and
100 mm ionization chamber.

CTDI 100

1
=
Cz

+50

∫ D ( z )dz

(5-1)

− 50

where, Cz is the collimation used in z-direction. The ionization chamber is placed in the
center and four peripheral locations (12, 3, 6, and 9-o’clocl positions) of a 150 mm long
CT phantom to measure the radiation exposure at different locations in the phantom. This
measured exposure is multiplied with weighting functions for the center and the
peripheral locations to convert into averaged absorbed dose in a cross-section of a
patient’s body. CTDIw is calculated using
2
1

CTDIw =  CTDI100, c + CTDI100, p  • f
3
3


(5-2)

where, f is the difference between the absorption of radiation in air and tissue, c and p
indicate center and peripheral locations in the phantom. Fahrig et al [171] estimated
CTDIw for C-arm CT imaging similar to that with MDCT by measuring CTDIc and
CTDIp at the center and average of the periphery of a 160 mm diameter head and 150 mm
length phantom. However, as the beam collimation with C-arm CT (~200 mm) is larger
than the phantom and integration length, CTDI100 may underestimate dose [172-176].
Hence, there is a need to adapt the CTDI concepts for C-arm CT and develop a procedure
to obtain a C-arm CT dose metric to estimate the radiation burden with 3D C-arm
acquisition.
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Kyriakou et al estimated dose using a 250 mm ionization chamber and 300 mm
long body phantom (320 mm) to calculate CTDIw,250 for C-arm CT imaging [177].
However, as the C-arm system employs AEC technique to modulate the x-ray exposure
depending on the DED settings, varying tube voltage and tube current-time product are
employed during each projection of the 3D acquisition [103]. With their experiment set
up, Kyriakou et al obtained dose values with varying tube voltage and tube current-time
product, but assumed them as constant. Since dose is proportional to the (tube voltage)n
where n=2.5 to 3, the dose measurements obtained from the experiments cannot be
translated to patients. For example, dose measured at a constant 90 kVp assumed during
their phantom experiment may actually employ tube voltages between 90 to 125 kVp for
each projection. This does not reflect the actual dose measured if the phantom was
imaged at 90 kVp in all the projections. Hence, there is a need to develop a procedure to
obtain a C-arm CT dose metric to estimate the radiation burden with 3D C-arm CT
acquisition. It is also required to estimate the necessary phantom and integration length to
include complete scatter radiation tails and estimate C-arm CT dose metric accurately.
This information can be further used to develop empirical equations to estimate dose in a
patient using the individual tube voltage and tube current time-product values from each
projection during 3D C-arm CT imaging.
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6.

CHAPTER VI

HYPOTHESIS AND SPECIFIC AIMS

The objective of the research is to develop strategies for employing novel x-ray
based technologies to improve planning, guidance and follow-up of minimally invasive
surgeries in patients with aortic diseases. The central hypothesis is that novel x-ray based
technologies can be used to acquire preprocedural images for interventional guidance and
obtain post- procedural images for patient follow-up. The central hypothesis was tested
and the objectives of this proposal were achieved using the following specific aims:

6.1 Specific Aim 1
Hypothesis: VNC images can be generated using arterial dual-energy computed
tomography (DECT) data and can replace true non-contrast (TNC) SECT images, thus
reducing radiation dose.
The hypothesis was tested by imaging 30 patients on a first generation dualsource DECT scanner with an arterial DECT protocol developed for imaging patients
post-endovascular aneurysm repair (EVAR). The DECT arterial images were processed
using three-material decomposition algorithm to eliminate contrast and generate VNC
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images. Noise and attenuation of tissues of interest post-EVAR were compared between
VNC images and TNC images acquired from a previous exam in the same patient.
Finally, radiation dose savings resulting from the omission of TNC imaging were
estimated.

6.2 Specific Aim 2
Hypothesis: VNC image generation can be improved by (a) achieving uniform
arterial enhancement during DECT data acquisition using patient-specific contrast
injection protocols and by (b) applying basis spectral and basis material decomposition to
resulting DECT images.
The hypothesis was tested by performing in-vitro and in-vivo experiments on a
second generation dual-source DECT scanner. With phantom experiments, samples
using varying concentrations of contrast and water, or calcium and water were imaged
with DECT. The resulting images were processed using a customized algorithm based
on basis spectral and basis material decomposition in the post-processing domain. The
algorithm assumes that each pixels is a mixture of water, calcium hydroxyapatite and
iodinated contrast agent and differentiates calcium and iodine pixels. Further, the mass
fractions of the iodine solutions was quantified and compared with theoretical values.
An algorithm for generating patient-specific contrast injection was developed.
However, its clinical use (and therefore in-vivo validation) was deemed unnecessary
because of significant improvements in the uniformity of arterial enhancement using
standard contrast protocols with shorter scan duration second generation dual-source
DECT techniques. One patient post-EVAR was imaged with non-contrast SECT,
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arterial DECT (using standard contrast injection protocols), and venous SECT. The
resulting arterial DECT images were processed using customized basis spectral and
basis material decomposition algorithm. To evaluate the efficiency of customized basis
spectral and material decomposition algorithm, aortic luminal attenuation in VNC
images was compared with those from TNC images.

6.3 Specific Aim 3
Hypothesis: Three-dimensional (3D) images similar to 3D MDCT images can be
obtained by rotating the X-ray source/detector system of a traditional C-arm machine
over a wide circular angle (>180°) and facilitate the registration of preprocedural 3D
MDCT images with real-time 2D fluoroscopic images from the C-arm system for
guidance during an interventional procedure.
The hypothesis was tested by imaging 6 pigs with C-arm CT and MDCT. Various
scan and contrast protocols were systematically evaluated to acquire optimal C-arm CT
images. Aortic root measurements critical for TAVI procedure were obtained from 3D
C-arm CT images and compared with those from 3D MDCT images. The 3D images
from the MDCT and C-arm CT were also fused by registering the center of volumes
from the two image sets to allow integration of 3D MDCT images with the 2D
fluoroscopic images for real-time guidance during interventional procedures. Finally, a
procedure to obtain a C-arm CT dose metric that can be compared to MDCT was
developed to estimate the radiation burden with C-arm CT acquisition.
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7.

CHAPTER VII

PRELIMINARY DATA

Preliminary studies were performed to develop contrast injection and imaging
protocols for the x-ray based imaging modalities used for minimally invasive surgeries.
Specific patient populations were selected to develop the protocols. Specific aims 1 and 2
were evaluated in post-EVAR population and specific aim 3 was evaluated in the context
of TAVI. Pilot studies were performed using phantom experiments for developing
imaging protocols that can be used to image the aforementioned patient populations.
Preliminary data acquired for the specific aims are described in the current chapter.

7.1 Specific Aim 1
Preliminary phantom experiments were performed to determine optimal imaging
and contrast injection protocols for arterial DECT imaging. Additionally, parameters
required for customizing existing algorithms were investigated to optimize VNC
generation in patients for post-EVAR application. Preliminary DECT and SECT imaging
were performed using a dual-source MDCT scanner (Somatom Definition, Siemens
Healthcare, Forchheim, Germany). The scanner is equipped with two x-ray tubes and
corresponding detector sets each with 32 detector-rows, mounted at a 90-degree angle in
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one gantry. While the detector for tube A has a field of view (FOV) of 50 cm, tube B has
a smaller FOV of only 26 cm. The two tubes can be operated independently at different
voltages (kVp) and tube currents (mA). Imaging was performed on an Alderson
anthromorphic thorax phantom (Figure 7-1) with internal organs (heart, lungs and liver)
inserted in the volume of the thoracic cavity.

Figure 7-1: Alderson Phantom mimicking human body.

7.1.1

Description of Standard SECT Contrast and Scan Protocol for Aortic

Imaging
For routine triple-phase SECT imaging post-EVAR, non-contrast, arterial and
venous phase SECT scans are acquired. For the arterial SECT scan, a total of 120 ml of
contrast (Ultravist 370, Berlex, Montville, NJ) is typically injected at a flow rate of 3.5
ml/sec and the descending aorta (DA) is monitored at 120 kVp. Once sufficient threshold
(~120 HU) is reached in the DA, a non-ECG gated helical scan covering the entire chest,
abdomen and pelvis regions is performed using a standard SECT protocol: tube voltage,
120 kVp (Tube A); effective tube current-time product, 270 mAs (Tube A) with
anatomic-based modulation; rotation time, 0.5 sec; beam collimation, 24 x 1.2 mm; pitch,
0.8. Images are reconstructed with 3.0 mm slice thickness and 3.0 mm slice increment
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using a medium-smooth kernel (B31f). This SECT protocol was used to image the
Alderson phantom and the resulting scan time, dose was recorded.

7.1.2

Development of DECT Imaging Protocol
A design of experiment (DOE) was performed on an Alderson phantom to

develop an optimal dual-energy scanning protocol using the dual-source MDCT scanner
(Definition, Siemens). Two spectrally separate energies available on the scanner (80 and
140 kVp) were used with tube A and tube B respectively, for ungated spiral DECT
imaging. Various options available for the acquisition and reconstruction parameters for
DECT imaging were selected:
1. Beam collimation: 64 x 0.6 mm; 14 x 1.2 mm
2. Rotation time: 0.5 sec; 0.33 sec
3. Pitch: 0.8; 0.7; 0.6
4. Tube current modulation (CareDose) with the maximum allowed effective tubecurrent product (eff mAs): Yes; No
5. Reconstructed slice thickness: 0.6 mm; 1.5 mm; 3.0 mm
A factorial design was developed with all the aforementioned parameters and
image acquisition was performed on the Alderson phantom. With each scan, data at 80
and 140 kVp was acquired. Two image sets were reconstructed from the raw spiral
projection data using a soft convolution kernel (D30f). The individual data sets were
then linearly mixed (30% of 80 kVp data with 70% of 140 kVp data) to generate a
weighted-average image. Noise was defined as standard deviation (SD) measured in the
individual 80 and 140 kVp images, and calculated as
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weighted-average images. Dose from the DECT acquisition (CTDIvol) reported at the end
of each scan was noted. The impact of the various acquisition and reconstruction
parameters on noise and dose was evaluated in all DECT image sets. The impact of the
following scan parameters on noise and dose was evaluated:
•

Effect of beam collimation: With constant pitch, rotation time, tube current
modulation, and reconstructed slice thickness, 64 x 0.6 mm beam collimation
resulted in lower dose and similar noise as compared to 14 x 1.2 mm beam
collimation.

•

Effect of rotation time: Using constant beam collimation, pitch, tube current,
reconstructed slice thickness, a decrease in rotation time (0.5 to 0.33 sec) resulted
in a decrease in dose and increase in noise.

•

Effect of pitch: Employing a constant beam collimation, rotation time, tube
current, and reconstructed slice thickness, a decrease in pitch resulted in an
increase in dose, but similar noise values.

•

Effect of tube current modulation: With a constant beam collimation, rotation
time, pitch, and reconstructed slice thickness, use of tube current modulation did
not impact noise.

•

Effect of reconstructed slice thickness: Reconstruction of thicker slices resulted
in decreased noise, with no impact on dose.
Noise measurements from the image sets were plotted against corresponding dose

measurements for all acquisition and reconstruction parameters to find the optimal
protocol resulting in minimum noise and dose values (Figure 7-2).
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Figure 7-2: Optimal beam collimation, rotation time, pitch, reconstructed slice thickness
and tube current values resulting in minimum noise and dose values developed for
imaging on a dual-source DECT scanner (Definition, Siemens).

The optimal protocol achieving these values required DECT scanning of the chest,
abdomen and pelvis to be performed using a non-ECG gated helical technique with tube
voltage, 140 kVp (Tube A), 80 kVp (Tube B); effective tube current-time product, 110
mAs (Tube A), 467 mAs (Tube B) with anatomic-based tube current modulation
employed for each tube; rotation time, 0.5 sec; beam collimation, 14 x 1.2 mm; pitch, 0.6.
Both 80 and 140 kVp image sets need to be reconstructed with 3.0 mm slice thickness
and 3.0 mm slice increment using a medium-smooth kernel (D30f).
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7.1.3

Development of DECT Contrast Injection Protocol
With the optimal DECT protocol identified above, the scan duration was almost

doubled as compared to the standard SECT protocol (12 sec with SECT and 26 sec with
DECT). Therefore, the contrast protocol typically used for aortic imaging was adjusted.
The iodine dose and input rate were calculated for the arterial SECT protocol using the
following equations:
Iodine Dose (gI) = contrast concentration (gI/ml) * contrast volume (ml)

(7-1)

Iodine Rate (gI/sec) = contrast concentration (gI/ml) * flow rate (ml/sec)

(7-2)

The iodine dose was calculated as 44.4 gI and the input rate as 1.3 gI/sec. In
order to inject the same iodine dose and rate for DECT imaging in patients, the contrast
injection flow rate was decreased to 3.0 ml/sec while maintaining the total injected
volume to that used with SECT.

7.1.4

VNC generation
VNC images were generated using DECT three-material decomposition post-

processing algorithm, where each voxel was assumed as a mixture of fat, soft tissue and
iodine. The known attenuation of these materials at 80 and 140 kVp was used to calculate
their relative contributions to the voxel and to generate an iodine distribution image.
VNC image was obtained by subtracting the iodine distribution image from the contrastenhanced DECT image. Key parameters that need to be input into the algorithm include
the average attenuation values for fat and soft tissue, the ratio of contrast attenuation
(luminal attenuation at 80 kVp/luminal attenuation at 140 kVp), and a maximum
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attenuation value or threshold above which voxels are excluded from processing.
Average attenuation values for fat and soft tissue at 80 and 140 kVp were determined
from our preliminary studies with patients. In these patients, a circular region of interest
of approximately 100 pixels was drawn in fat and subcutaneous (or soft) tissue on both
80- and 140-kVp axial images. Multiple measurements were made at different locations
within and across patients. Average attenuation values of –115 and –94 HU were noted
for fat and 75 and 61 HU for soft tissue on both 80-and 140-kVp images. In order to
avoid processing of inhomogeneous high density stent placed in EVAR patients, the
attenuation of stent material was obtained by measuring CT attenuation from multiple
circular regions of interest (25 pixels) in the DECT images. Stent attenuation was used to
compute the maximum threshold value and only pixels below the maximum value were
processed using the three-material decomposition algorithm.

7.2 Specific Aim 2
For specific aim 2, preliminary phantom studies were performed to develop
imaging protocol on the DECT scanner (Flash, Siemens) employing additional spectral
filtration. To achieve uniform enhancement during rapid aortic DECT imaging, patient
based modeling was performed in the time domain. As time domain modeling has not
been used for developing contrast injections, our preliminary work focused on
implementation of modeling test injection (use of saline as chase after contrast injection)
and enhancement data to accurately calculate impulse response, and further using the data
to calculate patient-specific contrast protocols in the time domain. Additionally, we
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developed an approach for implementing both basis spectral and basis material
decomposition for differentiating iodine and calcium.

7.2.1

Development of DECT Imaging Protocol on Flash
The DOE as described in 7.1.2 was repeated on an Alderson phantom imaged

with the second generation dual-source DECT scanner (Flash, Siemens). Images were
acquired at 80/140 kVp and 100/140 kVp with additional tin filtering applied to the 140
kVp tube. DECT protocol with the following scan parameters resulted in optimal noise
and dose values and was selected for imaging patients: non-ECG gated helical technique
with tube voltage, 100 kVp (Tube A), 140 kVp with tin filter (Tube B); quality reference
tube current-time product, 195 mAs (Tube A), 151 mAs (Tube B) with anatomic-based
tube current modulation employed for each tube; rotation time, 0.28 sec; beam
collimation, 64 x 0.6 mm; pitch, 0.65. Both 100 and 140 kVp image sets can be
reconstructed with 3.0 mm slice thickness and 3.0 mm slice increment using a mediumsmooth kernel (B31f).

7.2.2

Development of LTI Modeling in Time Domain
From tracer kinetics, we need to input a tracer into a system and measure the

output concentration to model the system. This is feasible in patients by injecting a small
bolus (10-20 ml) of contrast and measuring the resulting enhancement in a region of
interest. In fact, administration of small bolus (test bolus) is routinely used clinically for
determination of the appropriate scan delay (time between contrast injection and start of
the scan) used with the larger, diagnostic bolus. The contrast bolus is typically injected
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with a specified volume, flow rate, and injection duration and followed by saline using a
power injector. However, little is known about the utility of saline on the injection of
contrast into the venous system and the resulting measured enhancement curve, which are
critical for modeling patients as LTI system. So, the aim of this preliminary study was to:
(1) quantitatively evaluate the need for saline with the test injection for LTI modeling,
and (2) assess the feasibility of using the test injection and enhancement data to develop
modeling for patient-specific injections in the time domain for short duration imaging.
Applying tracer kinetics for contrast medium injection, patient can be considered
as a linear time-invariant (LTI) system [26]. The arterial enhancement (enh) could be
modeled as the convolution integral of the contrast agent flow rate (inj) and impulse
response of the patient (response to a Dirac impulse input, imp_resp)
t

enh(t) = ∫ imp_resp(τ ) • inj(t - τ ) • dτ

(7-3)

0

In the discrete domain, this can be approximated as

enh(n)= ∑ imp_resp(m
) • inj(n- m)

(7-4)

m

where m is the number of data points of the test bolus attenuation curve. For each patient
in this study, the two test bolus attenuation curves were used to estimate the effective
contrast profile (volumes and flow rates) of both test injections using customized
software (Excel Solver; Microsoft Corporation, Redmond, Wash). The mean differences
between the programmed and effective values of contrast volume and flow rate, as well
as 95% confidence intervals and Bland-Altman limits of agreement, were calculated for
both test injections.
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A total of 25 patients were included in the study. A single low-dose image was
obtained near the carina, and a circular region-of-interest (ROI) was drawn in the
ascending aorta (AA) to determine a baseline intensity value (attenuation without contrast
agent). This was followed by the administration of 2 test bolus injections: test injection
A, which consisted of 20 mL of contrast injected at 4.5 mL/s, and test injection B, which
consisted of 20 mL of contrast followed by 60 mL (for patients weighing < 90 kg) or 80
mL (for patients weighing ≥ 90 kg) of saline administered at 4.5 mL/s. The order of the
test injections was randomized, and an average of 4 minutes was allowed between
injections to eliminate any potential bias resulting from residual contrast from the
previous injection. From 10 s through 44 s after each injection, a test scan was performed
every 2 s at the same level (near the carina), with scan parameters as follows: number of
images, 18; tube voltage, 120 kVp; and tube current-time product, 40-60 mAs. Relative
time-attenuation curves (indicating enhancement due to contrast agent injection) were
obtained by subtracting the baseline intensity measured in the AA (prior to the injection
of contrast) from the absolute values measured from each test bolus method.

7.2.2.1 Impact of Saline on LTI Modeling
Each patient was considered as an LTI system characterized by an impulse
response (imp_resp). Using commercially available software (Excel Solver; Microsoft
Corporation, Redmond, Wash), the two effective inputs with test injections A and B (injA
and injB) were estimated by simultaneously using data from the two measured outputs of
test bolus attenuation curves (enhA-meas, enhB-meas) as described below (Figure 7-3):
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Algorithm
1. Assumed initial values for the unknowns (injA, injB, and imp_resp).
2. Computed the two convolved test enhancement curves by additive convolution of
impulse response with the corresponding inputs.

enh A - conv (n) = ∑ imp_resp(m ) • inj A (n - m)

(7-5)

m

enh B -conv (n) = ∑ imp_resp(m ) • inj B (n - m)

(7-6)

m

3. Computed sum of squared difference (error) between the measured and convolved
test bolus attenuation curves.

error = ∑ (enh A-meas - enh A-conv

)2 + (enh B-meas - enh B-conv )2

(7-7)

m

4. Minimized error while satisfying boundary conditions:
a. Impulse response must be non-negative.
b. Flow rate of contrast agent in both test injections must be non-negative
c. Flow rate of contrast agent in both test injections must be less than or
equal to the injected flow rate programmed in the injector (4.5 mL/s)
d. Total volume of contrast agent in each test injection must be less than or
equal to the injected volume programmed in the injector (20 mL).
Initial values of the two inputs and impulse response were modified with each
iteration. Iterations were converged by the program when a minimum error was
obtained along with feasible boundary conditions.
5. Obtained values for effective test injection profiles (injA, injB) along with patient
impulse response (imp_res).
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The volumes and flow rates of effective test injection profiles were compared with
programmed values (20 ml of contrast at 4.5 ml/s) using paired t-test with p <0.05
indicating difference was statistically significant.

Figure 7-3: Optimization technique used to estimate the effective test injection profiles
with and without saline along with the patient’s impulse response.

The results from the preliminary analysis showed that LTI modeling can be used
to determine the effective flow of contrast agent resulting from the injection of a contrast
only bolus and a contrast followed by saline bolus without any programming errors in all
25 patients (Figure 7-4).
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Figure 7-4: Effective contrast flow with test injections A (
) and B (
) along with
impulse response (
), measured (•) and convolved (---) test bolus attenuation curves
from test injection A, and measured (■) and convolved (---) test bolus attenuation curves
from test injection B. Graphs from a 67-year-old man weighing 88 kg showing (a)
administration of 13 mL of contrast at a maximum flow rate of 2.0 mL/s without use of
saline (test injection A) and the entire 20 mL of contrast at a flow rate of 4.5 mL/s with
the use of a 60-mL saline chaser (test injection B), and (b) the resulting measured and
convolved test attenuation bolus curves plus the patient’s impulse response. Graphs from
a 52-year-old woman weighing 115 kg showing (c) administration of 9 mL of contrast at
a maximum flow rate of 0.7 mL/s without use of saline (test injection A) and the entire 20
mL of contrast at a flow rate of 4.5 mL/s with the use of a 80-mL saline chaser (test
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injection B), and (d) the resulting measured and convolved test attenuation bolus curves
plus the patient’s impulse response.

The injector administered 20 mL of contrast at 4.5 mL/s for both test injections.
On average, however, only 13 mL of contrast was effectively delivered at 2.2 mL/s with
test injection A. With the use of saline after test injection B, the entire 20 mL of contrast
was injected at an effective rate of 4.4 mL/s. The mean difference, 95% confidence
interval for the mean difference, and Bland-Altman limits of agreement for volume and
flow rate were smaller for test injection B than for test injection A (Table 7.1), indicating
that programmed values were closer to being realized when saline was used after contrast
agent in a test bolus. These results demonstrate that saline flush is required to ensure the
programmed injection profile matches the effective injection profile and accurately model
the patient as an LTI system.
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Programmed

Effective

Mean

Value

Value

Difference

95% CI

Limits of
Agreement

Average volume of contrast (mL)
20 mL contrast
20 mL contrast followed by

13 ± 3

7.2 ± 3.4

5.8, 8.6

0.5, 13.9

20 ± 1

0.4 ± 1.3

0, 0.9

0, 2.9

20 ± 0

60/80 mL saline

Average flow rate of contrast (mL/s)
20 mL contrast
20 mL contrast followed by

2.2 ± 0.8

2.4 ± 0.8

2.0, 2.7

0.7, 4.0

4.4 ± 0.2

0.0 ± 0.2

0, 0.1

0, 0.4

4.5 ± 0

60/80 mL saline
Note. Data are mean ± standard deviation for programmed, effective, and mean difference values.
CI indicates the 95% confidence intervals for mean difference. Limits of agreement are the BlandAltman limits, indicating that 95% of all individual differences in patients lie within these limits.

Table 7.1: Impact of Saline on Contrast Volume and Flow Rate and Comparison with
Values Programmed in the Injector

7.2.2.2 Modeling of Contrast Injection
Using test bolus data, we performed LTI modeling in time domain and predicted
patient-specific contrast injection profiles that would achieve uniform enhancement in the
heart during fast cardiac MDCT scans. Hypothesizing that saline chase would impact
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tPME, scan delay was determined as 2 s + tPME from test injection B in each patient.
Further, a desired diagnostic enhancement of 300 HU in the heart [115] was defined for a
duration of 6 s after scan delay. Optimal patient-specific contrast injection protocols
were computed using the patient’s impulse response (described in section 7.2.2.1) and the
target diagnostic enhancement using non-linear optimization using the algorithm
described below (Figure 7-5).

Figure 7-5: Optimization technique for computing patient-specific injection profiles to
achieve uniform enhancement during a short duration cardiac scan.
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Algorithm
The impulse response of each patient was obtained as shown in section 7.2.2.1. Using
commercially available software (Excel Solver; Microsoft Corporation, Redmond,
Wash), a target diagnostic enhancement of 300 HU (enhdiag-target) was defined in the heart
for a 6-s scan (starting 2 s after tPME of the test bolus attenuation curve obtained from
test injection with saline) for each patient. An optimal patient-specific injection (injpat-sp)
was computed by minimizing the difference between the convolved diagnostic
enhancement (enhdiag-conv) and the desired target enhancement as described below:
1. Assumed initial values for the unknowns (injpat-sp).
2. Computed the convolved diagnostic enhancement curve by additive convolution
of impulse response with the patient-specific injection.

enhdiag-conv (n) = ∑ imp_resp(m) • injpat-sp (n - m)

(7-8)

m

3. Computed sum of squared difference (error) between the convolved and targeted
diagnostic enhancement curves during a 6-s scan duration.

(

error = ∑ enh diag-conv - enh diag -target

)2

(7-9)

n

4. Minimized error while satisfying following boundary conditions:
a. Flow rate of contrast agent must be non-negative.
b. Flow rate of contrast agent must be less than or equal to 7 mL/s
(physiologic limitations).
Initial values of patient-specific injection were modified with every iteration until
a minimum error was obtained along with feasible boundary conditions.
5. Obtained an optimal patient-specific injection (injpat-sp).
86

Preliminary result in a sample patient showed that patient-specific injection could
be predicted by performing LTI modeling in time domain to achieve the desired target
enhancement during a short duration cardiac MDCT scan (Figure 7-6).

Figure 7-6: Patient-specific injection predicted using LTI modeling to achieve 300 HU
(•) during a 6-s cardiac scan. A biphasic injection profile in a 60-year-old, 123-kg man
(BMI = 37.9 kg/m2) using a total of 52 mL of contrast () was required to achieve
uniform contrast enhancement of approximately 300 HU (-۔-۔-).

The results demonstrated that patient-specific contrast injection protocols could
be calculated in the time domain with convolution techniques and non-linear optimization
using data from test injection of contrast (followed by saline) and the resulting test
enhancement curve.
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8.

CHAPTER VIII

FEASIBILITY OF DUAL-ENERGY COMPUTED TOMOGRAPY IN THE
ARTERIAL PHASE: IMAGING AFTER ENDOVASCULAR ANEURYSM
REPAIR

The current chapter investigates the use of dual-energy CT (DECT) imaging
during arterial phase to generate virtual non-contrast (VNC) images. The VNC images
were compared to “true” non-contrast images routinely acquired using a single energy CT
scan. The feasibility of the study was evaluated by imaging 30 patients with an arterial
phase DECT protocol after endovascular aneurysm repair (EVAR) and described here.

8.1 Introduction
Endovascular aneurysm repair (EVAR) has become a reliable alternative to open
surgery for thoracic, thoracoabdominal, and abdominal aortic aneurysms [35, 37, 178].
Triple phase SECT is often used to evaluate patients 1 month, 6 months, and yearly after
such repairs [13]. The combination of non-contrast, arterial phase, and venous phase
SECT images is used to evaluate aneurysm size, stent-graft position and patency,
88

perigraft flow (endoleaks), graft fractures and kinks, and the patency of native vessels
near the graft [2, 3, 12-14]. Of concern is the high cumulative radiation dose to the
patient resulting from three-phase imaging in multiple follow-up examinations [15-17].
In an attempt to decrease radiation dose, studies have been conducted to
investigate eliminating one or more SECT acquisitions [179, 180] or limiting the
coverage of these acquisitions to stented segments. An emerging approach to reducing
radiation exposure is to replace two SECT acquisitions with one DECT acquisition [18,
19]. At DECT, data acquisition at two x-ray energies is followed by the reconstruction of
corresponding image sets with different attenuation properties [20-23]. DECT data
obtained during or after contrast injection can be used to generate not only arterial and
venous phase images but also VNC images [18, 19, 22, 24]. In studies of endoleak
detection [18, 19], DECT data have been acquired during the venous phase, but in no
studies to date, to our knowledge, has the feasibility of arterial phase DECT acquisition
been evaluated. The presence of high-density iodinated contrast medium adjacent to other
high-density materials, such as a stent and calcium, and, in many cases, the lack of
uniformity of contrast attenuation along the length of the aorta increase the challenge of
generating VNC CT images from arterial DECT data.
Our rationale for investigating the utility of arterial phase DECT is based on
considerations for EVAR and for future clinical applications of DECT. In the context of
EVAR, arterial images are important for the evaluation of luminal details, in particular
smaller branch vessels. In other indications for aortic imaging (aneurysm, dissection,
aortitis, preoperative and postoperative evaluation), arterial phase acquisition is the
clinical standard. Reliable reconstruction of VNC CT images from arterial DECT scans
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may yield information about tissue characteristics (e.g., intramural hematoma, surgical
material, low-density calcium versus contrast medium) in these situations.
The purpose of this study was to test the feasibility of replacing routine noncontrast and arterial phase SECT images with VNC and dual-energy arterial phase
images obtained in one arterial DECT acquisition and to estimate the resulting radiation
dose (single-energy venous phase acquisition was included in both the standard and the
study protocols). A secondary purpose was to describe the effect of dual-energy
acquisition on the attenuation of tissues of interest for overall assessment of anatomic
features after EVAR.

8.2 Material and Methods
8.2.1

Patients
This study was approved by the local institutional review board with waiver of

consent

and

was

compliant

with

HIPAA.

Only

patients

without

standard

contraindications to contrast-enhanced CT undergoing follow-up after EVAR and at least
one standard triple-phase SECT examination after EVAR were included in the study. A
total of 30 patients were prospectively identified. Patient characteristics, including age,
sex, weight, and body mass index (weight in kilograms divided by height squared in
meters), were noted.

8.2.2

Data Acquisition and Image Reconstruction
A dual-source CT scanner (Definition, Siemens Healthcare) with two x-ray tubes

(tubes A and B) was used to acquire data [21]. On the basis of preliminary phantom data
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and data on five patients not described in this report but supporting the suitability of VNC
CT for evaluation after EVAR, we decided to spare the patients radiation exposure and to
forgo acquisition of true non-contrast data. Hence, with our study protocol, each patient
was imaged only with arterial phase DECT followed by venous phase SECT, and imageprocessing techniques were used to generate non-contrast images from arterial phase
DECT data. The resulting scan time and dose–length product (DLP) were recorded.
Patient size indexes (maximum lateral width in the thorax and abdomen) were measured
from the anteroposterior radiograph acquired at the start of the examination.

Arterial phase DECT—The optimized contrast injection and scan protocol developed for
arterial phase DECT was based on preliminary data. In this protocol, 120–150 mL of
contrast medium (iopromide, Ultravist 370, Bayer HealthCare Pharmaceuticals) was
injected at a flow rate of 3.0 mL/s, and the descending aorta was monitored at 140 kVp.
Once a 120-HU threshold was reached, breathing instructions were given, and DECT
scanning of the chest, abdomen, and pelvis was performed with non-ECG-gated helical
technique (tube voltage, 140 kVp tube A, 80 kVp tube B; effective tube current–time
product, 110 mAs tube A, 467 mAs tube B, anatomy based tube current modulation for
each tube; rotation time, 500 milliseconds; beam collimation, 14 × 1.2 mm; pitch, 0.6).
Both 80-kVp and 140-kVp image sets were reconstructed with 3.0-mm slice thickness
and 3.0-mm slice increment with a medium-smooth kernel (D30f).

Venous phase SECT—A second non-ECG-gated helical scan covering the same
anatomic region was obtained 60 seconds after contrast injection according to our
standard SECT protocol (tube voltage, 120 kVp tube A; effective tube current–time
product, 270 mAs tube A with anatomy-based modulation; rotation time, 500
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milliseconds; beam collimation, 24 × 1.2 mm; pitch, 0.8). Images were reconstructed
with 3.0-mm slice thickness and 3.0-mm slice increment with a medium-smooth kernel
(B31f) and used without further modifications for venous phase analysis.

True non-contrast SECT from previous examination—True non-contrast images
acquired with the same CT scanner, scan acquisition, and reconstruction parameters used
for venous phase SECT were obtained from our archiving system. Anteroposterior
topographic images also were retrieved, and the maximum lateral width in the thorax and
abdomen was measured.

8.2.3

Dual-Energy Image Processing

Weighted-average arterial images—A weighted-average arterial image set was obtained
by linear combination of 80- and 140-kVp attenuation values (30%/70%) for all pixels.

VNC CT images—VNC CT images were generated with dual-energy postprocessing
software (Liver VNC, Syngo DE, Siemens Healthcare) on the basis of three-material
decomposition. In the algorithm, it is assumed that each voxel is composed of three
materials (fat, soft tissue, and iodine), and the known attenuation of these materials at 80
and 140 kVp is used to calculate their relative contributions to the voxel and to generate
an iodine distribution image. A VNC CT image is obtained by subtracting the iodine
distribution image from a weighted-average arterial image.
Important input parameters for the commercial software include the average
attenuation values for fat and soft tissue, the ratio of contrast attenuation (luminal
attenuation at 80 kVp/luminal attenuation at 140 kVp), and a maximum attenuation value
or threshold above which voxels are excluded from processing. These parameters were
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modified from default settings to customize postprocessing for follow-up after EVAR.
The manufacturer default values for fat and soft tissue at 80 and 140 kVp were replaced
with average attenuation values determined from our preliminary studies with five
patients. In these patients, a circular region of interest of approximately 100 pixels was
drawn in fat and subcutaneous (or soft) tissue on both 80- and 140-kVp axial images.
Multiple measurements were made at different locations within and across patients.
Average attenuation values of –115 and –94 HU were noted for fat and 75 and 61 HU for
soft tissue on both 80-and 140-kVp images. The default ratio of contrast attenuation in
the software was replaced with two custom values measured separately in the thoracic
and abdominal aorta to generate VNC CT images of the two regions separately. Finally,
the maximum threshold for each patient was reset to the attenuation of stent material
obtained by measuring CT attenuation from multiple circular regions of interest (25
pixels) in the weighted-average arterial images.

8.2.4

Radiation Dose Measurements
The effective dose in millisieverts was estimated as the product of the DLP in

milligray · centimeters and a conversion coefficient, k, in mSv/(mGy · cm) [20]. The
value of k is 0.014 for the chest and 0.015 for the abdomen and pelvis; the average k for a
single scan encompassing all three regions is 0.015. The total effective dose (EDTotal) for
each patient in our study was estimated with the DLPs from arterial DECT arterial
(DLPDECT Arterial) and venous SECT (DLPSECT Venous) acquisitions, as follows:

EDTotal = k · (DLPDECT Arterial + DLPSECT Venous)
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(8-1)

Because the venous SECT acquisition parameters are typically used for all three phases
of a standard imaging protocol, the total effective dose was estimated as:

ED’Total = k · (3· DLPSECT Venous)

8.2.5

(8-2)

Clinical Evaluation
Without blinding, a radiologist (8 or 16 years of experience in cardiovascular CT)

and a vascular surgeon independently, subjectively evaluated the images in routine
clinical follow-up to detect the presence of endoleaks and to evaluate the appearance of
stents and calcium. Endoleaks were defined as the presence of contrast material within
the aneurysm sac beyond the stent on weighted-average arterial phase DECT images
and/or venous phase SECT images and the absence in the corresponding location on
VNC CT images. Stents and calcium were visually assessed on virtual image noncontrast, weighted-average arterial and venous images.

8.2.6

Tissue Attenuation and Image Noise
A circular region of interest encompassing approximately 300 pixels was drawn at

multiple locations in the lumen of the thoracic aorta beginning at the level of the
pulmonary artery bifurcation and in the abdominal aorta starting at the level of the celiac
artery. Regions of interest were placed at the same z-axis locations based on anatomic
landmarks on VNC CT, arterial phase DECT (80 kVp, 140 kVp, weighted-average), and
venous phase SECT images from the study examination and on true non-contrast SECT
images acquired from the preceding triple-phase CT examination of each patient. The
average attenuation and SD were recorded at all locations.
94

The attenuation of thrombus present outside the stent was identified and measured
at the same locations in image sets from all three phases. Image noise was defined as the
SD in the aortic lumen on true non-contrast, VNC, arterial 80-kVp (SD80), arterial 140kVp (SD140), and venous images and calculated as follows on weighted-average arterial
images:
2

(0.7 ⋅ SD
2

2
140

2
+ 0.3 2 ⋅ SD80

)

(8-3)

Statistical Analysis: A paired Student’s t test was used to compare total effective dose for
the standard and study protocols. The scan times for dual-energy and SECT acquisitions
also were compared by use of paired Student’s t tests. To evaluate the ability of threematerial decomposition to remove iodine from arterial images, luminal attenuation on
VNC CT images was compared with that on previously acquired true non-contrast
images by use of a paired Student’s t test. Mixed-model one-way analysis of variance
was used to compare the attenuation of thrombus on VNC CT, weighted-average arterial,
and venous phase images. If the overall F-test value was significant, Tukey-Kramer
adjustments were used to make pairwise comparisons between image sets.
To analyze the effect of DECT acquisition on image quality, noise on DECT
arterial and SECT venous images acquired during the study examination was compared
in both the thoracic and abdominal regions by use of paired Student’s t tests.
Furthermore, noise on VNC CT images derived from DECT images and previously
acquired true non-contrast images were compared in both regions, again by use of a
paired Student’s t test. Because of the time lapse between the acquisitions of virtual and
true non-contrast images, patient size indexes obtained from the anteroposterior
radiograph acquired at the start of each examination were compared by use of a paired
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Student’s t test to determine whether a change in patient size had occurred that could
compromise noise comparisons. For all statistical analyses, p ≤ 0.05 was considered
significant.

8.3 Results
8.3.1

Clinical Evaluation
All patients underwent imaging with the study protocol (arterial phase DECT

followed by venous phase SECT) (Table 8.1); images of the chest, abdomen, and pelvis
were obtained.

Characteristic

Value

No. of patients

30

Male/female ratio

21/9

Age (y)

72 (35-88)

Weight (kg)

82 (45-116) *

Body mass index (kg/m2)

27 (18-38) †

Note Data are mean with range in parenthesis.

* Data obtained from 28 patients.
† Data obtained from 27 patients.

Table 8.1: Patient Demographics.

VNC CT and weighted-average arterial DECT images were generated from 80and 140-kVp arterial data (Figure 8-1) with a processing time of less than 5 minutes for
each patient. All images were deemed diagnostic by the radiologist and vascular surgeon
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and satisfied clinical requirements. Repetition of imaging (according to our standard
protocol) was not necessary for any patient.

Figure 8-1: 87-year-old 74-kg man after endovascular aneurysm repair for abdominal
aortic aneurysm. (A) Axial dual-energy VNC CT image shows non-contrast blood (33
HU) in aorta. Axial arterial phase (B) weighted-average, (C) 80-kVp, and (D) 140-kVP
images show high-attenuation contrast material (342 HU, 526 HU, and 263 HU,
respectively) in aorta.

Endoleaks (Figure 8-2) were detected in seven patients on the arterial phase
images and in one patient on the venous phase images. Thrombus was detected and
measured outside the stent in 28 of 30 patients. Thrombus was identified within the
stented lumen in one of the other two patients and was not present in the other; both
97

patients were excluded from thrombus analysis. Previously acquired true non-contrast
images of the chest were not available for five patients and of the abdomen for one
patient. Hence, luminal attenuation and noise comparisons were performed only for the
thoracic aorta in 25 patients and the abdominal aorta in 29 patients.

Figure 8-2: 76-year-old 52-kg woman with CT evidence of endoleak after endovascular
aortic repair. A, DECT VNC image (A) shows no contrast material outside the stent in
the aneurysm sac (arrow). (B) Weighted-average arterial phase DECT and (C) venous
phase SECT images show contrast enhancement.

In these patients, true non-contrast scans preceded the study examination by an
average of 7 months (range, 1–15 months) without interval acute events. Comparison of
patient size indexes measured from the topograms acquired in the previous and current
examinations (maximum thoracic width, 37.9 vs 39.6 cm; maximum abdominal width,
37.4 vs 38.9 cm) showed no significant difference (p > 0.1, paired Student’s t test),
indicating there was no change in patient body habitus within the scanned region between
CT time points.
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8.3.2

Radiation and Contrast Dose Measurements
The total effective radiation dose was significantly lower with the study (EDTotal,

26 mSv) than with the standard protocol (ED'Total, 37.5 mSv). An average radiation dose
reduction of 31% (range, 26.5%–34.2%) was realized for each patient examination
through elimination of the non-contrast acquisition (Figure 8-3). The dose reduction for a
given patient depended on the patient’s anatomic features and the subsequent efficiency
of anatomy-based tube current modulation during both dual-energy and SECT
acquisitions. Although DECT required a longer scan time (34 seconds) than SECT (15
seconds), the contrast injection flow rate for DECT (3.0 mL/s in the study protocol) was
lower than that for SECT (3.5 mL/s with our routine arterial protocol), yielding
equivalent contrast volumes for the single and dual-energy protocols.

Figure 8-3: Graph shows replacing two (non-contrast [light gray] and arterial phase
[dark gray]) of three SECT acquisitions in standard triple-phase protocol with single
arterial phase DECT acquisition in study protocol while retaining SECT venous phase
(white) acquisition in both protocols results in significant 31% dose
reduction.
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8.3.3

Tissue Attenuation
Average luminal attenuation in the thoracic and abdominal aorta on VNC CT

images was 32 HU and 30 HU, respectively, indicating the presence of non-contrast
blood [181]. Although the attenuation of blood on true non-contrast images was slightly
higher than on VNC CT images (Table 8.2), the magnitude of the difference was small
(mean difference, 3 HU in the thorax and 5 HU in the abdomen), indicating sufficient
removal of iodine from arterial DECT images by means of three-material decomposition
(Figure 8-4).

Figure 8-4: 57-year-old 74-kg man after endovascular stenting of descending thoracic
aorta. Comparison of (A) VNC CT image generated from DECT data obtained during
current examination with (B) true non-contrast image acquired at 120 kVp during
previous examination. Mean attenuation values of 28 HU and 31 HU were measured in
aorta on A and B, indicating presence of blood in lumen. Noise (SD of mean attenuation
in aorta) from VNC CT images (11 HU) was lower than noise from true non-contrast
images (24 HU). Stent (arrow) in A appears with lower attenuation than B.

For low-attenuation tissue such as thrombus (Figure 8-5), measurements on VNC
CT images were similar to measurements on weighted-average arterial but lower than
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those on venous images (Table 8.2). However, the attenuation measured on VNC (18–47
HU) and weighted-average arterial (18–47 HU) and venous (22–46 HU) images indicates
a range of thrombus attenuation values typically observed on SECT images [181, 182].
This finding shows that neither DECT acquisition nor VNC generation significantly
alters the attenuation of low-density tissue. For high-attenuation objects such as stents
and calcium, attenuation values varied significantly across images sets. At some
locations, some stent struts (Figure 8-5) and calcium (Figure 8-6) had lower attenuation
on VNC CT images than on weighted-average arterial and venous images, indicating that
some voxels of high-attenuation material were still below the user-defined threshold and
were processed during generation of VNC images.

(A)

(B)

(C)

Figure 8-5: Images from a 79-year-old 81-kg man show effect of DECT on tissue
attenuation. (A) Axial VNC CT DECT, (B) weighted-average arterial phase DECT, and
(C) venous phase SECT images show stent (arrow) and thrombus in excluded aneurysm
sac (star). Thrombus attenuation measures 24 HU in A, 26 HU in B, and 25 HU in C,
showing that low-attenuation tissues such as thrombus have similar attenuation in all
three phases. High-attenuation materials such as stent, however, have low attenuation on
VNC images.
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Tissue Type

n

Attenuation (HU)

25

32 ± 2

p

Blood in Thoracic Aorta
Virtual non-contrast

35 ± 4

True non-contrast

< 0.05

Blood in Abdominal Aorta
Virtual non-contrast

29

30 ± 3
35 ± 5

True non-contrast

< 0.05

Thrombus
Virtual non-contrast

28

32 ± 6

Weighted-average arterial

33 ± 7

0.07

Venous

34 ± 6

< 0.05

Note n indicates number of patients contributing to average values.
Attenuation values are mean ± SD.
Virtual non-contrast images were generated from arterial DECT data from current exam.
True non-contrast images were obtained from a previous clinical examination.
Values of p were obtained by paired Student’s t test (for blood attenuation) or TukeyKramer test (for thrombus attenuation) in comparison with virtual non-contrast images.
All p < 0.05 were considered statistically significant.

Table 8.2: Tissue Attenuation Measurements in Various Image Sets
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Figure 8-6: 76-year-old 103-kg man with stable endovascular stent-graft in abdominal
aorta. (A) Axial VNC DECT image shows decreased calcium attenuation (arrow) in wall
of aneurysm sac than in (B) venous phase SECT image.

8.3.4

Image Noise
VNC CT images were less noisy than routinely used true non-contrast images in

both the thoracic and abdominal aorta (Table 8.3) (p < 0.05). Therefore, noise on VNC
images was considered acceptable for clinical review. Noise was lower on weightedaverage arterial DECT images than on venous SECT images of the abdominal aorta
(Table 8.3) (p = 0.05), indicating an acceptable noise level for this image type in the
abdomen. Although noise on arterial DECT images of the thoracic aorta was slightly
greater than that on venous SECT images (Table 8.3) (p < 0.05), the magnitude of the
average difference (3 HU) was considered negligible by our readers because it did not
interfere with clinical interpretation. Therefore, the image noise for arterial phase DECT
of the thorax was considered acceptable.
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Location

n

Noise (HU)

25

10 ± 1

p

Thoracic Aorta
Virtual non-contrast

13 ± 4

True non-contrast
Weighted-average arterial

25

16 ± 2
13 ± 2

Venous

< 0.05

< 0.05

Abdominal Aorta
Virtual non-contrast

29

12 ± 2
19 ± 5

True non-contrast
Weighted-average arterial

29

21 ± 3
23 ± 5

Venous

< 0.05

0.05

Note n indicates number of patients contributing to average values.
Attenuation values are mean ± SD.
Virtual non-contrast images were generated from arterial phase DECT data from current
examination.
True non-contrast images were obtained from a previous clinical examination.
Values of p were obtained by paired Student’s t test.
All p < 0.05 were considered statistically significant

Table 8.3: Comparison of Noise Measurements on DECT and SECT Images.

8.4 Discussion
The results of our study show the feasibility of using arterial DECT acquisition to
obtain both VNC and arterial phase CT images. In combination with venous SECT
acquisition, substitution of one arterial phase DECT acquisition for both non-contrast and
arterial phase single-energy acquisitions led to an overall 31% average dose savings with
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no significant loss of diagnostic information in follow-up after EVAR. Virtual and true
non-contrast images had similar aortic luminal attenuation.
Thrombus attenuation values on VNC, arterial, and venous images were similar.
High-attenuation materials in the aneurysm sac, such as endoleak and calcium were
appropriately differentiated on VNC CT images. Although iodine in endoleaks on arterial
and/or venous images was removed at the corresponding locations on VNC CT images,
calcium was present on images from all three phases. However, stent and calcium had
decreased attenuation at some locations on VNC images, indicating improper
identification of these materials as iodine with the three-material decomposition
algorithm. Noise from DECT was considered similar to noise from SECT.

8.4.1

Technical Considerations
Commercially available three-material decomposition software is designed to

operate with a single contrast ratio for iodine removal from the entire set of VNC CT
images. Results of our preliminary studies indicated this approach can result in very small
or even negative aortic luminal attenuation on VNC CT images of patients with
inhomogeneous enhancement along the length of the aorta. Therefore, each DECT
arterial phase image set was processed twice with two different contrast ratios computed
separately for the thoracic and abdominal aorta. Use of this procedure resulted in luminal
attenuation on VNC images similar to that on true non-contrast images.
The significant decrease in the attenuation of high-density materials observed at
some locations on VNC images compared with weighted-average arterial and venous
images in both the current and previous studies [18, 19] was a limitation of the three105

material decomposition algorithm, in which it is assumed that each voxel is a
combination of only fat, tissue, and iodine. A voxel containing any other material was
still decomposed into a mixture of these three basis materials, and in the case of highdensity materials, the voxels were assumed by the algorithm to contain iodine. This
improperly identified material was then removed by the software, resulting in reduced
attenuation of the voxel. In an attempt to preserve the attenuation values of stent material
in this study, only voxels below a threshold equal to the weighted-average stent
attenuation were processed for each patient. Even with this approach, however, the
attenuation of some stent and even some calcium voxels on VNC CT images appeared
with reduced attenuation, indicating that these voxels were below the threshold (Figure 85).
A significant increase in the attenuation of high-density materials was observed at
some locations on both VNC and weighted-average arterial images compared with
venous images. When calcium and stent voxels were above the threshold, attenuation
values at 80 and 140 kVp were combined in a 30%/70% ratio, resulting in higher
attenuation values than those obtained at the same location with 120 kVp. These
observations indicate that this linear mixing ratio may not be optimal for maintaining
attenuation of high-density materials on DECT images that is similar to the attenuation
on SECT images obtained at 120 kVp.
Another technical consideration with DECT is the high noise associated with 80
kVp, particularly in imaging of large patients. In their study of venous phase DECT,
Chandarana et al. [18] excluded heavy patients (≥ 90 kg) with a large abdominal diameter
(>35 cm) to avoid poor image quality. In a similar study, Stolzmann et al. [19] reported a
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false prediction of endoleak in a patient with a body mass index of 36.5. In our study, no
patients were excluded on the basis of size. Yet noise did not affect clinical interpretation
even in six obese patients (102–116 kg; body mass index, 29.9–37.7). Moreover, in
contrast to the observation by Chandarana et al., with our approach, VNC CT images
were less noisy than true non-contrast images (Table 8.3). We also observed in our study
that, on average, noise from the weighted-average arterial DECT image set was similar to
that on venous phase SECT images, indicating that mixing 30% 80-kVp data with 70%
140-kVp data did not exact a noise penalty.
For both single- and dual-energy CT, dose requirements for the long-scan-range
aortic studies necessitated ungated data acquisition with slow gantry rotation times.
Inevitable misregistration artifacts present on the original 80- and 140-kVp images of
some patients were amplified on VNC CT images (Figure 8-7). These artifacts can be
reduced by use of either faster rotation times (0.33 vs 0.5 second) or ECG-referenced
techniques. However, the improved temporal resolution would further limit the maximum
power available for the lower-energy images and might result in increased noise. In
addition, the use of an ECG-referenced technique would require a substantial increase in
radiation dose, which does not seem justified, because the observed artifacts were not
found to interfere with clinical evaluation. Use of a new dual-source CT system (Flash,
Siemens Healthcare) with very high pitch ECG-referenced helical data acquisition [28]
may significantly reduce radiation exposure, allowing lower-dose ECG-gated single- or
dual-energy CT of the aorta.
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Figure 8-7: 76-year-old woman with weight of 52 kg who presented for follow-up of
endovascular stent for thoracoabdominal aortic rupture. Images show misregistration
artifacts (arrows) as result of ungated and low-temporal-resolution data acquisition.
Arterial phase DECT image obtained at (A) 80 kVp, (B) 140 kVp. (C) VNC DECT
image.

8.4.2

Limitations
Because of radiation exposure concerns, acquisition of true non-contrast data was

not included in our study protocol, preventing direct comparison of VNC and true noncontrast images obtained at the same time. We relied on previously acquired true noncontrast data to illustrate two main points: iodine was sufficiently removed from the
vessel lumen on VNC images and noise was sufficiently low on VNC images. Because
both true and VNC image sets were obtained with the same scanner and because patient
size in the scanned region was unchanged in the interval between examinations, we
believe the use of current VNC and previously acquired true non-contrast image sets to
establish these points was valid.
Reliance on VNC images may not be appropriate for follow-up imaging soon
after EVAR because residual contrast material in the excluded aneurysm sac likely would
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be removed and not visible on VNC images [19]. Hence, patients in the immediately
post-EVAR period were excluded from our study to avoid misdiagnosis. Images from
different phases were qualitatively assessed for the presence of endoleaks; quantification
and classification were considered outside the focus of this study. Similarly, the presence
of calcium in the aneurysm sac was assessed visually but not quantified. Because some
voxels containing stent metal and calcium (attenuation below threshold) were processed
with the three-material decomposition algorithm and some voxels (above the threshold)
were not, a quantitative evaluation of stent and calcified regions was not appropriate.

8.5 Conclusion
We conclude that both VNC and arterial phase images can be obtained from a
single arterial DECT acquisition rather than from two separate SECT acquisitions. The
attenuation of low-density tissues was similar on the dual-energy and standard SECT
images, but the attenuation values of high-density materials differed significantly.
Nevertheless, VNC and weighted-average arterial images from DECT can replace true
non-contrast and arterial phase SECT images, respectively, in the follow-up of patients
who have undergone EVAR (except immediately after the procedure) to provide
comparable diagnostic information with an average dose savings of 31%.
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9.

CHAPTER IX

IMPROVED DIFFERENTIATION OF CALCIUM AND IODINE WITH DECT
IMAGING

This chapter focuses on developing new approaches to address the limitations of
the three-material decomposition algorithm and non-uniform enhancement during
generation of virtual non-contrast (VNC) images described in the previous chapter. A
linear-time invariant based mathematical modeling approach for developing patientspecific contrast protocols for achieving uniform enhancement during the scan was
described in this chapter. Also a three-material decomposition algorithm based on a
combined basis spectral and basis material approach developed to improve VNC image
generation is explained here. Finally, the feasibility of applying the algorithm in both invitro and in-vivo studies was demonstrated.

9.1 Introduction
DECT has the ability to identify iodine from its surrounding tissues based on
differences in atomic number, density and energy of the x-ray spectrums employed [22,
183, 184]. A recent study by Numburi et al [183] evaluated the feasibility of generating
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VNC images using dual-energy technique on a first generation dual-source CT scanner
(Definition, Siemens) in arterial phase. But, due to limitations of the three-material
decomposition algorithm provided by the manufacturer, spectral overlap of the two
energy spectra employed (80 and 140 kVp) and non-uniform contrast enhancement,
calcium and iodine were not discriminated well resulting in removal of calcium in the
VNC images [183].
The manufacturer implementation of the basis three-material decomposition
algorithm assumes that each voxel is composed of fat, soft tissue and iodine, and the
attenuation of these materials is solved to identify and eliminate contrast pixels during
VNC generation. However, as calcium is not considered as one of the three basis
materials, discrimination between contrast material and calcium is challenging. The three
material decomposition algorithm can be improved by assuming calcium, blood and
contrast as the basis materials present in each pixel and employing a combined basis
spectral [77] and basis material analysis [79] to the DECT images to differentiate the
components of the mixture.
Spectral overlap of the two x-ray energies used for dual-energy imaging on the
first-generation dual-source DECT scanner (Definition, Siemens) also hampers
separation of calcium and iodine. Smaller spectral separation pose a challenge for
separating materials with similar atomic numbers [142]. Hence, improving spectral
separation between the two tube voltages has the potential to better differentiate and
quantify tissue like calcium and iodine. A recent study by Primak et al [142] on second
generation dual-source CT scanner (Flash, Siemens) showed that additional filtration of
the low energies in the 140 kVp spectrum increased the difference of dual-energy ratio
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(DEratio, defined as the ratio of CT numbers of the material and high and low energy)
between tissues with similar atomic numbers (like calcium and iodine).
In this study, the potential improvement in VNC generation from DECT was
explored by employing (1) an additional filter to separate the x-ray spectra for DECT
imaging, (2) a customized basis spectral and basis material decomposition algorithm, and
(3) an optimization algorithm for administrating patient-specific contrast protocols.

9.2 Material and Methods
9.2.1

Contrast Injection Optimization Algorithm
Using tracer kinetics, the effective flow profile of contrast in the venous system

with the test injections can be estimated. Fleischmann et al suggested that a patient could
be assumed as a linear time-invariant (LTI) system and arterial enhancement (enh) could
be modeled as the convolution integral of the contrast agent flow rate (inj) and impulse
response of the patient (imp_resp)
enh(n) = ∑ imp_resp(m ) • inj(n - m)
m

(9-1)

A test bolus of 20 mL of contrast agent followed by saline should be administered
to a patient and the resulting test bolus attenuation curve can be measured. Using the test
bolus data, LTI modeling can be performed in the time domain to predict patient-specific
contrast injection profiles that would achieve uniform enhancement in the CT images.
The target enhancement and scan duration desired during the diagnostic scan can be
defined and optimal patient-specific contrast injection protocols can be computed using
non-linear optimization algorithm as explained in section 7.2.2.2. A paper describing
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modeling of the contrast injections for short duration CT scans in explained in detail in
Appendix 4.

9.2.2

VNC Theory And Algorithm Development
Basis spectral method can provide the effective atomic number and density of the

mixture [77] and basis material analysis can identify the mass fraction of the individual
elements of the mixture [79]. Assuming, that each pixel consists of calcium, iodine and
blood, the combined spectral and material approach can be implemented as described:
Step 1: Find effective density and atomic number of the mixture in each pixel



Perform DECT measurements using spectrally separate 80 and 140 kVp acquisition
with additional filtration.



Measure CT number of the tissue from both 80 and 140 kVp images.



Compute the linear attenuation coefficient at both energies from definition of CT
number using linear attenuation of water at 80 and 140 kVp.
 HU80 
+1 • µ
 1000 

water, 100

(9-2)

 HU140 
+1 • µ
 1000 

water, 140

(9-3)

µ 80= 

µ 140 = 


Model the linear attenuation coefficient using the continuous x-ray spectrum S(E) and
detector sensitivity D(E) of the CT scanner

µ
µ = C • ρeff ∫ w(E) •  (E, Z eff ) • dE
ρ
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(9-4)

where, w(E) is the weighting function calculated from S(E) and D(E) for 80 and 140
kVp data (Figure 9-1), and C is an empirical value [C=1 for Zeff<10 and C=1.45(0.05*Zeff) for Zeff ≥10].

Figure 9-1: Weighting factor w(E) at 80 and 140 kVp for DECT scanner (Flash, Siemens
Medical Systems, Forchheim, Germany).



Compute the functions (f80 and f140) using w(E) for 80 and 140 kVp spectrum, and
mass attenuation coefficient of elements (Z=1 to 30) from National Institute of
Standards and Technology database [185]. Plot the ratio of the functions for all the
elements (Figure 9-2).

µ
f 80 = ∫ w80 (E) •   E, Z eff • dE
ρ

(9-5)

µ
f140 = ∫ w140 (E) •   E, Z eff • dE
ρ

(9-6)

(

)

(

)
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f 80 (Z )
= Fn(Z )
f140 (Z )

(9-7)

2.4
2.2

Fn

2.0
1.8
1.6
1.4
1.2
1.0
0

5

10

15

20

25

30

Z

Figure 9-2: Plot of Fn(Z) as function of atomic number (Z).


Calculate ratio of linear attenuation coefficient from 80 and 140 kVp from (9-1) and
(9-2) to obtain the effective atomic number of the mixture from Figure 9-2.

µ80
= Fn(Z )
µ140


(9-8)

Calculate density of the material.

ρ eff =

µ80
C • f100

(9-9)

Step 2: Find mass fractions of the three components of the mixture



Calculate linear attenuation coefficient at 80 and 140 kVp using ρeff from Step 1


 
 
µ
µ
µ
µ80 = C • ρeff  x1.∑ w80 •   • dE +  x2.∑ w80 •   • dE  +  x3.∑ w80 •   • dE



 ρ 3
 ρ 2
 ρ 1
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(9-10)



 
 
µ
µ
µ
µ140 = C • ρeff  x1.∑ w140 •   • dE  +  x2 .∑ w140 •   • dE  +  x3.∑ w140 •   • dE 
 
 


 ρ 3
 ρ 2
 ρ 1

 
 

(9-11)

where x1, x2, x3 are the mass coefficients of the three basis material.



Apply conservation of mass to the three component system

x1 + x2 + x3 = 1



(9-12)

Use linear attenuation coefficients from (9-1) and (9-2), and solve equations (9-8), (99) and (9-11) simultaneously with non-negative, non-linear least square optimization
to obtain values for x1, x2, x3.

Step 3: Create VNC image



Identify the amount of iodine and contrast agent in a pixel from step 2 and eliminate
the iodine content to create a VNC image.
A customized algorithm comprising of Steps 1 to 3 was developed (Matlab, The

Mathworks Inc., Natick, MA) to generate VNC images.

9.2.3

In-Vitro Study
All phantom and patient scans were performed using a second generation dual-

source DECT scanner (Flash, Siemens Healthcare, Forchheim, Germany) employing a tin
filter for removal of lower energies from the 140 kVp spectrum for improving spectral
separation (Figure 9-3).
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Figure 9-3: Plot of weighting function of x-ray spectrum at 80 kVp, 140 kVp and 140
kVp with tin filter as a function of energy. The tin filter applied to the 140 kVp spectrum
filtered lower energies allowing better separation between the 80 and 140 kVp energies.

To validate the proposed basis spectral and basis material algorithm, phantom
studies containing mixtures of water with calcium based hydroxyapatite [HA: Ca5(PO4)3
(OH)] or with iodinated contrast agent were performed. A phantom containing of total of
six HA inserts (QRM, Möhrendorf, Germany) and ten inserts of varying concentrations
of contrast agent was developed to simulate a range of CT numbers observed clinically in
patients. The HA inserts were composed of mixtures of water equivalent material and
HA. The contrast inserts were made up of varying mixtures of water with iodinated
contrast agent (Ultravist 240, Ultravist 300 or Ultravist 370, Berlex, Montville, NJ)
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containing 240, 300 and 370 mgI/mL respectively (Table 9.1). The theoretical densities
and mass fractions of each insert were known.

Insert

Iodine concentration
(mgI/mL)

Total volume
(mL)

Contrast
volume (mL)

Water
volume (mL)

1

240

10

9.7

0.3

2

240

10

9.5

0.5

3

240

10

9.3

0.7

4

300

10

9.8

0.2

5

300

10

9.6

0.4

6

300

10

9.4

0.6

7

370

10

9.8

0.2

8

370

10

9.7

0.3

9

370

10

9.6

0.4

10

-

10

0

10

Table 9.1: Composition of the ten inserts composed of aqueous contrast mixtures.

The phantom was imaged with the following parameters: tube voltage, 80 kVp
(Tube A) and 140 kVp with tin filter (Tube B); effective tube current-time product, 248
mAs (Tube A) and 134 mAs (Tube B); rotation time, 0.33 sec; beam collimation, 64 x 0.6
mm; pitch, 0.2. Both 80 and 140 kVp image sets were reconstructed with 0.6 mm slice
thickness and 0.6 mm slice increment using a medium-smooth kernel (D30f).
The DECT images were analyzed using the spectral analysis and material
decomposition algorithm to first calculate the effective atomic number (Zeff) and density
(ρeff) of the imaged tissues as described in Step 1 in 9.2.1. The iodinated contrast pixels
were identified and differentiated from calcium. Finally, the mass fractions of aqueous
contrast solutions was computed and compared with theoretically known values.
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9.2.4

In-Vivo Study
The patient-specific contrast protocols along with combined basis spectral and

basis material algorithm for VNC generation were intended to be evaluated in one
patient, who was imaged with a non-contrast SECT, arterial DECT and venous SECT
protocol.

True non-contrast SECT—A true non-contrast scan was acquired using a non-ECGgated helical scan prior to contrast injection according to standard SECT protocol (tube
voltage, 120 kVp tube A; effective tube current–time product, 220 mAs tube A with
anatomy-based modulation; rotation time, 500 milliseconds; beam collimation, 128 × 0.6
mm; pitch, 0.8). Images were reconstructed with 3.0-mm slice thickness and 3.0-mm
slice increment with a medium-smooth kernel (B31f).

Arterial phase DECT—The study design proposed administration of patient-specific
contrast protocols for arterial DECT imaging. However, from preliminary patient analysis
not described here, the contrast attenuation was observed to be uniform along the length
of the aorta (Figure 9-4). This is primarily due to the decreased scan time (15 s) with the
second generation dual-source DECT scanner as compared to the first generation scanner
(Definition, Siemens, scan time = 34 s). Hence, patient-specific injections were deemed
unnecessary and optimized contrast protocols were not implemented in the patients.
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Figure 9-4: Plot of enhancement vs. time showing uniform contrast enhancement (415 ±
10 HU) in a patient imaged with a uniphasic contrast protocol and DECT scan protocol
on a second generation dual-source DECT scanner.

In addition, Primak et al [142] suggested the use of 100 and 140 kVp (with
additional filtration) in large patients to decrease noise and increase contrast in DECT
images on the second generation dual-source DECT scanner. Hence, although the
phantom scans were performed using 80 and 140 kVp with tin filter, patient scans were
performed using 100 and 140 kVp with tin filter in attempt to decrease noise in patient.
Therefore, for arterial DECT imaging, a routine uniphasic contrast protocol consisting of
100 mL of contrast with 30 mL saline chase was administered at 3.5 mL/s and a nonECG gated helical acquisition was performed using the following parameters: tube
voltage, 100 kVp (Tube A), 140 kVp with tin filter (Tube B); quality reference tube
current-time product, 195 mAs (Tube A), 151 mAs (Tube B) with anatomic-based tube
current modulation employed for each tube; rotation time, 0.28 sec; beam collimation, 64
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x 0.6 mm; pitch, 0.65. Both 100 and 140 kVp image sets can be reconstructed with 3.0
mm slice thickness and 3.0 mm slice increment using a medium-smooth kernel (B31f).

Venous phase SECT—A third non-ECG-gated helical scan was obtained 5 minutes after
contrast injection with standard SECT protocol (tube voltage, 120 kVp tube A; effective
tube current–time product, 160 mAs tube A with anatomy-based modulation; rotation
time, 500 milliseconds; beam collimation, 32 × 1.2 mm; pitch, 0.8). Images were
reconstructed with 3.0-mm slice thickness and 3.0-mm slice increment with a mediumsmooth kernel (B31f).

Image Analysis—Arterial DECT image from the patient were analyzed as described in
the flow chart below (Figure 9-5) using the combined basis spectral and basis material
algorithm to create VNC images. Attenuation and noise were measured in the true noncontrast, arterial 140 kVp, and VNC images. To evaluate the impact of eliminating
contrast from arterial phase images with the VNC algorithm, attenuation from VNC
images were compared with those from true non-contrast and arterial 140 kVp images. In
addition, to assess the noise from DECT acquisition, noise from VNC was compared to
true non-contrast. To evaluate the impact of VNC generation using combined basis
spectral and basis material algorithm on high density substances, calcium and stent
attenuation were visually compared between VNC and true non-contrast images.

121

Figure 9-5: Flow chart of three-material decomposition in patients.
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Finally, the effective dose in millisieverts were estimated as the product of the
DLP in milligray · centimeters and a conversion coefficient, k, in mSv/(mGy · cm) [20].
The value of k is 0.014 for the chest and 0.015 for the abdomen and pelvis; the average k
for a single scan encompassing all three regions is 0.015. The total effective dose for the
patient in our study was estimated with the DLPs from true non-contrast SECT (DLPSECT
True non-contrast),

arterial DECT (DLPDECT

Arterial)

and venous SECT (DLPSECT

Venous)

acquisitions, as follows:

EDTotal = k · (DLPSECT True non-contrast + DLPDECT Arterial + DLPSECT Venous)

(9-13)

The total effective dose with the elimination of the true non-contrast scan in the patient
was also estimated:

ED’Total = k · (DLPDECT Arterial + DLPSECT Venous)

(9-14)

9.3 Results
9.3.1

In-Vitro Study
The reconstructed images acquired at 80 and 140 kVp with additional tin

spectrum from the in-vitro studies are shown in Figure 9-6. The average CT numbers of
calcium inserts varied from 184 to 1123 HU in 80 kVp images and from 137 to 710 in
140 kVp images. The mean CT numbers of the contrast solutions ranged from 252 to 732
HU in the 80 kVp images and from 88 to 258 HU in the 140 kVp images.
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Figure 9-6: Axial images of phantom with HA cylinders and aqueous iodinated mixtures
at (A) 80 kVp and (B) 140 kVp with additional tin filter.

Combined spectral and material analysis algorithm clearly differentiated calcium
and iodinated pixels in the phantom studies (Figure 9-7). The mass fraction of the
aqueous contrast solutions estimated using the proposed algorithm were in good
agreement with known values, with a mean error of 3% (Table 9.2).
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Figure 9-7: Axial images of phantom showing identification of only (A) iodine pixels in
contrast agent and (B) calcium pixels in HA.

1
2

Theoretical mass
fraction
0.963
0.938

Computed mass
fraction
0.994
0.985

3

0.914

0.980

7

4

0.974

0.995

2

5

0.948

0.988

4

6

0.922

0.988

7

7

0.972

0.988

2

8

0.959

0.985

3

9

0.945

0.983

4

Insert

Error (%)
3
5

Table 9.2: Comparison between theoretical and calculated mass fractions of aqueous
contrast mixtures.
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9.3.2

In-Vivo Study
One patient (male, 67 y, 94 kg) was imaged with true non-contrast SECT, arterial

DECT, and venous SECT scans. VNC images were successfully generated from the
arterial DECT (100 and 140 kVp) images using the combined basis spectral and basis
material algorithm. Average aortic lumen attenuation of 57 HU was measured in the
VNC images as compared to 222 HU in the arterial 140 kVp and 61 HU in the true noncontrast images indicating removal of iodinated contrast and presence of unattenuated
blood in VNC images (Figure 9-8).

(A)

(B)

(C)

Figure 9-8: Axial images in a patient showing aortic luminal attenuation in the aorta (A)
57 HU in VNC, (B) 222 HU in arterial 140 kVp, and (C) 61 HU in true non-contrast
images.

Noise from VNC images (35 HU) was higher as compared to noise from true noncontrast images (24 HU) suggesting increased noise associated with DECT acquisition.
Both calcium (Figure 9-9) and stent material appeared with slightly decreased intensity in
VNC images showing false identification of certain pixels of the high density materials as
iodine.
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(A)

(B)

Figure 9-9: Axial images in a patient showing calcium (white arrow) in (A) VNC and
(B) true non-contrast images. Calcium appeared with decreased attenuation in VNC
images.

The DLP from the arterial DECT acquisition (877 mGy-cm) was similar to the
true non-contrast acquisition (869 mGy-cm). Elimination of a true non-contrast scan from
a triple phase scan (EDTotal = 35.3 mSv) would decrease the total effective dose to 22.2
mSv (ED’Total) resulting in dose savings of 37%.

9.4 Discussion
Combined spectral and material based algorithm for three-material decomposition
of DECT images can be used to discriminate materials having similar high atomic
numbers. Additionally, improved spectral separation using an energy selective filter to
remove the low energy photons from the high energy spectrum with an energy spectrum
can improve calcium-iodine separation [142]. Our study demonstrates the feasibility of
differentiating iodine from calcium, and calculating mass fractions of contrast agent
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mixtures accurately in phantom models. The accurate identification of contrast pixels
helps to generate VNC images without contrast agent, while retaining calcium. This may
help to provide description of anatomy as well as characterization of calcifications and
differentiate them from contrast material from a single contrast-enhanced DECT scan.
In the in-vitro study, we used different volumes and concentrations of contrast
agent in aqueous solutions in order to simulate a range of CT numbers observed clinically
in patients. In some cases, the mixing resulted in similar CT numbers. For example,
mixing of 9.6 mL of 300 mgI/mL with 0.4 mL of water and 9.7 mL pf 370 mgI/mL with
0.3 mL of water resulted in similar CT numbers. The former mixture measured 463 and
163 HU and the later mixture measured 463 and 156 HU on 80 and 140 kVp images
respectively. But, the mass fractions were identified with relative small errors (4% and
3%) respectively in each case demonstrating that combined use of spectrally separate
energy spectrum for imaging and algorithm proposed in the study can accurately quantify
iodine. However, these errors may be amplified in clinical scenarios; especially where the
CT numbers of low attenuating contrast agent and bone may be close.
In the patient study, contrast was accurately identified and eliminated from VNC
images which were similar to true non-contrast images. However, in-vivo studies showed
that pixels containting tissues with high atomic numbers (stent/calcium), but low
densities were fasely identified as iodine by the algorithm. Hence, these pixels appeared
with decreased attenuation in VNC images. The attenuation values from VNC could not
be compared to true non-contrast images as they were acquired using different tube
voltages and attenuation of tissue depends on tube voltage employed for scanning.
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The algorithm utilizes the measured CT numbers from the images and hence
factors affecting CT numbers such as beam hardening need to be addressed in order to
have accurate values. While the beam hardening artifacts can be corrected by using the
basis spectral and basis material method in the pre-reconstruction space, its
implementation is a time intensive task. Hence, we used the algorithm in the postreconstruction space where the algorithm is relatively easy to implement and executes in
a short amount of time.
Although noise did not impact our phantom study, it plays a critical factor in
VNC generation in patients. Hence, 100 kVp and 140 kVp spectrum were employed for
patient study as suggested by Primak et al [142] instead of the 80 and 140 kVp spectrum
used for phantom scan. The current implementation of DECT scanner with spectrally
separate x-ray energies [28] uses 100 kVp on tube A and 140 kVp with additional tin
filter on tube B. Tube A has a scan field of view (SFOV) of 50 cm, while tube B has a
limited SFOV of 33 cm and may result in noisy images in patients. This can increase the
noise in the images causing decreased separation between low density calcium and
iodine, thus allowing false identification of calcium as iodine in few pixels. Hence,
employing 140 kVp with tin filter on Tube A and 100 kVp on tube B may help to
decrease noise and improve segmentation of iodine to create VNC images. Another
approach to decrease noise may be possible with use of energy resolving photon-counting
detectors [186-188] where photons are assigned to multiple energy bins.
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9.5 Conclusion
A three-material decomposition algorithm based on combined basis spectral and
basis material analysis for differentiating calcium and contrast agent with DECT imaging
was developed. Phantom data demonstrates the feasibility of the proposed algorithm to
compute the mass fraction of contrast agent mixtures. This method can be applied
clinically for the identification and removal of iodine in contrast-enhanced DECT images,
allowing generation of VNC images. However, high attenuating pixels with low density
values appear with decreased intensity in VNC images.
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10.

CHAPTER X

OPTIMIZATION OF ACQUISITION AND CONTRAST-INJECTION
PROTOCOL FOR C-ARM CT IMAGING IN TRANSCATHETER AORTIC
VALVE IMPLANTATION: INITIAL EXPERIENCE IN A SWINE MODEL

The current chapter explains the development of protocols for acquiring 3D Carm CT images using an existing 2D C-arm system in the interventional suite. The study
focuses on the feasibility of developing 3D images and their utility before, during and
after transcatheter aortic valve implantation (TAVI) procedure.

10.1

Introduction
Aortic stenosis, the most common type of native valvular heart disease [40, 41]

has a significant impact on cardiovascular mortality and morbidity [40, 41, 43].
Transcatheter aortic valve implantation (TAVI) has developed into a viable option for
patients with aortic stenosis who are deemed high risk for surgical aortic valve
replacement due to multiple comorbidities [58, 59, 61-64, 189, 190]. The valve is
implanted within the native valve using transfemoral, transapical, or trans-subclavian
methods. With any of these approaches, clinicians need detailed knowledge regarding the
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location of the native aortic valve and the aortic anulus (AN) to place the valve accurately
and prevent coronary complications, aortic regurgitation, valve embolization and
conduction abnormalities. With increasing use of TAVI, the central role of periprocedural
imaging has been recognized. However, the optimal imaging approach is still evolving
[191]. During TAVI, conventional angiography and transesophageal echocardiography
(TEE) are critical for interventional guidance. However, these modalities are limited by
their 2-dimensional (2D) nature.
More recently, 3-dimensional (3D) multidetector row computed tomography
(MDCT) and 3D TEE have been used in the context of TAVI to describe aortic root
anatomy and orientation [11, 71, 192-194]. Availability of this 3D information appears
valuable for visualization and intraprocedural guidance. However, the direct use of
MDCT images in this way has been limited because of registration challenges between
3D MDCT and 2D fluoroscopic images. Rotating a C-arm system around a patient allows
for acquisition of 3D C-arm CT images in the catheterization laboratory [195]. The 3D Carm CT images can be used for overlaying on the 2D fluoroscopy images obtained from a
C-arm system for guidance during TAVI. Alternatively, the 3D images from C-arm CT
and preprocedural MDCT can be registered to facilitate overlay of the high definition
MDCT images onto the live 2D fluoroscopic images for more accurate and safer valve
positioning during TAVI. For both the procedures, it is critical to have C-arm CT images
with adequate contrast opacification and optimal image quality.
C-arm CT imaging has been described in the context of endovascular repair of
aortic aneurysm [158, 196, 197], ablation procedures in electrophysiology [121, 198], and
other cardiac interventions [195, 199]. A recent study by Kempfert et al [170] showed the
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feasibility of obtaining C-arm CT images of the aorta for stent/valve implantation during
TAVI using a transapical approach. However, a systematic study exploring different Carm CT imaging techniques and injection protocols in the context of TAVI has not yet
been performed.
In this study, we sought to systematically determine optimal contrast and imaging
protocols for obtaining C-arm CT images before TAVI in a swine model and to compare
the resulting image measurements with those from MDCT. We then sought to evaluate
the utility of overlaying 3D preprocedural MDCT images onto real-time 2D fluoroscopy
images for intraprocedural guidance during TAVI, and finally to assess the feasibility of
making post-TAVI measurements from C-arm CT images.

10.2

Materials and Methods

10.2.1 Animal Preparation
This study was approved by the local Institutional Animal Care and Use
Committee. A total of 6 swine (average weight = 53 kg) were sedated (ketamine 10
mg/kg and xylazine 0.1-0.2 mg/kg via intramuscular injection) and prepared for TAVI.
The animals were intubated and mechanically ventilated. Anesthesia was maintained with
isoflurane (1 to 2.5%). During transportation between the operating room and the CT
scanner, isoflurane was stopped and intravenous propofol was administered (loading
dose, 3-5 mg/kg to effect). While sheaths were placed in the femoral arteries and veins to
prepare for the TAVI procedure, intravenous heparin (100 to 300 U/kg) was administered
to prevent thrombosis. After imaging and valve placement, the sedated animals were

133

sacrificed with an intravenous injection of pentobarbital sodium 390 mg/mL and
phenytoin sodium 50 mg/mL.

10.2.2 Image Acquisition
10.2.2.1

Pre-TAVI

Preprocedural MDCT images were obtained with a dual-source scanner
(Definition, Siemens Healthcare, Forchheim, Germany). Using an 18-gauge needle, we
injected a total of 75 to 80 mL of contrast agent (Ultravist 370 mgI/mL, Berlex,
Montville, NJ) at 5 mL/s for 15 to 16 s followed by 30 mL of saline (same flow rate)
through a peripheral vein (Table 10.1); we monitored the ascending aorta using bolus
tracking to determine the scan delay. Once a threshold of 120 Hounsfield units (HU) was
reached in the ascending aorta, an electrocardiogram (ECG)-gated helical scan of the
heart was performed during suspended ventilation so that data could be obtained during a
breath hold with the following scan parameters: tube voltage, 120 kVp; tube current-time
product per rotation, 400 mAs; rotation time, 0.33 s; beam collimation, 64 × 0.6 mm; and
pitch, 0.4 to 0.6 (heart rate dependent). Images were reconstructed at 70% to 75% of the
RR interval (heart rate dependent) with a slice thickness of 0.75 mm and a slice
increment of 0.4 mm using filtered back projection with a medium smooth kernel (B26f).
During the TAVI procedure, but before valve implantation, all swine were also
scanned with a C-arm CT imaging system (Axiom-Artis with syngo DynaCT, Siemens
Healthcare, Forchheim, Germany). Data were obtained with different image acquisition
(ungated and ECG-gated C-arm CT), cardiac rhythm (rapid pacing and normal sinus
rhythm [no pacing]), and contrast injection (peripheral and aortic root) protocols. Both
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ungated and ECG-gated C-arm CT protocols were acquired during suspended ventilator
respiration.
C-arm CT modulates x-ray exposure to maintain a constant dose at the detector:
first, by increasing the tube current-time product per pulse; and second, by increasing the
tube voltage [103]. The scan parameters employed for C-arm CT imaging in this study
were as follows: frame rate, 60 frames/s; detector entrance dose, 0.54 µGy per x-ray
pulse, with automatic modulation of tube voltage from 75 to 125 kVp and tube current
from 150 to 692 mAs; angular rotation, 220°; projections per rotation, 235; and scan
time, 5 s/rotation.
Ungated C-arm CT data were acquired during a single spin for 5 s during normal
sinus rhythm with aortic root (Method 1) or peripheral (Method 2) injection and during
rapid ventricular pacing at approximately 200 beats per minute with aortic root injection
(Method 3). Ungated 3D images with 0.4-mm isotropic spatial resolution were
reconstructed using all of the data acquired at different angular positions (Figure 10-1A).
ECG-gated C-arm CT data were obtained during 4 (2 forward and 2 backward) spins for
24 s during normal sinus rhythm with either aortic root (Method 4) or peripheral (Method
5) injection. ECG-gated 3D images with 0.4-mm isotropic spatial resolution were
reconstructed from data acquired in approximately the same cardiac phase at different
angular positions during the spins (Figure 10-1B). Additionally, a non-contrast, ungated
C-arm CT image was acquired during normal sinus rhythm to obtain baseline attenuation
values.
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Figure 10-1: Ungated and ECG-gated C-arm CT Imaging. (A) Ungated C-arm computed
tomography (CT) images reconstructed using data acquired continuously at different
angular positions during a single 5-s spin. (B) Electrocardiogram (ECG)-gated C-arm CT
images reconstructed from data acquired in approximately the same cardiac phase at
different angular positions during 4 spins (represented by blue, green, red, and yellow)
for 24-s.
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Based on our previous experience [200], we injected contrast (Ultravist 370
mgI/mL) alone or mixed with saline but did not follow this injection with a saline flush.
Contrast was administered to each animal via a peripheral vein with an 18-gauge needle
or through direct injection into the aortic root with a standard 6-F pigtail catheter (Table
10.1). The time between the start of injection and the start of the C-arm CT scan (scan
delay) was determined based on the injection site.
For ungated C-arm CT with aortic root injections (Methods 1 and 3), a total
injection volume (contrast and saline) of 65 to 90 mL was administered at 10 to 15 mL/s,
and images were acquired 1 to 2 s after the start of injection. For ungated C-arm CT with
peripheral injection (Method 2), an undiluted contrast volume of 50 to 65 mL was
injected at 6 to 7 mL/s, and the scan delay obtained from MDCT was decreased by 2 to 4
s to account for the higher flow rates (6-7 mL/s with C-arm CT vs 5 mL/s with MDCT).
ECG-gated C-arm CT was acquired by administering 120 to 145 mL of contrast at 4 to 6
mL/s for 22 to 30 s either in the aortic root (Method 4) or via peripheral vein (Method 5).
While 1-2 s scan delay was used for aortic root injections, the scan delay for peripheral
injection was adjusted by decreasing/increasing the scan delay from MDCT as the flow
rate with C-arm CT was increased/decreased in comparison to MDCT (Table 10.1) to
allow sufficient time for contrast to travel from the peripheral vein to the heart [115].
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rhythm

Normal sinus

16-28

22-30

4-6

120-145

370

Peripheral

Rapid pacing

1-2

22-30

4-6

120-145

370

Aortic root

ECG-gated C-arm CT

rhythm

Normal sinus

16-22

7-9

6-7

50-65

370

Peripheral

rhythm

Normal sinus

1-2

6-7

10-15

65-90

370

Aortic root

Ungated C-arm CT

CT Imaging.
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Table 10.1: Contrast Injection Parameters and Cardiac Rhythm Status During ECG-gated MDCT and ECG-gated and Ungated C-arm

Normal sinus rhythm

18-26

Scan delay, s

Cardiac rhythm during imaging

15-16

Injection duration, s

Flow rate, mL/s

5

75-80

Total volume (contrast and saline

mixture), mL

370

Peripheral

Injection site

Iodine concentration, mgI/mL

ECG-gated MDCT

Parameter

10.2.2.2

TAVI procedure

3D MDCT images were overlaid onto 2D real-time fluoroscopy images for
catheter guidance and placement of prosthetic valve during TAVI procedure.

The

registration of 3D MDCT images with 2D fluoroscopic images was performed using the
C-arm CT images in multiple steps. First, the MDCT images acquired before TAVI were
loaded into a software application (syngo InSpace, syngo X Workplace, Siemens
Healthcare) to mark the AN and coronary ostia. Second, the 3D images from MDCT and
C-arm CT were registered using an automatic, intensity-based registration algorithm
(syngo 3D Fusion, syngo X Workplace, Siemens Healthcare). This algorithm evaluates
the common characteristics between the two 3D sets and iteratively matches them based
on intensity data to enable registration. Manual corrections were made when necessary to
fit the image sets accurately using anatomic features or the catheter placed in the aortic
root. Finally, information from image registration of the preprocedural MDCT and preTAVI C-arm CT were used to overlay the previously marked structures from MDCT (AN
and coronary ostia) onto the real-time fluoroscopic images for guidance in placing the
valve prosthesis.

10.2.2.3

Post-TAVI

The imaging protocol post-TAVI included only a single scan. The animals were
scanned once with ungated C-arm CT imaging during normal sinus rhythm using aortic
root injection (Method 1).

139

10.2.3 Image Analysis
10.2.3.1

Pre-TAVI

All contrast-enhanced MDCT and C-arm CT images acquired pre-TAVI were
assessed for aortic root opacification, presence of artifacts, visibility and measurements
of aortic root structures.
Aortic root opacification was evaluated quantitatively by measuring attenuation
values at the level of the aortic root in all contrast-enhanced images. In addition,
measurements were performed at approximately the same location in non-contrast C-arm
CT images to obtain a baseline value (attenuation in the absence of contrast). Aortic root
opacification was deemed sufficient in MDCT images when the attenuation measurement
was greater than 250 HU. In C-arm CT images, aortic opacification was deemed
sufficient when attenuation values in contrast-enhanced images were significantly higher
than the baseline. However, we could not compare the attenuation measurements from Carm CT with those from MDCT because of the different x-ray tube voltages employed in
the scans: although the tube voltage is constant during a MDCT scan, the voltage varies
during a C-arm CT scan.
Images were evaluated for the presence of artifacts arising from motion and/or
beam hardening using a 4-point grading scale: 1 = no artifacts, with clear visibility of all
aortic root structures (coronary cusps and coronary ostia); 2 = mild artifacts not
interfering with visibility of aortic root structures; 3 = moderate artifacts preventing
visibility of some aortic root structures; and 4 = severe artifacts impeding visibility of all
aortic root structures.
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The contrast-enhanced C-arm CT and MDCT images were assessed for anatomic
landmarks critical for device placement and success during TAVI, including the aortic
annulus (AN), sinus of Valsalva (SOV), sinotubular junction (STJ), and mid-ascending
aorta (mid-AA). The number of visible coronary cusps and coronary ostia was quantified,
and the images were evaluated for the presence and orientation of aortic valve
calcifications. From reformatted sagittal and axial C-arm CT images, we measured the
mean AN diameter (average of the minimum and maximum diameters) and the diameters
of the SOV, STJ, and mid-AA, as described elsewhere [71]; these results were compared
with those obtained from MDCT.
Contrast volumes used for the various C-arm CT methods were compared. The
imaging method using minimal contrast volume, resulting in images with the highest
attenuation measurement and lowest artifact score, and leading to measurements of aortic
root structures similar to those obtained with MDCT was considered the optimal method.
MDCT images were used to predict the orientation of the aortic root relative to
the body axis in X-ray angiographic projection angles perpendicular to the valve plane
[10, 68, 201, 202]. The images were reformatted to a double-oblique view to correspond
to X-ray angiographic images, and the angiographic projections (left anterior oblique
[LAO]/right anterior oblique [RAO] and cranial/caudal) were displayed. The
cranial/caudal angulations for the standard LAO 40, LAO 0, and RAO 20 angiographic
projections and the LAO angulation for cranial/caudal 0 were noted [10, 68]. Similar
analysis was performed for the optimal C-arm CT images to predict optimal angiographic
projection angles; these results were compared with those from MDCT.
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10.2.3.2

Post-TAVI

C-arm CT images acquired after TAVI were reviewed to evaluate the valve
prosthesis implantation and to measure the diameters of the stent, STJ, and mid-AA and
the vertical distance of the stent from the left coronary ostia.

Statistical analysis: One-way analysis of variance (ANOVA) was used to test for
statistically significant differences in attenuation values among the C-arm CT methods
including the non-contrast C-arm CT; artifact scores and contrast volumes among the Carm CT methods; and pre-TAVI measurements among the C-arm CT methods and
MDCT. If a significant difference was found, the Tukey test was used to make pairwise
comparisons between image sets. Once the optimal C-arm CT method was determined,
Bland-Altman analysis was used to assess the mean difference, 95% confidence interval,
and limits of agreement between this method and MDCT for obtaining pre-TAVI
diameters. A paired Student t test was used to compare optimal angiographic projections
obtained from the optimal C-arm CT method with those obtained from MDCT. All
statistical analyses were performed using StatGuideTM (version 13.32, Minitab® Statistical
Software, State College, PA) and a p value <0.05 was considered statistically significant.

10.3

Results

10.3.1 Pre-TAVI
MDCT and C-arm CT scans were successfully performed in all subjects. ECGgated helical MDCT imaging during normal sinus rhythm with peripheral contrast
injection resulted in images with sufficient aortic root opacification (mean attenuation
>250 HU) and without any artifacts (mean artifact score = 1.0) and served as the
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reference standard (Table 10.2, Figure 10-2). C-arm CT Method 2 (ungated acquisition,
sinus rhythm, peripheral injection) resulted in nonevaluable images, as the contrast bolus
was missed in the aortic root during imaging. Hence, these images were removed from
further analysis.
C-arm CT protocols: Ungated C-arm CT images acquired without contrast
injection resulted in a baseline root attenuation value of 86 ± 10. Mean attenuation
measurements in C-arm CT images from Methods 1, 3, 4, and 5 were significantly above
the baseline value, and aortic root enhancement was deemed sufficient in these images
(ANOVA test, p < 0.05). However, the mean attenuation values among the contrastenhanced C-arm CT protocols were not significantly different (Table 10.2; Tukey test, p
> 0.05).
Artifact scores for Methods 1 and 4 indicated moderate artifacts, whereas scores
from Methods 3 and 5 suggested only mild artifacts (Table 10.2, Figure 10-2). However,
no significant differences were shown for artifact scores within the various C-arm CT
protocols (Table 10.2; ANOVA test, p > 0.05).
The AN, SOV, STJ, and mid-AA were visible in all evaluated C-arm CT images.
Out of 12 coronary ostia identified with MDCT, 2, 11, 8 and 12 were visible in C-arm CT
images with Methods 1, 3, 4, and 5, respectively (Table 10.2). Out of 18 coronary cusps
identified with MDCT, 16, 18, 15, and 18 were observed in C-arm CT images with
Methods 1, 3, 4, and 5, respectively (Table 10.2). Calcification was not observed in the
valves; hence, valve calcifications could not be evaluated.
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12/12
18/18

Visibility of coronary ostia

Visibility of coronary cusps

18/18

11/12

15/18

8/12

3.0 ± 0.8

1,005 ± 229

Aortic root

rhythm

Normal sinus

Yes

Method 4

18/18

12/12

2.2 ± 0.4

599 ± 222

Peripheral

rhythm

Normal sinus

Yes

Method 5
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Table 10.2: Analysis of Images Obtained From ECG-gated MDCT and C-arm CT Methods. Data are expressed as mean ± SD.

16/18

2/12

2.6 ± 0.5

1.0 ± 0

Artifact score

2.0 ± 0.6

1,226 ± 216

1,168 ± 341

523 ± 172 HU

Aortic root opacification

Aortic root

rhythm

rhythm

Rapid pacing

No

Method 3

C-arm CT

Aortic root

Normal sinus

No

Method 1

Normal sinus

Yes

MDCT

Peripheral

Injection site

Cardiac rhythm status

ECG gating

Parameter

Figure 10-2: Sagittal Images Obtained From MDCT and C-arm CT Methods. (A)
Multidetector row computed tomography (MDCT) image acquired with peripheral
injection showing no artifacts. C-arm CT image acquired from (B) Method 1 showing
moderate artifacts, (C) Method 3 showing mild artifacts, (D) Method 4 showing moderate
artifacts, and (E) Method 5 showing mild artifacts.
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In axial images reconstructed along the centerline from C-arm CT acquisitions
obtained with aortic root injections, measurement of the AN diameter was limited,
secondary to lack of contrast opacification below the valve (Figure 10-3). However, it
was possible to measure the annulus in sagittal images (Figure 10-4).

Figure 10-3: Comparison of Axial C-arm CT Images at the Level of the Aortic Annulus
Images obtained using (A) electrocardiogram (ECG)-gated C-arm computed tomography
(CT) with peripheral injection and (B) ungated C-arm CT with aortic root injection.
Aortic root contrast injection resulted in lack of opacification below the valve.
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Figure 10-4: Images From Ungated C-arm CT During Rapid Pacing With Aortic Root
Injection. (A) Volume-rendered computed tomography (CT) image of aortic root
showing the coronary arteries. Multiplanar reformatted images of well-enhanced aortic
root showing (B) vertical distance from aortic annulus (AN) to right coronary artery
(RCA) along with minimum AN diameter, and (C) distance from AN to left coronary
artery (LCA) along with maximum AN diameter.

Mean diameters of AN, STJ, and mid-AA measured with MDCT and C-arm CT
methods were not significantly different (Table 10.3). However, the SOV diameter
measured with ungated C-arm CT during normal sinus rhythm with aortic root injection
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(Method 1) was significantly smaller (Tukey test, p < 0.05) than the diameter seen with
MDCT and with the other C-arm CT protocols (Table 10.3).

Parameter
Average aortic annulus

C-arm CT

MDCT
2.1

Method 1
2.1

Method 3
2.0

Method 4
2.1

Method 5
2.1

2.6*

2.1*

2.5

2.5

2.5

2.0

2.1

1.8

1.8

1.8

2.1

2.1

1.9

1.9

1.9

diameter, cm
Sinus of Valsalva
diameter, cm
Sinotubular junction
diameter, cm
Mid-ascending aorta
diameter, cm
* indicates p<0.05 using paired Tukey test.

Table 10.3: Pre-TAVI aortic root measurements From MDCT Reference Images and Carm CT Images.

On average, ungated C-arm CT imaging required significantly lower contrast
volumes for aortic root injections (36 and 50 mL at 13 mL/s with Methods 3 and 1
respectively) in the study versus ECG-gated C-arm CT imaging with both peripheral and
aortic root injections (133 and 135 mL at 5 mL/s with Methods 5 and 4 respectively)
(Table 10.4; Tukey test, p < 0.05).
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Parameter

Method 1

Method 3

Method 4

Method 5

Total injection volume, mL

85 ± 11

80 ± 10

135 ± 22

133 ± 24

Contrast volume, mL

50 ± 15

36 ± 13

135 ± 22

133 ± 24

Saline volume, mL

35 ± 14

44 ± 17

0±0

0±0

Injection flow rate, mL/s

13 ± 2

13 ± 2

5±1

5±1

Injection duration, s

6±0

7±1

27 ± 3

27 ± 3

Data are expressed as mean ± SD

Table 10.4: Total injection volume, contrast volume, saline volume, and injection flow
rate for C-arm CT methods.

Optimal C-arm CT protocol: Ungated C-arm acquisitions during rapid pacing
with aortic root injection (Method 3) employed minimum contrast volume (36 mL),
resulted in images with the highest attenuation value (1,226) and the lowest artifact score
(2.0), and demonstrated image measurements similar to those from MDCT. The average
differences of the pre-TAVI root diameters between MDCT and optimal C-arm CT lie
within the Bland-Altman limits of agreement (Table 10.5). Further, there is no
relationship between the average difference between the two methods and the mean preTAVI root measurements. These results indicate that C-arm CT Method 3 can be used to
obtain pre-TAVI diameters similar to MDCT. The angiographic projections (cranial
angulations for the standard LAO 40, LAO 0 and RAO 20 as well as LAO angiogram
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corresponding to cranial/caudal 0 angulation) from MDCT and optimal C-arm CT were
not significantly different (Table 10.5; Student t-test, p>0.5).

Pre-TAVI measurements
Root measurement

Average difference

CI

Limits of agreement

AN (cm)

-0.12 ± 0.12

(0.25, 0.01)

(-0.37, 0.13)

SOV (cm)

-0.08 ± 0.14

(0.23, 0.06)

(-0.34, 0.19)

STJ (cm)

-0.17 ± 0.21

(0.72, 0.39)

(-0.59, 0.27)

mid-AA (cm)

-0.2 ± 0.22

(0.79, 0.39)

(-0.67, 0.26)

Optimal Angiographic Projections
Projection

MDCT

Optimal C-arm CT

LAO 40

16 ± 7

16 ± 6

LAO 0

20 ± 7

18 ± 5

RAO 20

18 ± 6

16 ± 4

Cranial/caudal 0

94 ± 7

99 ± 17

Note: Pre-TAVI measurements from MDCT and C-arm CT method were compared using
Bland-Atlman analysis. Average difference are expressed as mean ± SD, CI refers to the
95% confidence intervals for mean difference, and limits of agreement refer to the BlandAltman limits. Optimal angiographic projections were compared between MDCT and
optimal C-arm CT method using paired Student t-test.

Table 10.5: Comparison of aortic root diameters and angiographic projections from
optimal C-arm CT (Method 3) with MDCT.
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10.3.2 TAVI Procedure
Registration of 3D MDCT with 2D fluoroscopic images for intraprocedural
guidance during TAVI was successful. The TAVI procedure was performed using a
transfemoral approach in the swine. The AN and coronary ostia marked on original
MDCT images were also observed on 3D registered images from MDCT and C-arm CT.
The identified regions of interest from MDCT were then overlaid on the 2D fluoroscopic
images and were used to accurately place the valve prosthesis within the AN while
avoiding the coronary ostia (Figure 10-5).

Figure 10-5: Images from MDCT Fused With Fluoroscopy. (A) 3-dimensional (3D)
multidetector row computed tomography (MDCT) image with coronary ostia (yellow
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lines) and aortic annulus (AN) (white line) marked. (B) Overlay of 3D MDCT images on
2-dimensional (2D) fluoroscopy image showing the catheter in the aortic root. (C) 2D
image with contrast injected in the aortic root showing the AN and coronary arteries.

10.3.3 Post-TAVI
Ungated C-arm CT imaging during normal sinus rhythm using aortic root
injection was successfully performed. The resulting images were evaluable with
sufficient enhancement but with moderate artifacts. Ungated C-arm CT images obtained
after TAVI clearly showed the valve prosthesis after implantation (Figure 10-6).

Figure 10-6: Images From Ungated C-arm CT. (A) Multiplanar reformat (MPR) C-arm
CT image showing the valve and catheter before valve deployment. (B) MPR image
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showing the placement of the valve without any coronary occlusions. (C) Volumerendered image showing the valve after deployment.

The STJ and mid-AA were clearly visible in all images (average diameter, 1.8 and
1.6 cm, respectively). The mean diameter of the stent and vertical distance of the stent
from the ostia were 2.2 cm and 1.6 cm, respectively.

10.4

Discussion
Our systematic comparison of contrast injection and scan acquisition protocols

with C-arm CT in a swine model of TAVI demonstrated that ungated C-arm CT during
rapid ventricular pacing with aortic root injection provides the optimal combination of
minimal contrast, good aortic root visualization, mild artifacts, and aortic root
measurements that correlate closely with those obtained by MDCT. Without rapid
pacing, ungated C-arm CT imaging with aortic root injection during native sinus rhythm
resulted in sufficient aortic root enhancement but was associated with moderate artifacts;
gated protocols required increased contrast injection.
For patients undergoing TAVI, the optimal periprocedural imaging approach,
including 3D imaging with MDCT and 3D echocardiography, is still evolving [11, 191193]. Recently C-arm CT has also shown promise in this setting. The ability of this
modality to characterize and localize valve calcifications, identify coronary ostia, and
define relationships between coronary ostia and aortic leaflets may allow this technique
to complement traditional 2D projection images in the catheterization lab. However,
imaging protocols for this procedure have not been standardized. An imaging protocol
that is effective for intraprocedural application must produce good visualization of the
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aortic root with minimal contrast and reasonable radiation exposure, factors that are
affected by the timing and location of contrast injection (central versus peripheral
injection), acquisition protocol (ECG-gated versus ungated acquisition), and heart rate
during acquisition (normal sinus rhythm versus rapid gating).
In this study, we found that an ungated C-arm CT during rapid pacing with aortic
root injection could produce 3D “CT like” images with aortic root measurements similar
to those seen with MDCT while using approximately the same amount of contrast as is
used with conventional 2D root angiography [203]. This protocol could potentially
replace preprocedural CT scans in patients with impaired renal function, for whom an
imaging strategy with minimal contrast exposure is critical. Similar approaches have been
described for imaging of the pelvic arteries in this population [204].
The advantage of C-arm CT lies in its ability to perform 3D acquisition in the
catheterization laboratory and to integrate these 3D images directly with 2D fluoroscopic
images during TAVI, allowing for accurate definition of the aortic valve plane for
catheter guidance. Further, C-arm CT facilitated the registration of preprocedural 3D
MDCT images with 2D fluoroscopy images during TAVI allowing accurate definition of
the aortic valve plane for catheter guidance and precise placement of the valve in the
plane using the transfemoral approach without occluding coronary ostia. Finally, C-arm
CT images acquired post-TAVI allowed viewing of the prosthetic valve and
measurement of the diameters of the stent, STJ, and mid-AA as well as the vertical
distance of the stent from the left coronary ostia to ensure placement of the valve away
from coronary ostia. Alternatively, C-arm CT can also be registered with preprocedural
MDCT images, with critical structures marked to facilitate overlay of the MDCT images
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onto the real-time fluoroscopic images for procedural guidance; this technique has
recently been described in the context of TAVI [199]. Such an approach combines better
soft tissue characterization from MDCT with angiography images (Figure 10-5). C-arm
CT images acquired after TAVI may also allow clinicians to assess the prosthetic valve
and to measure the diameters of the stent, STJ, and mid-AA as well as the vertical
distance of the stent from the left coronary ostia to ensure placement of the valve away
from coronary ostia (Figure 10-6).

10.4.1 Limitations
Our study is limited by its small sample size. While a recent report in human
subjects used a contrast volume similar to the volume we used in Method 3 to obtain 3D
C-arm CT images of the aortic root geometry [170], the applicability of our results in
human subjects requires further evaluation. The swine examined in our study also did not
have aortic valve calcification, which is typically seen in human patients.
In our study ungated C-arm CT acquisitions with peripheral injection (Method 2)
did not provide diagnostic images, because the contrast bolus was missed during imaging.
One solution may be to use a test bolus (10-20 mL) before the ungated C-arm CT scan
and monitor the aortic root with low-dose fluoroscopy to estimate the transit time of
contrast. The main bolus of contrast could then be injected and an ungated C-arm CT
acquisition performed after the observed transit time. However, this would require an
additional amount of contrast and radiation dose for the test injection and fluoroscopic
scan.
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In current clinical practice, repeated fluoroscopy and TEE image acquisitions are
performed during the actual implantation of the valve in order to assure precise
positioning. We examined feasibility and optimal acquisition protocols for C-arm CT at
the time of the TAVI procedure, but prior to the actual implantation of the valve. C-arm
CT acquisition during valve deployment may not be feasible, mainly because repeated
imaging is limited by contrast and radiation exposure
Measuring the radiation exposure from C-arm CT is complex and only partially
understood. Therefore the radiation dose resulting from the ungated and ECG-gated Carm CT acquisitions in our study could not be described. Nevertheless, the radiation dose
for ungated C-arm CT should be lower than that for ECG-gated C-arm CT because of the
decreased scan time with ungated scan. Studies measuring the radiation dose for TAVI
procedures with and without ungated C-arm CT imaging are needed to demonstrate
whether the addition of these imaging procedures is justified by improved outcomes.

10.5

Conclusion
Ungated C-arm CT during rapid pacing with aortic root injection results in

sufficient aortic root enhancement for identification of the coronary ostia and
measurement of the aortic root diameters with a low contrast volume and minimal
artifacts. The 3D C-arm CT images allow valve plane evaluation and aortic root
measurements before TAVI, overlay of MDCT images onto 2D fluoroscopic images for
guidance of valve placement during TAVI, and assessment of valve positioning after
TAVI. These results, obtained in an animal model, provide guidance for future evaluation
in clinical scenarios.
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11.

CHAPTER XI

DOSE ASSESSMENT WITH C-ARM CT

C-arm is increasingly used to acquire 3D C-arm computed tomography (C-arm
CT) images for interventions in the cardiac catheterization lab. However, there is no
standard approach to estimate the resulting radiation dose. In this chapter, the
development of a methodology to obtain a C-arm CT dose metric to estimate the
radiation burden with 3D C-arm acquisition is explained.

11.1

Introduction
Recently, 3D C-arm computed tomography (CT) is increasingly used in the

cardiac catheterization laboratory to acquired 3D “CT like” images for procedural
guidance [171, 199, 205]. C-arm CT images are obtained by rotating interventional Carm systems mounted with flat panel detectors around the patient over a circular range of
greater than 180° [104, 171]. A series of 2D projection images are acquired during the
spin and 3D cone-beam algorithms are employed to reconstruct 3D images. The C-arm
CT images can be used directly or registered with multidetector row CT (MDCT) images
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to allow integration of 3D images with 2D real-time fluoroscopy images for procedural
guidance [121, 195, 199]. However, this additional procedure results in a cost of
increased radiation dose burden. Therefore, it is crucial to estimate dose to justify the
addition of C-arm CT imaging during interventional procedure.
As the C-arm systems are routinely used for 2D angiography, they are equipped
with dose-area product meters which estimate risk to skin exposure. Currently, these
scanners do not provide any metrics which estimates dose due to the 3D acquisition.
Standard CT dose index (CTDI100) obtained using a 150 mm length phantom and 100 mm
ionization chamber can be used as a dose descriptor.

CTDI100

1
=
Cz

+50mm

∫ D(z)dz

(11-1)

-50mm

where Cz is the collimation of the x-ray beam used. However, recent studies
showed that CTDI100 index may not be accurate for larger collimation MDCT scanners as
the maximum nominal beam width is greater than the length of the regular dose phantom
and standard integration length [172, 174, 176, 206, 207]. As C-arm CT systems have a
collimation of 200 mm at isocenter, the standard measuring equipment will underestimate
dose. It is also essential to estimate the necessary phantom and integration length in order
to measure dose integral profile from the enlarged beam. Kyriakou et al performed Monte
Carlo simulations and determined that phantoms and integration lengths of 600 mm or
greater are required to measure the entire dose profiles including scatter tails of the wide
beam to approximate CTDI within 1% [208]. However, the availability of such long
ionization chambers is limited. Hence, the purpose of the study is to determine sufficient
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phantom and integration length for C-arm CT imaging and develop a methodology to
obtain a metric for dose estimation in patients.

11.2

Materials and Methods

11.2.1 C-arm CT System
All phantom measurements were performed on a C-arm system (Axiom Artis,
Siemens Medical Solutions, Forchcheim, Germany) equipped with a 40 x 30 cm2 flat
panel detector. The system uses a fan angle of 19°, cone angle of 14.25°, angular rotation
of 200° and collimation of 200 mm in the z-direction to acquire images. Measurements
were performed by using automatic exposure control (AEC), which modulates x-ray
exposure according to detector entrance dose (DED) in two steps: first by increasing the
tube-current time product; second by increasing tube voltage in order to maintain the
noise levels as specified by the dose at the detector [103]. Dose measurements were
performed for two non-electrocardigram-gated (ungated) cardiac C-arm CT protocols
(Table 11.1).
Protocol
Parameters
5sDRUngated

5sDRC

Pulse width (ms)

5.0

12.5

Focus

Large

Small

Frames/s

60

30

Number of projections or frames

248

133

Table 11.1: X-ray imaging parameters used for ungated C-arm CT scan.
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11.2.2 Phantom Imaging
Polymethyl methacrylate (PMMA) phantoms with 470 mm lengths and 300 mm
diameter were used to make body measurements. The phantoms consist of five holes, one
center and four peripheral locations, with 1 cm diameter for inserting acrylic inserts. As
the C-arm system employs AEC, tube voltage may be modulated in each projection
during a 3D acquisition.

Figure 11-1: Schematic showing the center and periphery locations in a PMMA
phantom.

First, in order to obtain dose measurements at constant voltage, phantom
measurements were performed to find the highest possible system entrance dose required
to maintain constant tube voltage during the entire scan duration. Phantom measurements
were performed with different entrance dose values on a 470 mm body phantom at 90,
96, 102, 109, 117, 125 kVp, which are available to be set manually at the scanner. The
entrance dose detector was modified till constant tube voltage was seen in all the
projections throughout the scan, and the remaining phantom experiments were performed
using this value as DED setting.
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Second, dose profile measurements were performed with thermoluminscent
dosimeters (TLDs) placed in a customized holder of 300 mm length placed at center and
four periphery phantom locations in both the 320 and 470 mm phantoms. Dose profiles
were measured for every 1 mm for 70 mm at the center and for every 10 mm for the
remaining length using the two ungated C-arm CT protocols at 125 kVp. Dose profile
measurements were performed to examine dependence on the phantom length. Peak dose
values obtained from 320 mm phantom were normalized with those from 470 mm
phantom to examine the impact of phantom length of peak dose values.

Normalized Peak Dose =

Peak Dose 320
Peak Dose 470

(11-2)

Assuming phantom length of 900 mm and integration length of 300 mm are
required to include complete scatter radiation tails from the 200 mm collimation of C-arm
CT, a Savitzky-Golay filter was applied to the measured data and dose profiles were
simulated for phantom length of 900 mm. Dose was calculated as area under dose profile
curve (AUC) of 470 mm (AUC470-measured) and 900 mm (AUC900-simulated) phantoms and
the ratio was calculated as:

k=

AUC470−measured
AUC900−simulated

(11-3)

Phantom length of 470 mm and integration length of 300 mm were considered sufficient
if k≥95%.
Finally, dose profile integrals were measured using a 300 mm ionization chamber
(Dosimax plus A HV, IBA Dosimetry GmbH, Schwarzenbruck, Germany). Imaging was
performed with both the ungated C-arm CT protocols at the five locations of the 470 mm
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body phantom at constant peak tube voltages (90, 96, 102, 109, 117, 125 kVp) to
calculate CTDI300 (scaled per 100 mAs) at each voltage.

CTDI300

1
=
Cz

+150mm

∫ D(z)dz

(11-4)

-150mm

The central and peripheral CTDI300 values were used to calculate the weighted-CTDI
(CTDIw,300 scaled per 100 mAs, denoted as CTDIw henceforth) at all tube voltages. A
curve fit was applied to correlate CTDIw with tube voltage and correlation coefficient
(R2) was calculated.

1
2
CTDIw = CTDIc, 300 + CTDIp, 300
3
3

(11-5)

11.2.3 Patient Imaging
A total of 10 patient scans were performed using the ungated 5sDRC protocol
employing AEC for automatic tube current-time product and tube voltage modulation.
The DED dose was set to default value of 0.36 µG/pulse for patient scans. All scans were
performed to register preoperative 3D MDCT images with 2D fluoroscopic images for
navigating cardiovascular interventions. The power equation obtained from the dose
integral phantom scans was used to estimate CTDIw in these patients.

11.3

Results
Highest possible system entrance dose in order to maintain constant tube voltages

were obtained (Table 11.2). The remaining phantom scans were performed using these
entrance dose values for each tube voltage.
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Tube Voltage (kVp)

Highest entrance dose ( µG/pulse)

90

0.1

96

0.12

102

0.14

109

0.17

117

0.2

125

0.24

Table 11.2: Highest system entrance dose required to maintain corresponding tube
voltage constant during the C-arm CT acquisition.

TLD dose profiles from the 470 mm phantom were obtained at center and all the
periphery locations. Normalized peak dose values ranged from 0.97 to 0.99 indicating
that peak dose value decreased less than 4% when a 320 mm phantom was used to
perform dose measurements instead of a 470 mm phantom (Figure 11-2). Further, 3rd
degree fit of the Savitzky-Golay filter was applied for the measured data points and k
values of 98 % and 98 ± 2% were noted at center (Figure 11-3) and average of peripheral
(Figure 11-4) locations. Hence, phantom length of 470 mm and integration length of 300
mm were determined sufficient for measuring the scatter tails of 200 mm collimation of
C-arm system.
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Figure 11-2: Normalized Peak Dose as a function of phantom length at center and
periphery locations for the body phantom at 125 kVp. Peak dose did not vary by more
than 3% when phantom length was increased from 320 to 470 mm either at the center or
peripheral locations.

Figure 11-3: Longitudinal dose profiles using 300 mm TLDs in the body phantom at the
center. Dose profiles are measured using 470 mm phantom and simulated using 900 mm
phantom.
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Figure 11-4: Longitudinal dose profiles using 300 mm TLDs in the body phantom at the
periphery (average of four peripheral locations). Dose profiles are measured using 470
mm phantom and simulated using 900 mm phantom.

Dose profile integration values (CTDIw) were obtained for the ungated C-arm CT
protocols at different tube voltages (Table 11.3). Power equations correlating CTDIw and
tube voltage was obtained for both the ungated C-arm CT protocols with R2>0.998.

Tube Voltage (kVp)

CTDIw (mGy)
5sDRUngated

5sDRC

90

4.32

4.3

96

5.03

5.02

102

5.81

5.81

109

6.77

6.77

117

7.96

7.96

125

9.22

9.23

Table 11.3: CTDIw dose values measured at different tube voltages using 300 mm
ionization chamber and 470 mm body phantom.
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A total of 10 patient scans were imaged with the 5sDRC protocol with tube
voltages ranging from 75-125 kVp. Application of the power equation (Figure 11-4) to
patients yielded average CTDIw of 5.48 ± 2.02 mGy.

Figure 11-5: CTDIw values calculated from weighted average of center and periphery
locations for an ungated C-arm CT protocol. The power equation fit with correlation
coefficient R2=0.99 was used for calculating dose in patients.

11.4

Discussion
A procedure to obtain an appropriate C-arm CT dose metric in patients is required

to demonstrate whether the addition of C-arm CT imaging is justified during
interventional procedures. Using conventional 150 mm phantom and 100 mm integration
length to calculate standard CTDI100 underestimates dose for C-arm CT imaging due to
inability to measure the direct and scatter radiation from the 200 mm collimation [172,
174, 176, 206, 207]. An approach to estimate CTDI that can be used for C-arm CT
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imaging was developed in this study. Monte Carlo simulations were performed indicating
that 600 mm of phantom and integration length are required to capture 99% of dose from
scatter radiation [208]. However, phantom measurements supporting the observation
have not been performed. Moreover, as tube voltage is modulated during a C-arm CT
acquisition, care needs to be taken to estimate dose at constant tube voltage. Hence, the
detector entrance dose was modified in our study in order to maintain constant tube
voltage throughout the scan in our phantom experiments.
We also discuss the necessary phantom length and integration length for
estimating dose with C-arm CT. Although phantom and ionization chamber of 600 mm
length may be ideal, the availability of such phantoms and ionization chambers may be
challenging. Multiple phantoms of same diameter can be combined to simulate a larger
phantom; however a large chamber of 600 mm integration length is currently unavailable.
Hence we utilized the largest commercially existing ionization chamber of 300 mm in our
experiments.
The dose profile measurements showed that the peak radiation dose was
underestimated by <3 % with the use of a 320 mm phantom as compared to a 470 mm
phantom. This indicates that the peak radiation dose did not vary significantly either at
the center or periphery with change in phantom length. Hence, we assumed that peak
dose values may not vary drastically for a change in phantom length beyond 470 mm
phantom. Moreover, the area under curves of the dose profiles showed that 470 mm
phantom estimated 98% of the dose at center and periphery locations as compared to
simulated values from a 900 mm phantom. Hence, a phantom length of 470 mm and
integration length of 300 mm may be sufficient to measure dose with C-arm CT. These
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results are similar to the suggestions from Monte Carlo simulations showing that
phantoms and integration lengths > 350 mm estimate the CTDI within a range of 5% as
compared to CTDI measured with an infinite length of phantom and ionization chamber
[208].
Phantom studies were performed using the determined necessary lengths to
measure dose integral (CTDIw) at a given set of tube voltages. A correlation to compute
dose at any given tube voltage was developed and can be used to estimate radiation dose
burden in patients imaged with the ungated cardiac C-arm CT protocol during
interventional procedure. Dose estimates obtained for the C-arm CT protocol primarily
used for registration during intervention was low (5.48 ± 2.02 mGy).
Currently, effective dose (ED) is considered as the most appropriate quantity for
estimating the stochastic risk of exposure to ionizing radiation. Conversion factors to
estimate dose from the CTDI values exist for MDCT imaging. However, these factors
cannot be applied for C-arm CT imaging due to the partial rotation scanning resulting in
inhomogeneous dose distribution as compared to MDCT. Hence, conversion factors to
estimate ED are not yet available for C-arm CT.
Currently, the current use of CTDI is under discussion in the context of MDCT
imaging. An alternative approach using a small chamber at the center of the phantom and
scanning the entire length of phantom to measure dose profile integration or accumulated
dose at the center is being proposed [209]. As there is no table translation with C-arm CT,
this approach of measuring dose may not be feasible. C-arm CT imaging is similar to
MDCT imaging with a large cone beam for acquiring data without any table movement
[207]. A recent study by Lin et al employed a small solid state detector and moved it
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linearly using a step motor over a length of 810 mm to measure the dose profile [210]. In
these cases, a long ionization chamber as used in the current study can be used as an
alternative. Dose measurements with greater than 300 mm length may have limitations
for routine quality checks. Developing a methodology to estimate dose based on
measurements from readily available 150 mm long phantoms and 100 mm ionization
chambers may be pragmatic.
In conclusion, a 470 mm body phantom with 300 mm ionization chamber was
sufficient to measure C-arm CT dose and develop a power equation for estimating CTDIw
in patients based on applied tube voltage. Dose estimates for a C-arm CT protocol
primarily used for registration during intervention was low.
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12.

CHAPTER XII

DISCUSSION AND CONCLUSION

Minimally invasive cardiovascular surgeries refer to techniques that minimize
surgical trauma through smaller incisions as compared with a conventional sternotomy
procedure, where the sternum is divided to access the heart and lungs. Minimally
invasive cardiac surgeries represent a paradigm shift from traditional surgical techniques
and have evolved as a safe and efficient treatment option with increased patient comfort
and reduced complications [211, 212, 213]. Procedures ranging from coronary
interventions to intracardiac interventions and including valve repair/replacement, graft
placement, closure of leaks or defects are performed using smaller incisions with
transcatheter approaches [191]. The aim of this thesis was to develop contrast and scan
protocols for novel 3D x-ray based imaging techniques in the context of minimally
invasive surgical procedures to improve preprocedural anatomical assessment, procedural
guidance and postprocedural follow-up.
Transcatheter aortic valve implantation (TAVI) is a percutaneous valvular
intervention procedure, and is considered a safe alternative in patients who are denied
surgical valve replacement due to age, cardiovascular risk factors and comorbidities [41].
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The success of TAVI relies heavily on using imaging for patient selection as well as
visualization, guidance, and precise placement of valve during the procedure [214].
Typically, TAVI relies heavily on combined use of x-ray fluoroscopy with
transesophegal echocardiography (TEE) or intracardiac echocardiography (ICE) for
procedural guidance [60, 63, 191, 215]. However, these procedures display only a 2D
image and do not provide 3D visualization. Currently, this additional anatomical
information is obtained from preprocedural 3D MDCT images [10, 68, 216, 217]. 3D
preprocedural MDCT images are required to characterize and localize calcifications in
order to select appropriate patients for TAVI. It is also critical to understand the
relationship between the coronary ostia and the aortic leaflets to prevent coronary
occlusion. The 3D information routinely obtained from preprocedural MDCT has limited
use directly in the cardiac catheterization lab primarily due to registration challenges
between the 3D MDCT and 2D fluoroscopy images.
The modern C-arm fluoroscopy systems have the ability to acquire 3D “CT like”
images in the catheterization lab during the procedure. The C-arm CT images can then be
directly overlaid onto the real-time fluoroscopy images. Alternatively, 3D C-arm CT and
MDCT images can be fused to facilitate display of the high contrast MDCT images on
the 2D fluoroscopic images to facilitate catheter guidance and device positioning during
TAVI. It is critical to obtain C-arm CT with sufficient contrast and image quality to allow
overlay of either the C-arm CT or MDCT images.
Nolker et al [121] acquired C-arm CT images to compare crucial structures with
MDCT and overlay the left atrium and pulmonary veins onto an electroanatomic mapping
system for pulmonary vein isolation. Other studies have demonstrated the feasibility of
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evaluating aortic anatomy in patients before endovascular aneurysm repair (EVAR) [218]
and after EVAR to resolve endoleaks [122]. However, a systematic study exploring
different C-arm CT imaging techniques and injection protocols to acquire optimal images
for TAVI has not yet been performed.
As part of this thesis, feasibility of obtaining C-arm CT imaging in the context of
TAVI was evaluated in a swine model. Various contrast and imaging protocols were
systematically evaluated to obtain optimal scan and injection protocols for acquiring
sufficient C-arm CT images. Ungated C-arm CT images acquired during rapid pacing
with aortic root injection (36 mL contrast/44 mL saline mixture) were optimal for
evaluation and measurement pre-TAVI. These images were employed to assess anatomy
prior to placement of valve and resulted in measurements similar to those from currently
used clinical standard MDCT images. Based on this study, for situations where rapid
pacing cannot be performed, ungated C-arm CT imaging with aortic root injection during
native sinus rhythm may be appropriate. With the ungated protocol sufficient aortic root
enhancement was obtained using 50 mL of contrast, but moderate motion artifact was
present. Study results also demonstrated C-arm CT images facilitate the fusion of
preprocedural MDCT images with real-time 2D fluoroscopic images for intraprocedural
guidance. Finally, it was shown that C-arm CT images can be acquired post-TAVI to
evaluate the valve position and additionally provide diagnosis to avoid coronary
occlusion complications. Although the presence of leaks after the procedure was not
observed in this study, post-TAVI imaging may be useful for assessment of the location
of paravalvular leaks.
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The contrast and imaging protocols developed in the swine study may have to be
optimized for applications in patients. Nevertheless, a recent study by Kempfert et al
showed that small volumes of contrast may be sufficient even in patients to acquire Carm CT images [170]. The optimal C-arm CT images in the current study allowed precise
definition and measurement of aortic anatomy similar to MDCT. The 3D C-arm CT
images were fused with 3D preprocedural contrast-enhanced cardiac MDCT images for
guidance to improve safety and efficacy of the TAVI procedure itself. Although C-arm
CT images can be registered with the 2D fluoroscopy images, this approach was not
evaluated in the current study. Such image fusion may provide an opportunity to
minimize complications related to valve placement including coronary artery occlusion,
trauma to the anterior mitral leaflet or impingement of the conducting tissue due to
placement of valve within the left ventricular outflow tract. In addition, the overlay of 3D
images may be helpful to minimize use of multiple contrast injections and fluoroscopic
scans which are typically performed in order to define the valve plane for TAVI. This
may possibly reduce contrast dose and radiation exposure.
As C-arm CT is increasingly used in catheterization lab, there is a need to
understand the radiation dose required during image acquisition. Currently, there is a lack
of consensus regarding a C-arm CT dose metric. One option for dose estimation is the use
of the standard computed tomography dose index (CTDI) employed in MDCT imaging.
However, differences with C-arm CT acquisition as compared to MDCT including
modulation of tube voltage, larger z-coverage and partial scanning range demand a
different procedure for dose estimation from 3D C-arm CT. Imaging was performed at
constant tube voltage throughout the scan in phantom experiments by increasing detector
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entrance dose. The necessary phantom length and integration length for estimating dose
with C-arm CT scans was also discussed. Although phantom and ionization chamber of
600 mm length may be ideal [208], the availability of such phantoms and ionization
chambers is challenging. Although multiple phantoms of same diameter can be combined
to simulate a larger phantom; a large chamber of 600 mm integration length is currently
unavailable. Phantom measurements showed with a 300 mm integration length, peak
dose values from a 300 mm phantom were similar to those from a 470 mm phantom with
a maximum difference of 3%. Simulation results also showed that a 470 mm body
phantom with 300 mm ionization chamber was required to measure C-arm CT dose and
generate a power equation for estimating CTDIw in patients based on applied tube
voltage. Dose estimates for a C-arm CT protocol primarily used for registration during
intervention resulted in CTDIw of 5.48±2.02 mGy on average in patients. These values
indicate radiation burden from the additional C-arm CT scan was low. This approach
could be used estimate dose in the pig studies as well. However, the x-ray exposure
parameters used during C-arm CT pig studies were not recorded and hence, dose values
could not be estimated.
MDCT imaging is routinely performed for follow-up after minimally invasive
surgeries, such as endovascular aneurysm repair, a procedure for treating aortic aneurysm
by placing an endograft/stent. EVAR is associated with lower morbidity and mortality
rates than open surgical repair, along with reduced stay in the hospital after the procedure
[38]. After stent placement, triple-phase SECT is often used to monitor patients 1 month,
6 months, and yearly [13]. Combinations of the three phases, namely the pre-contrast
(non-contrast), contrast-enhanced (arterial) and post-contrast (venous) SECT images is

174

used to evaluate aneurysm size, stent-graft position and patency, perigraft flow
(endoleaks), graft fractures/kinks, and the patency of native vessels near the graft [2, 3,
12-14]. However, this repeated imaging is associated with increased radiation dose to the
patients.
An emerging approach to reduce radiation dose is the replacement of two SECT
acquisitions with a single DECT acquisition [18, 19]. DECT data obtained during or after
contrast agent injection can be used to create not only arterial or venous phase images,
respectively, but also virtual non-contrast (VNC) images [18, 19, 22, 24]. Previous
studies [18, 19] have acquired DECT data during the venous phase, but no studies to date
have evaluated the feasibility of arterial phase DECT acquisition. The presence of high
density iodinated contrast adjacent to other high density materials like stent or calcium
and, in many cases, the non-uniformity of contrast attenuation along the length of the
aorta make generation of VNC images from arterial DECT data more challenging.
An additional purpose of this work was to test the feasibility of obtaining VNC
images from arterial DECT images using a dual-source DECT scanner (Definition,
Siemens) and replacing routine non-contrast and arterial phase SECT images with VNC
and dual-energy arterial phase images obtained in one arterial DECT acquisition. The
results showed that both VNC and arterial phase images could be obtained from a single
arterial DECT acquisition rather than from two separate SECT acquisitions. The
attenuation of low-density tissues was similar on the dual-energy and standard SECT
images, but the attenuation values of high-density materials differed significantly.
Nevertheless, it was concluded that VNC and weighted-average arterial images from
DECT can replace true non-contrast and arterial phase SECT images, respectively, in the
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follow-up of patients who have undergone EVAR (except immediately after the
procedure) to provide comparable diagnostic information with an average dose savings of
31%. Arterial phase DECT imaging has utility not only for EVAR, but for other future
clinical applications. In the context of EVAR, arterial images are important for the
evaluation of luminal details, in particular smaller branch vessels. In other indications for
aortic imaging (aneurysm, dissection, aortitis, preoperative and postoperative evaluation),
arterial phase acquisition is the clinical standard. Reliable reconstruction of VNC images
from arterial DECT scans may yield information about tissue characteristics (e.g.,
intramural hematoma, surgical material, low-density calcium versus contrast medium)
and thus elimination of the true non-contrast acquisition can help to decrease radiation
dose burden in these patients.
However, the study of EVAR patients described above showed that due to
limitations of the three-material decomposition algorithm, calcium and iodine were not
discriminated well resulting in removal of calcium in the VNC images [183]. The current
implementation of the basis three-material decomposition algorithm assumes that each
voxel is composed of fat, soft tissue and iodine, and the attenuation of these materials is
solved to identify and eliminate contrast pixels during VNC generation. However, as
calcium is not considered as one of the three basis materials and due to the spectral
overlap between the two tube voltages (80 and 140 kVp), discrimination between contrast
material and calcium is challenging. The three material decomposition algorithm was
improved by assuming calcium, blood and contrast as the basis materials present in each
pixel and applying a combined basis spectral [77] and basis material analysis [79] to the
DECT images to differentiate the components of the mixture.
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Additionally, it was hypothesized that improving spectral separation between the
two tube voltages would help to better differentiate and quantify tissue with similar
atomic numbers like calcium and iodine with DECT. Recent study by Primak et al [142]
on a second generation dual-source CT scanner (Flash, Siemens) showed that additional
filtration decreased noise and increased contrast in images. Hence, we anticipated
improvement in VNC generation by applying an additional filter to the higher energy xray spectra using the latest dual-source DECT scanner.
Difficulties in the creation of VNC images from dual-energy data acquired with
first generation dual-source DECT were also attributed to non-uniform contrast
enhancement along the length of the aorta. To address this issue, patient-specific
modeling employing linear-time invariant concepts for optimizing contrast injection
protocols was developed. However, we observed that contrast agent optimization was not
required with the latest generation dual-source scanner (Flash, Siemens) as contrast
attenuation along the length of the aorta was uniform in patients. This is most likely a
result of shorter scan times with the latest scanner as compared to the previous generation
dual-source scanner (Definition, Siemens). On average, an approximately 34 s scan time
was required for DECT on the Siemens Definition CT scanner, while an average of 15 s
was required on the Siemens Flash. Hence, patient-specific injections were deemed
unnecessary with this new scanner.
The utility of added filtration to separate x-ray spectra and a combined basis
spectral and material decomposition algorithm were evaluated in phantoms. The phantom
data results showed the feasibility for differentiating calcium and contrast agent and
computing the mass fraction of contrast agent mixtures. It was determined that this
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method could be employed clinically for identification and removal of iodine in contrastenhanced DECT images to generate VNC images. Therefore, the potential benefit of the
improved spectral separation of low and high energies and a modified dual-energy image
processing algorithm, but not patient-specific injection were further investigated in
patients. One patient imaged was administered with a routine contrast injection protocol
and imaged with a DECT acquisition at 100 and 140 (with tin filter) kVp on the second
generation dual-source scanner and the resulting arterial images were analyzed using the
new VNC processing algorithm. The luminal attenuation measurements in VNC images
demonstrated adequate elimination of contrast agent.
In conclusion this project described the development of optimal imaging and
contrast protocols for C-arm CT in the context of TAVI to provide data complimentary to
preprocedural MDCT images and permit the registration of preprocedural images with
real-time 2D fluoroscopic images for safer valve implantation during procedure. In
addition, the feasibility of acquiring C-arm CT images post-TAVI to record valve
position and avoid complications was demonstrated. This work also described an
approach for estimating radiation dose with C-arm CT that allows direct comparison with
dose estimates for MDCT. The methodology was used to estimate dose in patients
imaged with C-arm CT primarily for purpose of image registration (3D MDCT with 2D
fluoroscopy images) during the intervention.
Additionally, novel DECT imaging techniques were developed to image postEVAR patients and generate virtual non-contrast images from DECT data. The results
showed that both VNC and arterial phase images could be obtained from a single arterial
DECT acquisition rather than from two separate SECT acquisitions and replace true non-
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contrast and arterial phase SECT images, respectively, with an average dose savings of
31%. Finally, a three-material decomposition algorithm based on combined basis spectral
and basis material analysis for differentiating calcium and contrast agent with DECT
imaging was developed which can be used clinically to identify and remove iodine in
contrast-enhanced DECT images to generate VNC images. However, pixels with high
atomic number but low density were falsely identified as iodine and appear with
decreased attenuation in VNC images.
The work presented in the dissertation has generated possible future
developments. In the context of preprocedural planning and intraprocedural guidance, the
feasibility of overlying the C-arm CT images directly for navigating minimally invasive
surgeries, thus eliminating need of a preprocedural MDCT needs to be explored.
Additionally, the accuracy of overlaying aortic root structures marked from 3D MDCT or
C-arm CT images onto 2D fluoroscopic images needs to be quantified to see the utility of
3D images for intraprocedural guidance. The rationale of using C-arm CT images in the
catheterization lab is to minimize 2D fluoroscopic acquisitions in patients. Hence,
obtaining dose measurements from the entire TAVI procedure with and without C-arm
CT imaging is required to understand whether the additional dose burden from C-arm CT
is reducing the dose by decreasing the number of 2D fluoroscopic acquisitions.
For post-procedural imaging, the proposed patient-specific contrast protocol
optimization was not required for second generation dual-source CT scanner. However,
the utility of employing patient-specific protocols can still be explored with other DECT
imaging techniques. Finally, the proposed combined basis spectral and basis material
algorithm showed that low density calcium is still present with low intensity in VNC
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images. One approach to minimize calcium loss in VNC images is to improve separation
between iodine and calcium by decreasing noise in DECT arterial images. This can be
possible by implementing the combined basis spectral and basis material algorithm in raw
space domain.
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APPENDICES

APPENDIX 1: Matlab code for calculating patient-specific contrast protocol
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
MAIN FUNCTION TO CALCUALTE PATIENT-SPECIFIC INJECTIONS
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
clear all
clc
global t c len test_time test_inj test_enh start_time_test_enh
stop_time_test_enh impulse_response scan_delay scan_duration target_enh
% ENTER WEIGHT and HEIGHT
wt_lbs=input('weight in lbs =');
ht_in=input('height in inches =');
wt_kg=0.4536*wt_lbs;
ht_m= 2.54*ht_in/100;
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% CALCULATE PATIENT PARAMETERS: WT, HT, BMI, BSA
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% CALCULATE BMI & BSA
BMI=wt_kg/ht_m^2;
BSA=(sqrt(wt_kg*ht_m*100))/60;
% BSA=0.1173*wt_kg^0.6466
% Input Baseline Attenuation (HU of blood) from Control Scan
base_enh=input('baseline attenuation from control scan (HU) =');
% Input Test Bolus Data from DynaEval text document.
% matrix = input('\n enter the test enhancement curve \n');
time=matrix(1:2:length(matrix));
enh = matrix(2:2:length(matrix));
time=round(time);
temp_enh=enh-base_enh;
for i = 1:length(temp_enh)
if temp_enh(i)<0
temp_enh(i)=0;
end
end
max_index=find(temp_enh==max(temp_enh));
min_index=find(temp_enh(1:max_index)==min(temp_enh(1:max_index)));
base_time=time(min_index(length(min_index)));
temp_time=time-base_time;
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rel_time=temp_time(min_index(length(min_index))+1:length(time));
rel_enh = temp_enh(min_index(length(min_index))+1:length(time));
t=rel_time;
c=rel_enh;
plot(t,c)
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%CALCULATE GAMMA FIT & CURVE CHARACTERISTICS: TPH, PH, MTT, RT, AUC, CO
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
v = [1 1 1];
ans = fminsearch(@functionforgammafit,v,optimset('TolX',1e20,'Display','off','MaxFunEvals',900));
k=ans(1);
a=ans(2);
b=ans(3);
for i = 1:length(t)
gam_enh(i)= k*((t(i))^a)*(exp(-t(i)/b));
end
fprintf('\n k=%3.4f \n a=%3.4f \n b=%3.4f \n',k,a,b);
figure(); subplot(2,1,1);plot(rel_time,rel_enh,'b*',t, gam_enh,'r-');
grid
legend('original curve', 'gamma fit');
xlabel('Time (sec)');
ylabel('Relative Enhancement (\Delta HU)');
I=find(rel_enh==max(rel_enh));
TPH=rel_time(I)+ base_time;
PH=k*(a*b/exp(1))^a;
MTT=b*(a+1);
AUC=k*(b^(a+1))*gamma(a+1);
RT=a*b;
result=[k a b TPH PH MTT AUC RT];
p = polyfit(rel_enh,gam_enh',1);
R = corrcoef(rel_enh,gam_enh');
r_sq=R(1,2)^2;
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
END OF GAMMA FIT
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% INTERPOLATE TEST BOLUS DATA FOR EVERY 1 SECOND
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
time=matrix(1:2:length(matrix));
enh = matrix(2:2:length(matrix));
xx=time(1):1:time(length(time));
yy=interp1(time,enh,xx);
plot(time,enh,'d',xx,yy);
time=matrix(:,1);
enh = matrix(:,2);
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time_start=time(1);
time_stop=round(time(length(time)));
xx=time_start:1:time_stop;
% yy=interp1(time,enh,xx);
yy1 = spline(time,enh,xx);
subplot(2,1,2);
plot(time,enh,'d',xx,yy1,'--');legend('original','spline')
xlabel('Time (sec)');
ylabel('Relative Enhancement (\Delta HU)');
plot(time,enh,'d',xx,yy,'*',xx,yy1,'--');
legend('original','interpol','spline')
%%%%%%%%%%% Input Test Injection Volume & Flow Rate %%%%%%%%%%%%
test_time=[0:1:60];
len=length(test_time);
test_inj_fr=input('\n test injection flow rate =');
test_inj_vol=input('\n test injection volume =');
%Calculate Cardiac Output
CO=25*r_sq*test_inj_vol/AUC*1000/60;
test_inj_dur=floor(test_inj_vol/test_inj_fr);
secondary_fr=rem(test_inj_vol,test_inj_fr);
test_inj_initial=[0 test_inj_fr*ones(1,test_inj_dur) secondary_fr];
test_inj=[test_inj_initial zeros(1,len-length(test_inj_initial))];
test_inj_vol_sum=trapz(test_time,test_inj);
fprintf('\n Contrast volume in test injection= % 2.0f ml
\n',test_inj_vol_sum)
start_time_test_enh=round(time(1));
stop_time_test_enh=round(time(length(time)));
test_enh_initial=[zeros(1,start_time_test_enh) yy1];
test_enh=[test_enh_initial zeros(1,len-length(test_enh_initial))];
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% CALCULATE IMPULSE RESPONSE AND EFFECTIVE TEST INJECTION
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% CONSTRAINS FOR FINDING IMPULSE RESPONSE:
%-------------------------- BOUNDARIES -------------------------------% 1) LOWER BOUNDARY: IMPULSE RESPONSE CANNOT BE NEGATIVE
%-------------------------- INEQUALITIES------------------------------% 2) IMPULSE RESPONSE FROM TIME=0 SEC TO 8 SEC IS ZERO
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
lb = [zeros(1,len)];
% Set lower bounds
ub = [];
% MAKE ALL IMPULSE RESPONSE LESS THAN T=8 SECONDS EQUAL TO ZERO
for i=1:9
Aeq(i,:)=[zeros(1,i-1) 1 zeros(1,len-i)];
end
beq=zeros(1,9)';
%%%%%%%%%%%%%%%% Initial Values for Impulse Response %%%%%%%%%%%%
imp_resp=[zeros(1,len)];
%--------SOLVER TO CACULATE IMPULSE FUNCTION ------------------------z = fmincon(@impulsefunction,imp_resp,[],[],Aeq,beq,lb,ub,[],...
optimset('MaxFunEvals',10000));
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impulse_response=z;
%-----------------------COMPUTE CONVOLVED TEST ENHANCEMENT------------k=1;
for j = 1:len
l=1;
for i = k:len
a(i,j)=test_inj(j)*impulse_response(l);
l=l+1;
end
k=k+1;
end
for i = 1:len
tot(i)=sum(a(i,:));
end
convolved_enh=tot';
figure();
subplot(2,1,1); plot(test_time,impulse_response,'r',test_time,test_enh,'b*',test_time,convolved_enh,'k--');title('Test
Enhancement');legend('impulse','measured','convolved');
subplot(2,1,2); plot(test_time,test_inj,'--');title('Test Injection');
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
END OF IMPULSE RESPONSE COMPUTATION
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
CALCULATE PAT-SP INJECTION
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% CONSTRAINS FOR FINDING PAT-SP INJECTION:
%-------------------------- BOUNDARIES -------------------------------% 1) LOWER BOUNDARY: FLOW RATES CANNOT BE NEGATIVE
% 2) UPPER BOUNDARY: FLOW RATES CANNOT BE GREATER THAN 5.5 ML/SEC
%-------------------------- INEQUALITIES------------------------------% 3) SUM OF TEST INJECTION >= 0
% 4) FLOW RATE OF INECTION (i+1) <= FLOW RATE OF INJECTION(i) (i.e.,
% MONOTONOUS DECREASING INJECTION
%-------------------------- EQUALITIES-------------------------------% 5) FLOW RATE OF TEST INJECTION AT TIME=0 SEC IS 0 ML/SEC
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
fprintf('Time to Peak = %2d sec
\n',test_time(find(max(test_enh)==test_enh)));
scan_delay=input('Enter the scan delay desired =');
scan_duration=input('Enter the scan duration =');
desired_enh=input('Enter the desired enhancement level =');
target_enh=desired_enh-base_enh;
lb1 = [zeros(1,len)];
% Set lower bounds
ub1 = [0 5.5*ones(1,len-1)];
% BOUNDARY CONDITIONS
Aeq1=[1 zeros(1,len-1)];
temp_ind=2;
for i=25:len
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Aeq1(temp_ind,:)=[zeros(1,i-1) 1 zeros(1,len-i)];
temp_ind=temp_ind+1;
end
beq1=zeros(1,1+length(25:len))';
temp_ind=1;
for i=2:25
A1(temp_ind,:)=[zeros(1,i-1) -1 1 zeros(1,len-(i+1))];
temp_ind=temp_ind+1;
end
b1=zeros(1,1+length(2:24))';
temp_time = scan_delay:1:scan_delay+scan_duration;
aa=1;
for i = scan_delay:1:scan_delay+scan_duration
target_enh_matrix(aa)=target_enh;
aa=aa+1;
end
initial_vals=[0 ones(1,test_inj_dur*10) zeros(1,len-1test_inj_dur*10)];
%--------SOLVER TO CACULATE PATIENT-SPECIFIC INJECTION----------------z1 =
fmincon(@patspinjfunction,initial_vals,A1,b1,Aeq1,beq1,lb1,ub1,[],optim
set('MaxFunEvals',10000,'TolFun',1e-20,'TolX',1e-20));
pat_sp_inj=z1;
% calculate the diagnostic enhancement using convolution of the patspecific injection and impulse response
k=1;
for j = 1:len
l=1;
for i = k:len
a1(i,j)=pat_sp_inj(j)*impulse_response(l);
l=l+1;
end
k=k+1;
end
for i = 1:len
tot1(i)=sum(a1(i,:));
end
diag_enh=tot1';
pat_sp_inj1=pat_sp_inj;
indices=find(pat_sp_inj1);
k=1;
for i=1:length(indices)
if (indices(length(indices)) > 25 || indices(1)>5)
fprintf('\n CHECK CHECK CHECK....the injection duration may be
extremely long OR the injection doesn \''t start early ?');
end
if pat_sp_inj1(indices(i))<=0.4
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pat_sp_inj1(indices(i))=0;
end
if abs(pat_sp_inj1(indices(i))-pat_sp_inj1(indices(i)-1)) <=0.6
pat_sp_inj1(indices(i))=pat_sp_inj1(indices(i)-1);
end
end
figure();
subplot(2,1,1); plot(temp_time,
target_enh_matrix,'*',test_time,diag_enh,'r--');title('Diagnostic
Enhancement');legend('target','predicted');
subplot(2,1,2); plot(test_time,pat_sp_inj,'-',test_time,pat_sp_inj1,'');title('Patient Specific Injection');legend('original','modified');
fprintf('\n \n------------------------------------------------------');
fprintf('\n Contrast volume in original patient-specific injection=
%3.0f ml
\n Contrast volume in modified patient-specific
injection= %3.0f ml \n',sum(pat_sp_inj),sum(pat_sp_inj1));
fprintf('--------------------------------------------------\n \n \n');
break_val=0;
pat_sp_inj_duration=find(pat_sp_inj1);
brk=1;
for i=1:pat_sp_inj_duration(length(pat_sp_inj_duration))
if pat_sp_inj1(i+1)~=pat_sp_inj1(i)
break_val(brk)=i+1;
brk=brk+1;
end
end
fprintf('|------------------------------------------------------|');
fprintf('\n|PATIENT-SPECIFIC PROTOCOL FROM LTI MODELING
|\n');
fprintf('|------------------------------------------------------|\n');
fprintf('| PHASE | FLOW RATE(ML/S) \t VOLUME (ML) \t DURATION(S) \n');
fprintf('|------------------------------------------------------|\n');
% Construct phases and volumes of injection
no_of_phases=length(break_val)-1;
for i=1:no_of_phases
phase_volume(i)=sum(pat_sp_inj1(break_val(i):break_val(i+1)-1));
phase_fr(i)=pat_sp_inj1(break_val(i));
phase_dur(i)=phase_volume(i)./phase_fr(i);
fprintf('|
%d\t\t
%2.1f \t\t\t\t\t %3.0f \t\t\t %3.0f \t\t
| \n',i, phase_fr(i),phase_volume(i),phase_dur(i));
end
fprintf('|-------------------------------------------------------|\n');
fprintf('| TOTAL
\t\t\t
\t\t\t\t %3.0f \t\t\t %3.0f \t
| \n',sum(pat_sp_inj1),sum(phase_dur));
fprintf('|---------------------------------------------------|\n\n\n');
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%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
FUNCTION 1: TO CALCUALTE GAMMA FIT
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
function e = functionforgammafit(v)
global t c
k = v(1);
a = v(2);
b = v(3);
for i = 1:length(c)
d(i)=k*((t(i))^a)*(exp(-t(i)/b));
end
for i=1:length(c)
diff(i)=(c(i)-d(i))^2;
end
e=sum(diff);

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
FUNCTION 2: TO CALCUALTE IMPULSE RESPONSE
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% THIS FUNCTION HELPS TO CALCULATE THE IMPULSE RESPONSE OF A PATIENT.
function e = impulsefunction(imp_resp)
global len test_time test_inj test_enh start_time_test_enh
stop_time_test_enh
% "INJ" IS THE DEFINITION OF TEST INJECTION FOR EVERY 1 SECOND.
% "C" IS THE DEFINITION OF THE MEASURED TEST ENHANCEMENT OBTAINED FOR
% EVERY 2 SECONDS.
% THE INITIAL VALUES OF THE IMPULSE ARE USED AND MODIFIED SUCH THAT THE
% DIFFERENCE BETWEEN CONVOLVED TEST ENHANCEMENT AND THE MEASURED TEST
% ENHANCEMENT IS ZERO.
imp=imp_resp;
k=1;
for j = 1:len
l=1;
for i = k:len
imp(l)>=0;
a(i,j)=test_inj(j)*imp(l);
l=l+1;
end
k=k+1;
end
for i = 1:len
tot(i)=sum(a(i,:));
end
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diff(1:len)=0;
for i = 1:len
diff(i)=(tot(i)-test_enh(i))^2;
end
e=sum(diff);
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
FUNCTION 3: TO CALCUALTE IMPULSE RESPONSE
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
function e = patspinjfunction(initial_vals)
global len scan_delay scan_duration target_enh impulse_response
test_time
patspinj=initial_vals;
k=1;
for j = 1:len
l=1;
for i = k:len
a(i,j)=patspinj(j)*impulse_response(l);
l=l+1;
end
k=k+1;
end
for i = 1:len
tot(i)=sum(a(i,:));
end
diff(1:len)=0;
for i = scan_delay+1:1:scan_delay+scan_duration+12
if (i>=scan_delay+1 && i<=scan_delay+scan_duration+1)
diff(i)=(tot(i)-target_enh)^2;
end
end
e=sum(diff);
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APPENDIX 2: Matlab code for generating VNC image using three-material
decomposition based on combined basis spectral and basis material approach.
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
Main Function to perform 3-material decomposition based on %
%
combined basis spectral and basis material approach
%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
clear all;
clc;
%%%%%%%%%%%%%%%%%%%%%%%%% Global Variables%%%%%%%%%%%%%%%%%%%%%%%%%
global i j c rho_100_value rho_140_value fn1_100 fn2_100 fn3_100
fn1_140 fn2_140 fn3_140 fn1_100 fn2_100 fn3_100 F_value_pass
mu_tiss_meas_100_pass mu_tiss_meas_140_pass mu_tiss_meas_100_pass
mu_tiss_meas_diff_pass
%%%%%%%%%%%%%%%%%%%%% Initializing Matrices
Z_matrix = zeros(512,512);
rho_100_matrix = zeros(512,512);
rho_140_matrix = zeros(512,512);
mass_frac_water = zeros(512,512);
mass_fract_HA = zeros(512,512);
mass_fract_UV = zeros(512,512);

%%%%%%%%%%%%%%%%%%%%%%

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Read f1, f2, and F values for different Z (F vs Z curve) %
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
file=dlmread('FvsZ_def.txt');
Z_temp=file(:,1);
f1_temp=file(:,2);
f2_temp=file(:,3);
F_temp=file(:,4);
len=length(F_temp);
%%%%%%%%%%%%%% Interpolate data for f1, f2 and F %%%%%%%%%%%%%%
Z = 0:.001:30;
f1 = spline(Z_temp,f1_temp,Z);
f2 = spline(Z_temp,f2_temp,Z);
F= (f1./f2);
plot(Z_temp,F_temp,'*',Z,F,'-');
F= round(F.*10^4);
%%%%%%%%%%%%%% Specify paths for the two DECT images %%%%%%%%%%%%%%
inputPath = ['C:\Documents and
Settings\numburu\Desktop\DUAL_ENERGY_FLASH\P27\'];
outputPath = ['C:\Documents and
Settings\numburu\Desktop\DUAL_ENERGY_FLASH\P27\VNC'];
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%%%%%%%%%%%%%% Specify number of images %%%%%%%%%%%%%%
total_images=input(‘ ’);
for imageNum = 1:total_images
%---------------------------------------------------------------------%
Read the Higher kV image:
%---------------------------------------------------------------------if (i>=1 && i<10)
inputFile = dir([inputPath 'P27.*.000' num2str(imageNum) '.*.IMA']);
elseif (i>=10 && i<100)
inputFile = dir([inputPath 'P27.*.00' num2str(imageNum) '.*.IMA']);
elseif (i>=100 && i<999)
inputFile = dir([inputPath 'P27.*. 0' num2str(imageNum) '.*.IMA']);
end
inputFileName = [inputPath inputFile.name];
info_140 = dicominfo(inputFileName);
X_140 = dicomread(info_140);
%---------------------------------------------------------------------%
Read the Lower kV image:
%---------------------------------------------------------------------if (i>=1 && i<10)
inputFile1 = dir([inputPath 'P27.*.000' num2str(imageNum) '.*.IMA']);
elseif (i>=10 && i<100)
inputFile1 = dir([inputPath 'P27.*.00' num2str(imageNum) '.*.IMA']);
elseif (i>=100 && i<999)
inputFile1 = dir([inputPath 'P27.*.0' num2str(imageNum) '.*.IMA']);
end
inputFileName1 = [inputPath inputFile1.name];
info_100 = dicominfo(inputFileName1);
X_100= dicomread(info_100);
%%%%%%%%%%% Calculate CT Number %%%%%%%%%%%
HU140=double(X_140)-1024;
HU100=double(X_100)-1024;
slope=(HU140-HU100)/(140-100);
intercept=(HU140-slope.*140);
%---------------------------------------------------------------------% APPLY MEDIAN FILTER FOR LOW AND HIGH ENERGY IMAGES
%---------------------------------------------------------------------HU_140=medfilt2(HU140,[3 3]);
HU_100=medfilt2(HU100,[3 3]);
%---------------------------------------------------------------------% LINEAR ATTENUATION COEFFICIENT OF WATER AT LOW AND HIGH ENERGY
%---------------------------------------------------------------------%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% For Flash: From summation of weighting function and NIST
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% database for water
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
mu_water_140=0.1783;
mu_water_100=0.2131;
%---------------------------------------------------------------------% CALCULATE LINEAR ATTENUATION COEFFICIENT OF IMAGES AT LOW AND HIGH %
%
ENERGY
%---------------------------------------------------------------------mu_tiss_meas_100=(1+HU_100/1000).*mu_water_100;
mu_tiss_meas_140=(1+HU_140/1000).*mu_water_140;
F_value=mu_tiss_meas_100./mu_tiss_meas_140;
%---------------------------------------------------------------------% OBTAINING HC AND HP MAPS FROM LOW AND HIGH ENERGY DATA
%---------------------------------------------------------------------%STEP 1: CALIBRATION
Hw1 = -1;
Hw2 = -1;
Ha1 = -975;
Ha2 = -907;
%STEP 2: MEASURE QUALITY FACTOR WITH 1% KI SOLUTION
Hmki1 = 167;
Hmki2 = 89;
Hki1 = abs(1000*(Hmki1-Hw1)/(Hw1-Ha1));
Hki2 = abs(1000*(Hmki2-Hw2)/(Hw2-Ha2));
% For 1% KI solution: Hkic=3; Hkip=2430
Hkic = 3;
Hkip = 2430;
% Q1 = 100*(Hki1 - Hkic)/(Hkip-Hki1);
% Q2 = 100*(Hki2 - Hkic)/(Hkip-Hki2);
Q1=0.12;
Q2=0.078;
% for segmentation
Hm1=HU_140;
Hm2=HU_100;
H1 = 1000.*(Hm1-Hw1)./(Hw1-Ha1);
H2 = 1000.*(Hm2-Hw2)./(Hw2-Ha2);
difference = H2-H1;
num1 = Q1*(1+Q2)/(Q2-Q1);
num2 = (1+Q1)/(Q2-Q1);
Hc1 = H1-difference*num1;
Hp1 = H2+difference*num2;
Hc = H1 - ((H2-H1).*(Q1*(1+Q2)/(Q2-Q1)));
Hp = H2 + ((H2-H1).*((1+Q1)/(Q2-Q1)));
figure();imshow(Hc,[]);pixval on; title('Hc Map');
figure();imshow(Hp,[]);pixval on; title('Hp Map');
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%---------------------------------------------------------------------% CALCULATING VARIOUS INDICES USING 100 AND 140 KVP IMAGES
%---------------------------------------------------------------------% DIFFERENCE BETWEEN 100 AND 140 KVP IMAGES
diff_img=HU_100-HU_140;
figure();imshow(diff_img);pixval on; title('Diff Image');
% DUAL ENERGY INDEX IMAGE FROM 100 AND 140 KVP IMAGES
num=imsubtract(HU_100,HU_140);
den=imadd(HU_100,HU_140);
DE_ind_img=imdivide(num,den);
figure();imshow(DE_ind_img);pixval on; title('DE_ind Image');
% DUAL ENERGY RATIO IMAGE FROM 100 AND 140 KVP IMAGES
DE_ratio=HU_100./HU_140;
figure();imshow(DE_ratio);pixval on; title('Ratio Image');
%---------------------------------------------------------------------% IDENTIFY HIGH DENSITY PIXELS USING (1)DIFF, (2) DUAL ENERGY INDEX,
% (3) DUAL ENERGY RATIO), (4) HC AND (5) HP INFO
%---------------------------------------------------------------------CF_im_pixels= ((diff_img > 50) & (DE_ind_img > 0) & (DE_ratio > 1.5) &
(Hc > 0) & (Hp < 0));
%---------------------------------------------------------------------% MARK HIGH DENSITY PIXELS IN LOW AND HIGH ENERGY IMAGES
%---------------------------------------------------------------------HU_100_1=CF_im_pixels.*HU_100;
HU_140_1=CF_im_pixels.*HU_140;
%---------------------------------------------------------------------% PERFORM DUAL ENERGY OPTIMIZATION FOR THE PIXELS.
%---------------------------------------------------------------------for i=1:512
for j=1:512
% PERFORM DE OPTIMIZATION ONLY FOR HIGH DENSITY PIXELS IN
if ((HU_100_1(i,j)> 0) && (HU_140_1(i,j)> 0))
F_temp=round(F_value(i,j)*10^4);
if (F_temp >= 11008 && F_temp <= 40856) % for FLASH
ind = find(F==F_temp);
while (isempty(ind))
F_temp = F_temp+1;
ind = find(F==F_temp);
end
% Find effective Z and rho values
Z_value=Z(ind(1));
rho_100_value=mu_tiss_meas_100(i,j)/f1(ind(1));
rho_140_value=mu_tiss_meas_140(i,j)/f2(ind(1));
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else
Z_value=0;
rho_100_value=0;
rho_140_value=0;
end
fprintf('Z= %2.3f, rho_100= %2.3f, rho_140= %2.3f \n', Z_value,
rho_100_value, rho_140_value);
% Values to be passed to the optimization function
F_value_pass=F_value(i,j);
mu_tiss_meas_100_pass=mu_tiss_meas_100(i,j);
mu_tiss_meas_140_pass=mu_tiss_meas_140(i,j);
%%%%%%%%%%%%%%%%%%%%%%%%%%%%% FIND MASS FRACTIONS%%%%%%%%%%%%%%%%%%
if Z_value<=0
c=0;
elseif Z_value<10
c=1;
elseif Z_value >= 10
c=1.45-(0.05*Z_value);
end
if (Z_value<=0)
Z_value=0;
rho_100_value=0;
rho_140_value=0;
sol(1)=0; sol(2)=0; sol(3)=0;
else
% fn=integral(w.(mu/rho))
%1-blood. 2- Ca. 3- Iodine
fn1_100=0.2541;
fn1_140=0.2060;
fn2_100=0.8476;
fn2_140=0.4461;
fn3_100=7.3119;
fn3_140=3.9724;

x0 = [0.1; 0.1; 0.1];
A=[-1 0 0
0 -1 0
0 0 -1];
b=[0
0
0];
Aeq=[1 1 1];
Beq=[1];

% Starting guess at the solution

% A*x<=B

% Aeq*x<=Beq

lb=0;
ub=1;
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options = optimset('TolFun',1e-20,'MaxFunEvals',10000);
sol = fminimax(@optim3,x0,A,b,Aeq,Beq,lb,ub,[],options);
end
fprintf('mass_fraction_water= %2.4f, mass_fraction_HA= %2.4f,
mass_fraction_I= %2.4f,\n', sol(1),sol(2),sol(3));
%---------------------------------------------------------------------% FOR THE PIXELS, SHOW: (1)Z MATRIX, (2) DENSITY AT LOW KVP
% 3) DENSITY AT HIGH KVP, AND MASS FRACTION OF:
% (4)WATER, (5) HYDROXYAPATITE, AND (6) IOPROMIDE
%---------------------------------------------------------------------Z_matrix (i,j)= Z_value;
rho_100_matrix(i,j) = rho_100_value;
rho_140_matrix(i,j) = rho_140_value;
mass_frac_water(i,j) = sol(1);
mass_fract_HA(i,j) = sol(2);
mass_fract_UV(i,j) = sol(3);
end
end
end
figure();imshow(rho_100_matrix,[]);pixval on; title('rho 100 matrix');
figure();imshow(rho_140_matrix,[]);pixval on;title('rho 140 matrix');
figure();imshow(Z_matrix,[]);pixval on;title('Z matrix');
figure();imshow(mass_frac_water,[]);pixval on;title('mass frac water');
figure();imshow(mass_fract_HA,[]);pixval on;title('mass fract HA');
figure();imshow(VNC_im,[]);pixval on;title('VNC');
figure();imshow(mass_fract_UV,[]);pixval on;title('mass fract UV');
%---------------------------------------------------------------------%
GENERATE VNC IMAGE
%---------------------------------------------------------------------bw=mass_fract_UV > 0; % Identify pixels which contain contrast
VNC=X_140; % Initialize VNC as 140 image
VNC=((HU_140-bw.*HU_140+mass_fract_UV.*HU_140)); % Create VNC image
figure();imshow(VNC,[]);pixval on;title('VNC');
VNC_im=medfilt2(VNC,[3 3]); % Filter VNC using a median filter
figure();imshow(VNC_im,[]);pixval on;title('VNC');
dicomwrite(VNC,'VNC_CT.117_approach3.dcm',info_140);
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%---------------------------------------------------------------------%
FUNCTION PERFORMING 3-MATERIAL DECOMPOSITION USING
%
NON-LINEAR OPTIMIZATION
%---------------------------------------------------------------------function e = optim3(x0)
global fn1_100 fn2_100 fn3_100 fn1_140 fn2_140 fn3_140 fn1_100
fn2_100 fn3_100 F_value_pass mu_tiss_meas_100_pass
mu_tiss_meas_140_pass mu_tiss_meas_100_pass % c rho_100_value
rho_140_value fn1_diff fn2_diff fn3_diff mu_tiss_meas_diff_pass
mf1=x0(1);
mf2=x0(2);
mf3=x0(3);
rho1=1.06;
rho2=3.2;
rho3=2.06;
% For Three Material decomposition
rho_eff=mf1*rho1+mf2*rho2+mf3*rho3;
mu_tiss_calc_100=rho_eff*(mf1*fn1_100 +
mf3*fn3_100);
mu_tiss_calc_140=rho_eff*(mf1*fn1_140 +
mf3*fn3_140);
mu_tiss_calc_100=rho_eff*(mf1*fn1_100 +
mf3*fn3_100);
F_value_calc= %2.4f \n', mf1, mf2, mf2,

mf2*fn2_100 +
mf2*fn2_140 +
mf2*fn2_100 +
F_value, F_value_calc);

% ERROR value
e=(1-sum_mf)^2+(mu_tiss_calc_100mu_tiss_meas_80_pass)^2+(mu_tiss_calc_140mu_tiss_meas_140_pass)^2+(mu_tiss_calc_100mu_tiss_meas_100_pass)^2;
end
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APPENDIX 3: Matlab code for interpolation using Savitzky-Golay filter
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
MAIN FUNCTION FOR ENTERING DATA AND APPLYING FILTER
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
global x y
x=[-145,-135,-125,-115,-105,-95,-85,-75,-65,-55,-45,-35,-26,-25,-24,23,-22,-21,-20,-19,-18,-17,-16,-15,-14,-13,-12,-11,-10,-9,-8,-7,-6,-5,4,-3,-2,1,0,1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,2
6,35,45,55,65,75,85,95,105,115,125,135,145]';

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
SAVITZKY-GOLAY (SG) FILTER
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
N = 3;
% Order of polynomial fit
F = 5;
% Window length
[b,g] = sgolay(N,F); % Calculate SG coefficients
HalfWin = ((F+1)/2) -1;
ind=1;
for n = (F+1)/2:length(x)-(F+1)/2,
x_val(ind)=x(n);
y_val(ind)=y(n);
dx(ind)=x(n)-x(n-1);
% Zero-th derivative (for smoothing the data)
SG0(ind) =
dot(g(:,1), y(n - HalfWin: n + HalfWin));
% 1st differential of the curve
SG1(ind) =
dot(g(:,2), y(n - HalfWin: n + HalfWin));
% 2nd differential of the curve
SG2(ind) = 2*dot(g(:,3)', y(n - HalfWin: n + HalfWin))';
ind=ind+1;
end
SG1_1 = SG1./dx;
% Convert 1st differential into 1st derivative
SG2_1 = SG2./(dx.*dx); % Convert 2nd differential into 2nd derivative
% Extrapolate SG curve fit data for 900 mm length
% For Left Side Extrapolation
ind=1;
for i=-125:-10:-450
al=SG0(2);
bl=SG1_1(2)/SG0(2);
y_left_extrap_temp(ind)=al*exp(bl*(i-x_val(2)));
ind=ind+1;
end
x_left_extrap_temp=[-125:-10:-450];
% Reverse the matrix from -450 to -125 instead of -125 to -450
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z=length(x_left_extrap_temp);
for i = 1:z
x_left_extrap(z)= x_left_extrap_temp(i);
y_left_extrap(z)= y_left_extrap_temp(i);
z=z-1;
end
% For Right Side Extrapolation
len=length(x_val)-1;
ind_2=1;
for i=115:10:450
ar=SG0(len);
br=SG1_1(len)/SG0(len);
y_rt_extrap(ind_2)=ar*exp(br*(i-x_val(len)));
ind_2=ind_2+1;
end
x_rt_extrap=[115:10:450];
% SG filter values
x_SG_filt=[x_left_extrap_temp(3) x_left_extrap_temp(2)
x_left_extrap_temp(1) x(2:71)' x_rt_extrap(1:4)];
y_SG_filt=[y_left_extrap_temp(3) y_left_extrap_temp(2)
y_left_extrap_temp(1) SG0(2:71) y_rt_extrap(1:4)];
% Compute errors
for i = 1:length(x)
err1(i)=(y(i)-y_SG_filt(i))^2;
end
SSE_SG=sum(err1);
RMSE_SG=sqrt(sum(err1)/length(y));
% Final Extrapolation Values for SG filter
x_SG_filt_extrap=[x_left_extrap x(4:73)' x_rt_extrap];
y_SG_filt_extrap=[y_left_extrap SG0(2:71) y_rt_extrap];
% Find AUC for the SG filter data
AUC_SG_extrap_300mm=trapz(x_SG_filt, y_SG_filt);
AUC_SG_extrap_900mm=trapz(x_SG_filt_extrap, y_SG_filt_extrap);
plot(x,y,'b.',x_SG_filt_extrap, y_SG_filt_extrap,'r*-');
axis([-300 300 0 1]);
grid
legend('original values', 'SG Filter 3rd degree interpolation');
xlabel('Longitudinal Distance (mm)');
ylabel('Relative Dose');
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APPENDIX 4: Modeling of Contrast Agent Injection For Coronary MDCT With
Short Scan Times Utilizing Test Bolus Data

A4.1

Introduction
The technology of multi-detector computed tomography (MDCT) has evolved

rapidly since its inception, resulting in continuous improvements in cardiac imaging.
State-of-the-art MDCT scanners with faster rotating gantries, increased numbers of
detector rows (1-3), or additional x-ray sources (4) allow imaging of the heart with very
short scan times (< 6 s). These technical advances have changed the paradigm of contrast
injection for cardiac imaging: optimization of contrast administration is becoming
increasingly important to insure adequate enhancement during imaging (5, 6).
These short scan times allow injection of lower contrast volumes for a short
duration, resulting in a narrow peak enhancement curve during the diagnostic scan. In
these situations, a low-volume test bolus is used for planning injection of the main
contrast bolus and data acquisition during peak enhancement (4). Currently, the only
information typically gathered from a test bolus is the time to peak maximal enhancement
(tPME) to compute the scan delay, despite the availability of much more data about an
individual patient’s response to contrast agent. Although a few modeling techniques have
customized diagnostic injection using patient-specific information obtained from a test
bolus and the resulting attenuation curve (7-9), these techniques were developed for an
earlier generation of scanners (1- and 16-slice scanners) with longer acquisition times.
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However, this type of patient-specific modeling should also allow for optimization of
contrast administration with the latest scanners, as well.
The use of a test bolus to either determine timing of a standard injection or to
develop a patient-specific injection relies on a correspondence between the bolus
geometries of a low-volume test bolus and a high-volume main bolus. However, studies
have demonstrated moderate (10) to no (11) correlation between the tPMEs for a test and
main bolus, indicating that there are differences between these boluses. This discrepancy
is attributed to faster dispersion of the low-volume test bolus in the venous system
compared with the high-volume main bolus, a difference that can be reduced with the
administration of saline immediately following the test bolus of contrast (12). Although a
saline chaser is routinely included with a test bolus, its impact on delivery of the small
contrast bolus has not been quantitatively evaluated.
The objectives of this study were two-fold. First, we sought to systematically
evaluate the impact of saline on contrast in a test bolus injection profile and the resulting
test enhancement curve characteristics, including the tPME. We then sought to determine
the average volume of contrast required for short scan time (6-, 4-, 2- and 1-s) cardiac
MDCT from patient-specific contrast injection protocols modeled using test bolus data.

A4.2

Materials and Methods
The local institutional review board approved this study. This study also complies

with the Health Insurance Portability and Accountability Act. A total of 25 patients who
were referred for contrast-enhanced cardiac MDCT were enrolled after they provided
informed consent. Patient age, sex, weight, and body mass index (BMI) were recorded.
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Image Acquisition
All examinations were performed with an MDCT scanner (Sensation 64; Siemens
Medical Solutions, Forchheim, Germany). Contrast agent (Ultravist 370; Berlex,
Montville, N.J.) was administered to each patient through an 18-gauge needle in the
antecubital vein with a dual power injector (Stellant D; Medrad Inc., Pittsburgh, Pa.) in
accordance with standard clinical practice at the time of the study.
A single low-dose image was obtained near the carina, and a circular region-ofinterest (ROI) was drawn in the ascending aorta (AA) to determine a baseline intensity
value (attenuation without contrast agent). This was followed by the administration of 2
test bolus injections: test injection A, which consisted of 20 mL of contrast injected at 4.5
mL/s, and test injection B, which consisted of 20 mL of contrast followed by 60 mL (for
patients weighing < 90 kg) or 80 mL (for patients weighing ≥ 90 kg) of saline
administered at 4.5 mL/s. The order of the test injections was randomized, and sufficient
time was allowed between injections to eliminate any potential bias resulting from
residual contrast from the previous injection. From 10 s through 44 s after each injection,
a test scan was performed every 2 s at the same level (near the carina), with scan
parameters as follows: number of images, 18; tube voltage, 120 kVp; and tube currenttime product, 40-60 mAs. The time-attenuation curves in the AA resulting from each test
bolus were measured using scanner software (Syngo; Siemens Healthcare) to determine
the tPME. The scan delay time (time between the start of contrast injection and the start
of the main/diagnostic scan) was defined as 3 s after tPME randomly obtained either from
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test injection A or B. Standard contrast and imaging protocols for the diagnostic scan
were then applied.

Data Analysis
Only data from the test injections and the test scans, not the main injection and scan,
were analyzed for the current study. Test bolus attenuation values (indicating
enhancement caused by contrast agent injection) were obtained by subtracting the
baseline intensity measured in the AA from the time-attenuation curves in the AA
resulting from the test injections.

A4.2.1 Test Bolus Contrast Injection
Applying tracer kinetics, the effective flow profile of contrast in the venous
system with the test injections can be estimated. Fleischmann et al (7) suggested that a
patient could be assumed as a linear time-invariant (LTI) system and arterial
enhancement (enh) could be modeled as the convolution integral of the contrast agent
flow rate (inj) and impulse response of the patient (response to a Dirac impulse input,

imp_resp)
t

enh(t) = ∫ imp_resp(τ ) • inj(t - τ ) • dτ

(1)

0

In the discrete domain, this can be approximated as
enh(n) = ∑ imp_resp(m ) • inj(n - m)
m

(2)

where m is the number of data points of the test bolus attenuation curve. For each patient
in this study, the two test bolus attenuation curves were used to estimate the effective
contrast profile (volumes and flow rates) of both test injections using customized
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software (Excel Solver; Microsoft Corporation, Redmond, Wash) (described in Section
7.2.2.1). The mean differences between the programmed and effective values of contrast
volume and flow rate, as well as 95% confidence intervals and Bland-Altman limits of
agreement (13), were calculated for both test injections.

A4.2.2 Test Bolus Attenuation Curve Characteristics
Various indices describing test bolus attenuation curves resulting from the test
injections were computed. A gamma-variate curve was fitted to each of the test bolus
attenuation curves to correct for recirculation of contrast agent; curve characteristics,
including peak of maximal enhancement (PME), area under the curve (AUC), mean
transit time (MTT), and rise time (RT), were computed from the gamma fit (14) using
customized software (Matlab; The Mathworks, Inc., Natick, Mass). All curve
characteristics including tPME were compared using paired Student t tests. The same
analysis was repeated for the heaviest patients (≥ 90 kg) exclusively. A P value ≤ .05
indicated statistical significance.

A4.2.3 Prediction of Contrast Injection for Short Scan Time Cardiac Imaging
Using test bolus data, we predicted patient-specific contrast injection profiles that
would achieve uniform enhancement in the heart during cardiac MDCT. Hypothesizing
that saline chase will impact tPME, scan delay was determined as 2 s + tPME from test
injection B in each patient. Further, a desired diagnostic enhancement of 300 HU in the
heart (15) was defined for a duration of 6 s after scan delay. Optimal patient-specific
contrast injection protocols were computed using the patient’s impulse response and the
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target diagnostic enhancement (explained in section 7.2.2.2). The total number of contrast
phases and volume and flow rate of contrast for each phase were determined for each
patient; average values for the 25 patients were reported. Similarly, patient-specific
injection profiles were computed to achieve 300 HU for 4-, 2-, and 1-s scan durations in
all of the patients using the aforementioned approach. Through the use of paired Student t
tests with Bonferroni adjustment, contrast volumes were compared between the 6- and 4s scan durations; the 4- and 2-s scan durations; and the 2- and 1-s scan durations. A P
value ≤ .05/3 (.017) indicated statistical significance.

A4.3

Results
All 25 patients (16 men, 9 women) received two test injections and a single

uniphasic diagnostic injection with no cases of extravasation. Patient information is
summarized in Table A4.1.

Patient Characteristic

Mean Value for Study Patients (N = 25)

Age (y)

59 (30-71)

Weight (kg)

96 (59-135)

Height (m)

1.77 (1.5-1.96)

Body mass index (kg/m2)

30.7 (20.3-44)

Note.Data are mean values, with range in parentheses.

Table A4.1: Patient Characteristics
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A4.3.1 Test Bolus Contrast Injection
The effective flow of contrast agent with test injections A and B were
successfully computed for all 25 patients. Results from a typical patient are shown in
Figure A4-1.

Figure A4-1: Effective flow profile of contrast agent injected with test injections A (20
mL contrast only) and B (20 mL contrast followed by saline) in 71-year-old man
weighing 74 kg. Use of 60 mL saline chaser resulted in injection of the entire 20 mL of
contrast at an effective rate of 4.5 mL/s; without saline, only 13 mL of contrast was
delivered at a rate of 2.4 mL/s.

The injector administered 20 mL of contrast at 4.5 mL/s for both test injections.
On average, however, only 13 mL of contrast was effectively delivered at 2.2 mL/s with
test injection A. With the use of saline after test injection B, the entire 20 mL of contrast
was injected at an effective rate of 4.4 mL/s. The mean difference, 95% confidence
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interval for the mean difference, and Bland-Altman limits of agreement for volume and
flow rate were smaller for test injection B than for test injection A (Table A4.2),
indicating that programmed values were closer to being realized when saline was used
after contrast agent in a test bolus.
Programmed Value

Effective
Value

Mean
Difference

95% CI

Limits of
Agreement

Average volume of contrast (mL)
Test injection A (20 mL
contrast)
Test injection B (20 mL contrast
followed by 60/80 mL saline)

13 ± 3

7.2 ± 3.4

5.8, 8.6

0.5, 13.9

20 ± 1

0.4 ± 1.3

0, 0.9

0, 2.9

20 ± 0

Average flow rate of contrast (mL/s)
Test injection A (20 mL
contrast)

2.2 ± 0.8

2.4 ± 0.8

2.0, 2.7

0.7, 4.0

4.5 ± 0

Test injection B (20 mL contrast
0, 0.1
0, 0.4
4.4 ± 0.2
0.0 ± 0.2
followed by 60/80 mL saline)
Note: Data are mean ± standard deviation for programmed, effective, and mean difference values.
CI indicates the 95% confidence intervals for mean difference. Limits of agreement are the
Bland-Altman limits, indicating that 95% of all individual differences in patients lie within these
limits.

Table A4.2: Impact of Saline on Contrast Volume and Flow Rate and Comparison with
Values Programmed in the Injector.

A4.3.2 Test Bolus Attenuation Curve Characteristics
Injection of a saline chaser after test injection B significantly decreased tPME
values in the AA (mean decrease, 1.7 s) for the entire group of patients compared with
patients who received test injection A (Table A4.3). In the subset of the 11 heavy patients
(weight, ≥ 90 kg), an 80-mL saline chaser reduced the average tPME by 2.7 s.
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Gamma fit was successfully computed for the two test enhancement curves in all
but one obese patient (BMI=42.6 kg/m2). In this patient, a gamma curve could not be
fitted to the enhancement curve resulting from test injection A, so this case was
eliminated from further analysis. Among the remaining 24 patients, test injection B
resulted in a significantly higher PME and AUC and a shorter MTT than test injection A
(Table A4.3). The same patterns were observed in the subset of heavy patients. Although
the average RT was reduced with test injection B for the entire group and in the subset of
heavy patients, the difference was only significant in the heavy group.

Curve
Characteristics

n

Test Injection A
-(20 mL
contrast)

Test Injection B (20 mL contrast
followed by 60/80 mL saline)

Mean
Difference

All patients
tPME (s)
PME (HU)
AUC (HU-s)
MTT (s)
RT (s)

25

21.1 ± 4.5

19.4 ± 3.5

–1.7*

24

67 ± 23

151 ± 27

84*

24

935 ± 567

1458 ± 378

523*

24

13.0 ± 14.8

10.4 ± 3.3

–2.6*

24

9.2 ± 6.9

8.6 ± 3.1

–0.5

Heavy patients (≥ 90 kg)
tPME (s)
PME (HU)
AUC (HU-s)
MTT (s)
RT (s)

11

21.3 ± 4.8

18.5 ± 2.5

–2.7*

10

61 ± 19

149 ± 25

88*

10

846 ± 381

1229 ± 303

383*

10

13.0 ± 6.0

9.0 ± 2.3

–4.0*

10

9.1 ± 3.2

7.5 ± 2.1

–1.6*
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Data are mean ± standard deviation. n indicates number of patients contributing to mean
values. Mean difference is the average difference in curve characteristics between test
injections A and B.
tPME = time to PME, PME = peak of maximal enhancement, AUC = area under the curve,
MTT = mean transit time, RT = rise time;
*
Significant difference at a P value ≤ .05 according to paired Student t test.

Table A4.3: Impact of Saline (60/80 mL) on Test Bolus Attenuation Curve
Characteristics in the Ascending Aorta.

A4.3.3 Prediction of Contrast Injection for Short Scan Time Cardiac Imaging
Contrast injection profiles required to achieve the target enhancement during a 6-s
(Figure A4-2), 4-s (Figure A4-3), 2-s (Figure A4-4), and 1-s (Figure A4-5) scan were
predicted for all 25 patients. All patient-specific contrast profiles could generally be
described as biphasic.
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Figure A4-2: Patient-specific contrast profiles predicted to achieve a constant attenuation
of 300 HU during a 6-s cardiac scan. Injections were computed for 25 patients from LTI
modeling.

Figure A4-3: Patient-specific contrast profiles predicted to achieve a constant attenuation
of 300 HU during a 4-s cardiac scan. Injections were computed for 25 patients from LTI
modeling.

236

Figure A4-4: Patient-specific contrast profiles predicted to achieve a constant attenuation
of 300 HU during a 2-s cardiac scan. Injections were computed for 25 patients from LTI
modeling.
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Figure A4-5: Patient-specific contrast profiles predicted to achieve a constant attenuation
of 300 HU during a 1-s cardiac scan. Injections were computed for 25 patients from LTI
modeling.

For a 6-s scan duration, an average volume of 23 mL injected at 4.9 mL/s for 5 s
was required for phase 1, followed by an average volume of 41 mL injected at 3.5 mL/s
for 12 s for phase 2 (Table A4.4). Therefore, a total volume of 64 mL of contrast injected
over 17 s may be appropriate for a 6-s scan. Reduction of the scan duration from 6 to 4, 2,
and 1 s resulted in a decrease of the average total contrast volume (from 64 to 55, 46, and
40 mL, respectively) and flow rate in both phase 1 (from 4.9 to 4.6, 4.3, and 4.1 mL/s,
respectively) and phase 2 (from 3.5 to 3.3, 2.8, and 2.0 mL/s, respectively), with an
increase in phase 1 injection duration (from 5 to 6, 8, and 8 s, respectively) and a
decrease in phase 2 injection duration (from 12 to 8, 4, and 3 s, respectively) (Table A4.4;
Figure A4-6 and A4-7).

Phase 1

Phase 2

Total

Volume (mL)

23

41

64

Duration (s)

5

12

17

Flow rate (mL/s)

4.9

3.5

–

Volume (mL)

29

26

55

Duration (s)

6

8

14

P value

6-s scan

–

4-s scan
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.005*

Flow rate (mL/s)

4.6

3.3

–

Volume (mL)

34

12

46

Duration (s)

8

4

12

Flow rate (mL/s)

4.3

2.8

–

Volume (mL)

34

6

40

Duration (s)

8

3

11

Flow rate (mL/s)

4.1

2.0

–

2-s scan
.002*

1-s scan
.05

Note. P values were obtained by comparing contrast volume from a 6-s and 4-s scan, a
4-s and 2-s scan, and a 2-s and 1-s scan using 2-sided paired t tests with Bonferroni
adjustment.
* Significant difference in volume at a P value ≤ .017.

Table A4.4: Average Contrast Injection Parameters for 6-, 4-, 2-, and 1-s Scan.

These differences are illustrated for 2 sample patients in Figure A4-8. The amount of
contrast required reached a plateau when the scan duration decreased below 2 s (Figure
A4-7 and A4-8).
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Figure A4-6: Biphasic contrast profiles obtained by averaging data from 25 patientspecific injection profiles for 6-, 4-, 2-, and 1-s cardiac scans.
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Figure A4-7: Average total contrast volumes computed from 25 patient-specific
injections. Contrast volumes of 64, 55, 46, and 40 mL were required for 6-, 4-, 2-, and 1-s
scans. Paired Student t tests with Bonferroni adjustments were used to compare average
contrast volumes for 6- and 4-s scans, 4- and 2-s scans, and 2- and 1-s scans ; a P value <
.017 indicated statistical significance. * and † indicate difference between contrast
volumes was statistically significant.

Figure A4-8: Total contrast volumes required in two sample patients for different scan
durations. For 6-, 4-, 2-, and 1-s cardiac scans, a 62-year-old man 122-kg man (−−•−−)
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required 94, 78, 64, and 63 mL of contrast, whereas a 67-year-old 85-kg man (−−♦−−)
required 58, 48, 36, and 35 mL of contrast, respectively.

A4.4

Discussion
Latest MDCT systems allow for very short acquisition times for cardiac imaging,

necessitating modification of the contrast administration routinely used with 16- and 64slice CT scanners. In our study, contrast protocols for achieving uniform enhancement
during 6-, 4-, 2-, and 1-s cardiac scans were predicted using LTI modeling. The protocols
were generally biphasic, using a total of approximately 64 mL of contrast at an initial
flow rate of 4.9 mL/s followed by 3.5 mL/s for a 6-s scan; while an average volume of 40
mL injected at a rate of 4.1 mL/s during phase 1 and 2.0 mL/s during phase 2 was
sufficient for a 1-s scan. Although our results suggest that contrast volume can be
reduced with decreasing scan time, they also indicate that a physiologic limit (16, 17) is
reached when the scan duration is less than 2 s. Hence, a minimum amount of
approximately 40 mL of high iodine concentration contrast agent (370 mgI/mL) is still
required to achieve adequate arterial enhancement, even for subsecond cardiac imaging.
These predicted average volumes are comparable to those currently used in
clinical protocols, which were determined largely through experience. Recent studies (14) employing fast scanners have used uniphasic contrast injections of 50 to 80 mL
administered at higher flow rates (5-6 mL/s) for coronary exams ranging from less than 1
s to 4 s. Typically uniphasic injections with decreasing volumes and increasing flow rates
are employed as scan times decrease, resulting in narrow peak enhancement curves with
increasing peak attenuation values.

Hence, uniphasic protocols may allow uniform
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enhancement during very short scan durations, but only when the main scan is timed
accurately during the narrow peak, avoiding the precipitous rise or fall of the
enhancement curve. However, the average biphasic injections predicted by our model
employ decreasing flow rates with increasing phase 1 and decreasing phase 2 injection
durations (Table 4) as scan times decrease, resulting in a broader peak enhancement with
constant attenuation values. With biphasic protocols, the contrast injected during phase 1
serves to achieve the target enhancement, while the contrast injected during phase 2
serves to maintain the enhancement.

Moreover, the total injection duration of the

modeled biphasic protocols (11-17 s) is consistent with recommendations for short
duration scanning (17).
In the short term, the average contrast profiles presented here could be used to
eliminate some of the guesswork in contrast administration for short-duration cardiac
imaging. In the longer term, incorporation of LTI modeling into the injector and/or
scanner platform could be useful for optimizing contrast load and arterial enhancement
for each patient.
Developing patient-specific contrast protocols with LTI modeling requires the
administration of a low-volume test bolus. In this study, we examined the impact of
administering a saline chaser after injection of the test bolus of contrast. A comparison of
data obtained with and without a saline chaser demonstrated that saline significantly
changes the effective flow of contrast and results in smaller differences between
programmed and effective contrast profiles. Saline also flushed contrast from the tubing
and peripheral veins into the central blood volume; this led to an increase in PH and
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AUC, which produced a better-defined test bolus attenuation curve with decreases in
tPME, MTT, and RT.
These results suggest that saline should be administered when test enhancement
data are used to model the main bolus geometry (7, 9), predict diagnostic enhancement
(18, 19), or estimate cardiac functional parameters (20, 21). However, when test
enhancement data are used simply to determine the appropriate onset of the main scan,
the use of saline may not be necessary for all patients. We observed a decrease in tPME
of 0.9 s with saline for patients weighing < 90 kg and a decrease in tPME of 2.7 s with
saline in patients weighing ≥ 90 kg. Because test data are typically acquired every 2 s,
differences in tPME less than 2 s will likely have no clinical impact. Therefore, our
results suggest that for CT imaging at higher flow rates, using a saline chaser is not
necessary in patients weighing less than 90 kg when the test injection data (tPME) is used
simply to determine the timing of data acquisition relative to injection of the main bolus.
This result differs slightly from the results of an early study examining contrast injection
with 16-slice cardiac CT, which described a decrease in tPME of approximately 4 s with
the injection of saline following a test bolus of contrast (22). These conflicting results
may be attributable to differences in flow rates between the two studies: a flow rate of 3
mL/s was used in the previous study, whereas a rate of 4.5 mL/s was used in our study.
Our study had some limitations. As lower contrast volumes are employed with
shorter scan durations, the 20-mL test bolus constitutes a larger fraction of the total
contrast dose administered to the patient. Decreasing the test bolus contrast volume to 10
or 5 mL may be feasible but was not examined here. Secondly, although our study
demonstrated that administering saline with a test bolus is critical for modeling in all
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patients and for timing in heavy patients, the amount of saline required was not
definitively established. Bae et al suggested that 20 to 30 mL of saline may be sufficient
to flush contrast into the central blood volume (17). However, results from Numburi et al
indicate that a saline chaser of 20 mL for patients weighing < 90 kg and 40 mL for
patients weighing ≥ 90 kg might not be adequate for modeling main bolus injections (9).
Studies by Mahnken et al (18) and Rist et al (19) found that the use of 50 mL of saline
with a test bolus could successfully predict diagnostic attenuation values in the great
vessels and left ventricle. Finally, although we performed LTI modeling to predict
patient-specific injections, the injections were not administered to patients, and so their
accuracy in achieving uniform enhancement was not evaluated. Nevertheless, previous
studies (8, 9) have suggested that administration of optimized injections will provide
uniform inter- and intraindividual enhancement.
In conclusion, administering saline after a low-volume test contrast bolus insures
attainment of the programmed injector values, enabling LTI modeling of optimized
contrast profiles for short-duration cardiac MDCT; contrast volumes of 64, 55, 46, and 40
mL were sufficient for 6-, 4-, 2-, and 1-s scans.
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